Stephen Y. Lai, M.D., Ph.D., FACS

Peer-Reviewed Articles

1. West, NA, Kamel, S, Wentzel, A, Kaffey, Z, Abdelaal, MA, Elisabeta Marai, G, Canahuate, GM, Zhang, X, Chen, MM, Wahid, K, Rigert, J, Brock, K, Chambers, MS, Otun, AO, Aponte Wesson, R, He, R, Naser, M, Hutcheson, KA, Mohamed, AS, van Dijk, L, Moreno, AC, Lai, SY, Fuller, C, Humbert-Vidan, L. Clinical and dosimetric dataset of time-to-event normal tissue complication probability for osteoradionecrosis. Scientific Data 13(1), 2026. e-Pub 2026. PMID: 41513675.
2. Michel, KA, Harlan, CJ, Walker, CM, Merrit, ME, Chen, Y, Lai, SY, Bankson, JA. Pharmacokinetic modeling strategies for dynamic hyperpolarized urea imaging. Magnetic resonance in medicine 95(3):1671-1683, 2026. e-Pub 2026. PMID: 41077903.
3. Chari, N, Chen, C, Ramasamy, T, Chen, X, Wadhwa, G, Paranjape, AN, Lai, SY, Villanueva, FS. Local Delivery of miR-27a* Using Ultrasound-Targeted Microbubble Cavitation Inhibits Squamous Cell Carcinoma Growth. Ultrasound in Medicine and Biology 52(2):462-469, 2026. e-Pub 2026. PMID: 41274844.
4. McMillan, H, Okoro, C, Buoy, S, Woodman, K, Anderson, N, Fuller, C, Lai, SY, Hutcheson, KA. Hypoglossal Neuropathy in the Pathogenesis of Fibrosis-Related Late-Radiation Associated Dysphagia. Head and Neck 48(2):438-448, 2026. e-Pub 2026. PMID: 40927950.
5. Frank, SJ, Busse, PM, Lee, JJ, Rosenthal, D, Hernandez, M, Swanson, DM, Garden, AS, Gunn, GB, Patel, SH, Snider, JW, Ma, DJ, Molitoris, JK, Lee, N, Parvathaneni, U, McDonald, MW, Kalman, NS, Lin, A, Mohammed, N, Henson, CE, Hyde, C, Bajaj, GK, Katz, SR, Dagan, R, Morrison, WH, Reddy, JP, Fuller, C, Shah, SJ, Phan, J, Chronowski, G, Mayo, LL, Sturgis, EM, Ferrarotto, R, Zhu, XR, Zhang, X, Wang, L, Hutcheson, KA, El-Naggar, AK, Moreno, AC, Lee, A, Spiotto, MT, Gross, N, Lai, SY, Liao, JJ, Paly, JJ, Liao, Z, Foote, RL, Bates, JE, Chambers, MS, Chun, SG, Kaiser, A, Lester, SC, Lukens, JN, McGee, LA, Neben-Wittich, MA, Nguyen, Q, Routman, DM, Schlembach, PJ, Skinner, H, Soike, MH, Rwigema, JM, Wiederhold, LR, Blanchard, P, Choi, I, Koong, A, Langendijk, H, Mohan, R, Carlson, BJ, Mapps, A, Sarmiento, JG, Teferra, MY, Bosch, WR, Followill, DS, Taylor, PA, Fuentes, SY, Ning, M, Toumazis, I, Wogan, CF, De Gracia, B, Fink, K, Grippin, A, Ma, J, Pettersen, EA, Sareyeldin, RM, Cronin, C, Muise, S, Johnson, M, Pyfferoen, K, Tranby, BN, Leonard, J, Watkin, S, Eggleston, C, Barrow, B, Wolcott, J, Antonio, J, Brand, J, Cleverdon, A, Drake, M, Peters, E, Small, C, Clark, K, Holder, R. Proton versus photon radiotherapy for patients with oropharyngeal cancer in the USA. The Lancet 407(10524):174-184, 2026. e-Pub 2026. PMID: 41391462.
6. Yadollahi, P, McCord, KA, Li, Y, Dayoub, H, Saab, K, Essien, FN, Hyslop, ST, Kan, E, Ahmed, KM, Kirby, PR, Putluri, V, Ambati, CR, Kami Reddy, KR, Castro, PD, Skinner, H, Coarfa, C, Decker, WK, Osman, AA, Patel, R, Myers, JN, Lai, SY, Putluri, N, Johnson, FM, Frederick, MJ, Hudson, WH, Sandulache, VC. Bypassing cisplatin resistance in Nrf2 hyperactivated head and neck cancer through effective PI3Kinase targeting. British journal of cancer 133(12):1802-1814, 2025. e-Pub 2025. PMID: 41053162.
7. Li, Y, Yadollahi, P, Essien, FN, Putluri, V, Ambati, CR, Kami Reddy, KR, Kamal, AM, Putluri, N, Abdurrahman, L, Ruiz Echartea, ME, Ernste, KJ, Trivedi, AJ, Vazquez-Perez, J, Hudson, WH, Decker, WK, Patel, R, Osman, AA, Kheradmand, F, Lai, SY, Myers, JN, Skinner, H, Coarfa, C, Lee, K, Jain, A, Malovannaya, A, Frederick, MJ, Sandulache, VC. Tobacco smoke exposure is a driver of altered oxidative stress response and immunity in head and neck cancer. Journal of translational medicine 23(1), 2025. e-Pub 2025. PMID: 40188338.
8. Moreno, AC, Sahli, A, Johnson, FM, Sun, X, Barbon, CE, Rinsurongkawong, W, Song, W, Luciani, FM, Liang, H, Li, J, Liu, W, Lee, JJ, Frank, SJ, Lai, SY, Fuller, C, Hutcheson, KA, Fuller, C, Lee, J, Frank, S, Mohamed, AS, Peterson, CB, McMillan, H, Ma, J, Brock, K, Wang, L, Chambers, MS, Williams, MD, Naser, M, He, R, Shete, S, Zhang, X, Whinsenant, M. Stiefel MD Anderson OroPharynx cancer (MDA-OPC) cohort. BMJ open 15(11), 2025. e-Pub 2025. PMID: 41290309.
9. Reber, B, He, R, Abdelaal, MR, Mohamed, AS, Mulder, SL, Humbert-Vidan, L, Fuller, C, Lai, SY, Brock, K. Post-RT Head and Neck DCE-MRI. Cancers 17(19), 2025. e-Pub 2025. PMID: 41097750.
10. Brewer Savannah KJ, Lai SY, Fuller CD, Brock KK. From Imaging to Impact: A Multi-Disciplinary T32 Program Framework and Initial Insights for Training in Image-Guided Cancer Therapy. Advances in Cancer Education and Quality Improvement 1(2), 2025. e-Pub 2025.
11. Michel KA, Harlan CJ, Walker CM, Merritt ME, Chen Y, Lai SY, Bankson JA. Pharmacokinetic modeling strategies for dynamic hyperpolarized urea imaging. Magn Reson Med:1-13. e-Pub 2025.
12. Kamel, S, Humbert-Vidan, L, Kaffey, Z, Mirbahaeddin, S, Abusaif, A, Fuentes, DA, Wahid, K, Dede, C, Naser, M, He, R, Moawad, AW, Elsayes, KM, Chen, MM, Otun, AO, Rigert, J, Chambers, MS, Hope, A, Watson, E, Brock, K, Hutcheson, KA, van Dijk, L, Moreno, AC, Lai, SY, Fuller, C, Mohamed, AS. Computed tomography radiomics-based cross-sectional detection of mandibular osteoradionecrosis in head and neck cancer survivors. Oral Oncology 167, 2025. e-Pub 2025. PMID: 40516152.
13. Kaffey, Z, Mirbahaeddin, S, Wahid, K, Kamel, S, Vouffo, M, Otun, AO, Belal, Z, Aponte Wesson, R, Carriere, P, Dede, C, Maniakas, A, Goepfert, RP, Garden, AS, Lee, A, Choi, KY, Christensen, JM, Lincoln, C, Manzar, G, Dudzinski, SO, Thomas, R, Mehrens, H, Cardoso, R, Schellingerhout, D, Watson, E, Chen, MM, Lai, SY, Fuller, C, Moreno, AC, Humbert-Vidan, L. Radiographic classification of mandibular osteoradionecrosis. Radiotherapy and Oncology 208, 2025. e-Pub 2025. PMID: 40320174.
14. Humbert-Vidan, L, Castelo, A, He, R, van Dijk, L, Rhee, DJ, Wang, C, Wang, H, Wahid, K, Joshi, S, Gerafian, P, West, NA, Kaffey, Z, Mirbahaeddin, S, Curiel, J, Acharya, S, Shekha, A, Oderinde, P, Ali, AS, Hope, A, Watson, E, Wesson-Aponte, R, Frank, SJ, Barbon, CE, Brock, K, Chambers, MS, Walji, M, Hutcheson, KA, Lai, SY, Fuller, C, Naser, M, Moreno, AC. Image-based mandibular and maxillary parcellation and annotation using computed tomography (IMPACT). Physics and Imaging in Radiation Oncology 35, 2025. e-Pub 2025. PMID: 40894269.
15. Humbert-Vidan, L, Kamel, S, Wentzel, A, Kaffey, Z, Abdelaal, MA, Spier, KB, West, NA, Marai, EG, Canahuate, GM, Zhang, X, Chen, MM, Wahid, K, Rigert, J, Hosseinian, S, Schaefer, AJ, Brock, K, Chambers, MS, Otun, AO, Aponte Wesson, R, Patel, V, Hope, A, Phan, J, Garden, AS, Frank, SJ, Morrison, WH, Spiotto, MT, Rosenthal, D, Lee, A, He, R, Naser, M, Watson, E, Hutcheson, KA, Mohamed, AS, Sandulache, VC, van Dijk, L, Moreno, AC, Guerrero Urbano, T, Fuller, C, Lai, SY. Externally validated digital decision support tool for time-to-osteoradionecrosis risk-stratification using right-censored multi-institutional observational cohorts. Radiotherapy and Oncology 207, 2025. e-Pub 2025. PMID: 40222595.
16. Mao, S, Wang, J, McMillan, H, Mohamed, AS, Buoy, S, Ahmed, S, Mulder, SL, Naser, M, He, R, Wahid, K, Chen, MM, Ding, Y, Moreno, AC, Lai, SY, Fuller, C, Hutcheson, KA. Exploring Quantitative MRI Biomarkers of Head and Neck Post-Radiation Lymphedema and Fibrosis. Head and Neck 47(5):1487-1496, 2025. e-Pub 2025. PMID: 39794912.
17. West, NA, Attia, S, Kaffey, Z, Dede, C, Mulder, SL, El-Habashy, D, Neuberger, R, Naser, M, Frank, SJ, Mao, S, McMillan, H, Smith, BG, Rosenthal, D, Lai, SY, Hutcheson, KA, Moreno, AC, Fuller, C. Evaluating observer reliability and diagnostic accuracy of CT-LEFAT criteria for post-treatment head and neck lymphedema. Oral Oncology 164, 2025. e-Pub 2025. PMID: 40174310.
18. Cabanillas, ME, Akhave, NS, Banuchi, VE, Busaidy, NL, Dadu, R, Ferrarotto, R, Gunn, GB, Hamidi, S, Hofmann, M, Hosseini, SM, Iyer, PC, Lai, SY, Lee, A, Maniakas, A, Ning, M, Spiotto, MT, Wang, RJ, Williams, MD, Zafereo, M. Reimagining the Therapeutic Approach for Anaplastic Thyroid Cancer. Thyroid 35(5):462-470, 2025. e-Pub 2025. PMID: 40388579.
19. McMillan, H, Warneke, C, Buoy, S, Porsche, C, Savage, K, Lai, SY, Fuller, C, Hutcheson, KA. Manual Therapy for Fibrosis-Related Late Effect Dysphagia in Head and Neck Cancer Survivors. JAMA Otolaryngology - Head and Neck Surgery 151(4):319-327, 2025. e-Pub 2025. PMID: 39913160.
20. Hosseinian, S, Suarez-Aguirre, D, Dede, C, Garcia, R, McCullum, L, Hemmati, M, Karagoz, A, Mohamed, AS, Lai, SY, Hutcheson, KA, Moreno, AC, Brock, K, Nosrat, F, Fuller, C, Schaefer, AJ. Cost-effectiveness of personalized policies for implementing organ-at-risk sparing adaptive radiation therapy in head and neck cancer. Physics and Imaging in Radiation Oncology 34, 2025. e-Pub 2025. PMID: 40584456.
21. Sahin O, Kamel S, Wahid KA, Dede C, Taku N, He R, Naser MA, Sharafi CS, Makitie A, Kann BH, Kaski K, Sahlsten J, Jaskari J, Amit M, Chronowski GM, Diaz EM Jr, Garden AS, Goepfert RP, Guenette JP, Gunn GB, Hirvonen J, Hoebers F, Hutcheson KA, Guha-Thakurta N, Johnson J, Kaya D, Khanpara SD, Nyman K, Lai SY, Lango M, Learned KO, Lee A, Lewis CM, Maniakas A, Moreno AC, Myers JN, Phan J, Pytynia KB, Rosenthal DI, Sandulache VC, Schellingerhout D, Shah SJ, Sikora AG, Mohamed ASR, Chen MM, Fuller CD. International multispecialty expert physician preoperative identification of extranodal extension in patients with oropharyngeal cancer using computed tomography: Prospective blinded human inter-observer performance evaluation. Cancer 131(7):e35815, 2025. e-Pub 2025. PMID: 40159431.
22. Moreno AC, Watson EE, Humbert-Vidan L, Peterson DE, van Dijk LV, Urbano TG, Bosch LVD, Hope AJ, Katz MS, Hoebers FJP, Wesson RAA, Bates JE, Bossi P, Dayo AF, Dore M, Fregnani ER, Galloway TJ, Gelblum DY, Hanna IA, Henson CE, Kiat-Amnuay S, Korfage A, Lee NY, Lewis CM, Lynggaard CD, Makitie AA, Magalhaes M, Mowery YM, Munoz-Montplet C, Myers JN, Orlandi E, Patel J, Rigert JM, Saunders D, Schoenfeld JD, Selek U, Somay E, Takiar V, Thariat J, Verduijn GM, Villa A, West NS, Witjes MJH, Won AM, Wong ME, Yao CMKL, Young SW, Al-Eryani K, Barbon CEA, Buurman DJM, Dieleman FJ, Hofstede TM, Khan AA, Otun AO, Robinson JC, Hum L, Johansen J, Lalla R, Lin A, Patel V, Shaw RJ, Chambers MS, Ma D, Singh M, Yarom N, Mohamed ASR, Hutcheson KA, Lai SY, Fuller CD. International Expert-Based Consensus Definition, Classification Criteria, and Minimum Data Elements for Osteoradionecrosis of the Jaw: An Interdisciplinary Modified Delphi Study. Int J Radiat Oncol Biol Phys, 2025. e-Pub 2025. PMID: 39826846.
23. Vargas, L, Langlie, J, McGee, C, Ma, R, Perdigon, O, Lai, SY, Chepeha, DB, Civantos, F. Cross-Cultural Adaptation and Translation of the Neck Dissection Impairment Index (NDII) into Spanish. CANAD. J. OTOLARYNGOL 54:19160216251321457, 2025. e-Pub 2025. PMID: 40071635.
24. Stricker, E, Peckham-Gregory, EC, Lai, SY, Sandulache, VC, Scheurer, ME. Targeted Variant Assessments of Human Endogenous Retroviral Regions in Whole Genome Sequencing Data Reveal Retroviral Variants Associated with Papillary Thyroid Cancer. Microorganisms 12(12), 2024. e-Pub 2024. PMID: 39770638.
25. El-Habashy, D, Wahid, K, He, R, McDonald, B, Mulder, SL, Ding, Y, Salzillo, TC, Lai, SY, Christodouleas, JP, Dresner, A, Wang, J, Naser, M, Fuller, C, Mohamed, AS. Dataset of weekly intra-treatment diffusion weighted imaging in head and neck cancer patients treated with MR-Linac. Scientific Data 11(1), 2024. e-Pub 2024. PMID: 38734679.
26. Stricker E, Peckham-Gregory EC, Lai SY, Sandulache VC, Scheurer ME. Targeted Variant Assessments of Human Endogenous Retroviral Regions in Whole Genome Sequencing Data Reveal Retroviral Variants Associated with Papillary Thyroid Cancer. Microorganisms 12(12):2435, 2024. e-Pub 2024.
27. Hamidi S, Dadu R, Zafereo ME, Ferrarotto R, Wang JR, Maniakas A, Gunn GB, Lee A, Spiotto MT, Iyer PC, Sousa LG, Akhave NS, Ahmed S, Learned KO, Lu C, Lai SY, Williams M, Hosseini SM, Busaidy NL, Cabanillas ME. Initial Management of BRAF V600E-Variant Anaplastic Thyroid Cancer: The FAST Multidisciplinary Group Consensus Statement. JAMA Oncol 10(9):1264-1271, 2024. e-Pub 2024. PMID: 38990526.
28. Sehl OC, Guo K, Mohtasebzadeh AR, Kim P, Fellows B, Weyhmiller M, Goodwill PW, Wintermark M, Lai SY, Foster PJ, Greve JM. Magnetic particle imaging enables nonradioactive quantitative sentinel lymph node identification: feasibility proof in murine models. Radiol Adv 1(3):umae024, 2024. e-Pub 2024. PMID: 39574515.
29. Hosseinian S, Hemmati M, Dede C, Salzillo TC, van Dijk LV, Mohamed ASR, Lai SY, Schaefer AJ, Fuller CD. Cluster-Based Toxicity Estimation of Osteoradionecrosis Via Unsupervised Machine Learning: Moving Beyond Single Dose-Parameter Normal Tissue Complication Probability by Using Whole Dose-Volume Histograms for Cohort Risk Stratification. Int J Radiat Oncol Biol Phys 119(5):1569-1578, 2024. e-Pub 2024. PMID: 38462018.
30. Wang JR, Zafereo ME, Cabanillas ME, Wu CC, Xu L, Dai Y, Wang W, Lai SY, Henderson Y, Erasmus L, Williams MD, Joshu C, Ray D. The association between thyroid differentiation score and survival outcomes in papillary thyroid carcinoma. J Clin Endocrinol Metab, 2024. e-Pub 2024. PMID: 39087944.
31. Schilling, C, Sahovaler, A, Lai, SY. Sentinel Node Biopsy in Oral Cancer-Indications, Analysis, and Outcomes. JAMA Otolaryngology - Head and Neck Surgery 150(7):634, 2024. e-Pub 2024. PMID: 38842844.
32. Lai, SY, Sandulache, VC, Schellingerhout, D, Fuller, C, Chen, Y, Walker, CM, Bankson, JA. First-in-Human Hyperpolarized MRI for Tumor Metabolism in HNSCC. JAMA Otolaryngology - Head and Neck Surgery 150(7):628-630, 2024. e-Pub 2024. PMID: 38780963.
33. Anderson BJ, Moreno AC, Qing Y, Lee JJ, Johnson FM, Lango MN, Barbon CEA, Tripuraneni L, Sahli A, Piper V, Gross N, Fuller CD, Lai SY, Myers JN, Hutcheson KA. Revisiting Feeding Tube Utilization in Oropharynx Cancer: 6-Year Prospective Registry Analysis. Otolaryngol Head Neck Surg 170(5):1319-1330, 2024. e-Pub 2024. PMID: 38353360.
34. Hansen NJ, Woodman K, Buoy S, Mao S, Barbon CEA, Lai SY, Fuller CD, Hutcheson KA, Sanchez B. Tongue electrical impedance myography correlates with functional, neurophysiologic, and clinical outcome measures in long-term oropharyngeal cancer survivors with and without hypoglossal neuropathy: An exploratory study. Head Neck 46(3):581-591, 2024. e-Pub 2024. PMID: 38133080.
35. Zeng PYF, Prokopec SD, Lai SY, Pinto N, Chan-Seng-Yue MA, Clifton-Bligh R, Williams MD, Howlett CJ, Plantinga P, Cecchini MJ, Lam AK, Siddiqui I, Wang J, Sun RX, Watson JD, Korah R, Carling T, Agrawal N, Cipriani N, Ball D, Nelkin B, Rooper LM, Bishop JA, Garnis C, Berean K, Nicolson NG, Weinberger P, Henderson YC, Lalansingh CM, Tian M, Yamaguchi TN, Livingstone J, Salcedo A, Patel K, Vizeacoumar F, Datti A, Xi L, Nikiforov YE, Smallridge R, Copland JA, Marlow LA, Hyrcza MD, Delbridge L, Sidhu S, Sywak M, Robinson B, Fung K, Ghasemi F, Kwan K, MacNeil SD, Mendez A, Palma DA, Khan MI, Shaikh M, Ruicci KM, Wehrli B, Winquist E, Yoo J, Mymryk JS, Rocco JW, Wheeler D, Scherer S, Giordano TJ, Barrett JW, Faquin WC, Gill AJ, Clayman G, Boutros PC, Nichols AC. The genomic and evolutionary landscapes of anaplastic thyroid carcinoma. Cell Rep 43(3):113826. e-Pub 2024. PMID: 38412093.
36. Khoury, M, Guertin, W, Hao, C, Saltychev, M, Ayad, T, Bissada, E, Christopoulos, A, Moubayed, SP, Olivier, MJ, Chepeha, DB, Lai, SY, Maniakas, A. Canadian French Translation and Validation of the Neck Dissection Impairment Index. Journal of Otolaryngology - Head and Neck Surgery 53, 2024. e-Pub 2024. PMID: 38899627.
37. Sandulache VC, Kirby RP, Lai SY. Moving from conventional to adaptive risk stratification for oropharyngeal cancer. Front Oncol 14:1287010, 2024. e-Pub 2024. PMID: 38549938.
38. Turner N, Hamidi S, Ouni R, Rico R, Henderson YC, Puche M, Alekseev S, Colunga-Minutti JG, Zafereo ME, Lai SY, Kim ST, Cabanillas ME, Nurieva R. Emerging therapeutic options for follicular-derived thyroid cancer in the era of immunotherapy. Front Immunol 15:1369780, 2024. e-Pub 2024. PMID: 38868771.
39. Choi, KY, Hao, Q, Carlisle, K, Hollenbeak, CS, Lai, SY. Cost-Effectiveness of [99mTc]Tilmanocept Relative to [99mTc]Sulfur Colloid for Sentinel Lymph Node Biopsy in Early Stage Oral Cavity Cancer. Annals of surgical oncology 30(12):7689-7698, 2023. e-Pub 2023. PMID: 37556007.
40. Choi KY, Hao Q, Carlisle K, Hollenbeak CS, Lai SY. Cost-Effectiveness of [99mTc]Tilmanocept Relative to [99mTc]Sulfur Colloid for Sentinel Lymph Node Biopsy in Early Stage Oral Cavity Cancer. Ann Surg Oncol 30(12):7689-7698, 2023. e-Pub 2023. PMID: 37556007.
41. Tanco K, Olson A, Fellman B, Jankowski M, Lai SY, Shete S, Harbison K, Scheid J, Bruera E. Analysis of Dispensing and Utilization Patterns of Medical Cannabis Products in State Licensed Cannabis Dispensaries. J Palliat Med 26(11):1482-1487, 2023. e-Pub 2023. PMID: 37285183.
42. Joint Head and Neck Radiation Therapy-MRI Development Cooperative, MR-Linac Consortium Head and Neck Tumor Site Group, El-Habashy DM, Wahid KA, He R, McDonald B, Rigert J, Mulder SJ, Lim TY, Wang X, Yang J, Ding Y, Naser MA, Ng SP, Bahig H, Salzillo TC, Preston KE, Abobakr M, Shehata MA, Elkhouly EA, Alagizy HA, Hegazy AH, Mohammadseid M, Terhaard C, Philippens M, Rosenthal DI, Wang J, Lai SY, Dresner A, Christodouleas JC, Radwan Mohamed AS, Fuller CD. Longitudinal diffusion and volumetric kinetics of head and neck cancer magnetic resonance on a 1.5?T MR-linear accelerator hybrid system: A prospective R-IDEAL stage 2a imaging biomarker characterization/pre-qualification study. Clin Transl Radiat Oncol 42:100666, 2023. e-Pub 2023. PMID: 37583808.
43. Reber B, Van Dijk L, Anderson B, Mohamed ASR, Fuller C, Lai S, Brock K. Comparison of Machine-Learning and Deep-Learning Methods for the Prediction of Osteoradionecrosis Resulting From Head and Neck Cancer Radiation Therapy. Adv Radiat Oncol 8(4):101163, 2023. e-Pub 2023. PMID: 36798732.
44. Mohamad I, Glaun MDE, Prabhash K, Busheri A, Lai SY, Noronha V, Hosni A. Current Treatment Strategies and Risk Stratification for Oral Carcinoma. Am Soc Clin Oncol Educ Book 43:e389810, 2023. e-Pub 2023. PMID: 37200591.
45. Lu L, Wang JR, Henderson YC, Bai S, Yang J, Hu M, Shiau CK, Pan TY, Yan Y, Tran TM, Li J, Kieser R, Zhao X, Wang J, Nurieva R, Williams MD, Cabanillas ME, Dadu R, Busaidy N, Zafereo M, Navin N, Lai SY, Gao R. Anaplastic transformation in thyroid cancer revealed by single cell transcriptomics. J Clin Invest. e-Pub 2023. PMID: 37053016.
46. Yu W, Chen Y, Putluri N, Osman A, Coarfa C, Putluri V, Kamal AHM, Asmussen JK, Katsonis P, Myers JN, Lai SY, Lu W, Stephan CC, Powell RT, Johnson FM, Skinner HD, Kazi J, Ahmed KM, Hu L, Threet A, Meyer MD, Bankson JA, Wang T, Davis J, Parker KR, Harris MA, Baek ML, Echeverria GV, Qi X, Wang J, Frederick AI, Walsh AJ, Lichtarge O, Frederick MJ, Sandulache VC. Evolution of cisplatin resistance through coordinated metabolic reprogramming of the cellular reductive state. Br J Cancer. e-Pub 2023. PMID: 37012319.
47. Donohoe KJ, Carroll BJ, Chung DKV, Dibble EH, Diego E, Giammarile F, Grant FD, Lai SY, Linden H, Miller ME, Pandit-Taskar N, Tawa NE, Vidal-Sicart S. Summary: Appropriate Use Criteria for Lymphoscintigraphy in Sentinel Node Mapping and Lymphedema/Lipedema. J Nucl Med 64(4):525-528, 2023. e-Pub 2023. PMID: 36958856.
48. Zhao X, Wang JR, Dadu R, Busaidy NL, Xu L, Learned KO, Chasen NN, Vu T, Maniakas A, Eguia AA, Diersing J, Gross ND, Goepfert R, Lai SY, Hofmann MC, Ferrarotto R, Lu C, Gunn GB, Spiotto MT, Subbiah V, Williams MD, Cabanillas ME, Zafereo ME. Surgery After BRAF-Directed Therapy Is Associated with Improved Survival in BRAFV600E Mutant Anaplastic Thyroid Cancer: A Single-Center Retrospective Cohort Study. Thyroid 33(4):484-491, 2023. e-Pub 2023. PMID: 36762947.
49. S R Mohamed A, Abusaif A, He R, Wahid K, Salama V, Youssef S, McDonald BA, Naser M, Ding Y, Salzillo TC, AboBakr MA, Wang J, Lai SY, Fuller CD. Prospective validation of diffusion-weighted MRI as a biomarker of tumor response and oncologic outcomes in head and neck cancer: Results from an observational biomarker pre-qualification study. Radiother Oncol:109641. e-Pub 2023. PMID: 36990394.
50. Wilde DC, Kansara S, Banner L, Morlen R, Hernandez D, Huang AT, Mai W, Fuller CD, Lai S, Sandulache VC. Early detection of mandible osteoradionecrosis risk in a high comorbidity veteran population. Am J Otolaryngol 44(2):103781, 2023. e-Pub 2023. PMID: 36640532.
51. Yao CMK, Jozaghi Y, Danker S, Karami R, Asaad M, Lai SY, Hanna EY, Esmaeli B, Gidley PW, Chang EI. The combined profunda artery perforator-gracilis flap for immediate facial reanimation and resurfacing of the radical parotidectomy defect. Microsurgery. e-Pub 2022. PMID: 36541252.
52. Naser MA, Wahid KA, Ahmed S, Salama V, Dede C, Edwards BW, Lin R, McDonald B, Salzillo TC, He R, Ding Y, Abdelaal MA, Thill D, O'Connell N, Willcut V, Christodouleas JP, Lai SY, Fuller CD, Mohamed ASR. Quality assurance assessment of intra-acquisition diffusion-weighted and T2-weighted magnetic resonance imaging registration and contour propagation for head and neck cancer radiotherapy. Med Phys. e-Pub 2022. PMID: 36519973.
53. Chen YH, Cabanillas M, Sperling J, Xu L, Goswami M, Maniakas A, Williams MD, Lai SY, Busaidy N, Dadu R, Zafereo ME, Wang JR. Prior thyroid and non-thyroid cancer history do not significantly alter overall survival in patients diagnosed with anaplastic thyroid carcinoma. Thyroid. e-Pub 2022. PMID: 36511380.
54. Contrera KJ, Gule-Monroe M, Hu MI, Cabanillas M, Busaidy N, Dadu R, Waguespack SG, Wang JR, Maniakas A, Lai SY, Diersing J, Kwon M, Grubbs EG, Subbiah V, Williams MD, Zafereo ME. Neoadjuvant Selective RET Inhibitor for Medullary Thyroid Cancer: A Case Series. Thyroid. e-Pub 2022. PMID: 36503246.
55. Hofmann MC, Kunnimalaiyaan M, Wang JR, Busaidy NL, Sherman SI, Lai SY, Zafereo M, Cabanillas ME. Molecular mechanisms of resistance to kinase inhibitors and redifferentiation in thyroid cancers. Endocr Relat Cancer 29(11):R173-R190, 2022. e-Pub 2022. PMID: 35975971.
56. Hemmati M, Barbon C, Mohamed ASR, van Dijk LV, Moreno AC, Gross ND, Goepfert RP, Lai SY, Hutcheson KA, Schaefer AJ, Fuller CD, Head MD, Working Group NCS. Optimized decision support for selection of transoral robotic surgery or (chemo)radiation therapy based on posttreatment swallowing toxicity. Cancer Med. e-Pub 2022. PMID: 36229990.
57. Jang SS, Davis ME, Vera DR, Lai SY, Guo TW. Role of sentinel lymph node biopsy for oral squamous cell carcinoma: Current evidence and future challenges. Head Neck. e-Pub 2022. PMID: 36193862.
58. Barbon CEA, Peterson CB, Moreno AC, Lai SY, Reddy JP, Sahli A, Martino R, Johnson FM, Fuller CD, Hutcheson KA. Adhering to Eat and Exercise Status During Radiotherapy for Oropharyngeal Cancer for Prevention and Mitigation of Radiotherapy-Associated Dysphagia. JAMA Otolaryngol Head Neck Surg 148(10):956-964, 2022. e-Pub 2022. PMID: 36074459.
59. McGurk M, Chegini S, Schilling C, Lai SY. What is the optimum operative approach for the N0 neck in patients with early mouth cancer - a review of current status. Br J Oral Maxillofac Surg 60(7):864-867, 2022. e-Pub 2022. PMID: 35843759.
60. Wang JR, Montierth M, Xu L, Goswami M, Zhao X, Cote G, Wang W, Iyer P, Dadu R, Busaidy NL, Lai SY, Gross ND, Ferrarotto R, Lu C, Gunn GB, Williams MD, Routbort M, Zafereo ME, Cabanillas ME. Impact of Somatic Mutations on Survival Outcomes in Patients With Anaplastic Thyroid Carcinoma. JCO Precis Oncol 6:e2100504, 2022. e-Pub 2022. PMID: 35977347.
61. Contrera KJ, Huang AT, Shenson JA, Tang C, Roberts D, Myers JN, Weber RS, Lai SY, Williams M, El-Hallal M, Jacob D, Zafereo M. Primary and recurrent regional metastases for lateralized oral cavity squamous cell carcinoma. Surg Oncol 44:101804. e-Pub 2022. PMID: 35932620.
62. Aggarwal P, Nader ME, Gidley PW, Pratihar R, Jivani S, Garden AS, Mott FE, Goepfert RP, Ogboe CW, Charles C, Fuller CD, Lai SY, Gunn GB, Sturgis EM, Hanna EY, Hutcheson KA, Shete S. Association of hearing loss and tinnitus symptoms with health-related quality of life among long-term oropharyngeal cancer survivors. Cancer Med. e-Pub 2022. PMID: 35695117.
63. Glas HH, Kraeima J, Tribius S, Leusink FKJ, Rendenbach C, Heiland M, Stromberger C, Rashad A, Fuller CD, Mohamed ASR, Lai SY, Witjes MJH. Three-Dimensional Evaluation of Isodose Radiation Volumes in Cases of Severe Mandibular Osteoradionecrosis for the Prediction of Recurrence after Segmental Resection. J Pers Med 12(5), 2022. e-Pub 2022. PMID: 35629256.
64. Aggarwal P, Hutcheson KA, Yu R, Wang J, Fuller CD, Garden AS, Goepfert RP, Rigert J, Mott FE, Lu C, Lai SY, Gunn GB, Chambers MS, Li G, Wu CC, Hanna EY, Sturgis EM, Shete S. Genetic susceptibility to patient-reported xerostomia among long-term oropharyngeal cancer survivors. Sci Rep 12(1):6662, 2022. e-Pub 2022. PMID: 35459784.
65. Taku N, Chronowski G, Gunn GB, Morrison WH, Gross ND, Moreno AC, Ferrarotto R, Frank SJ, Fuller CD, Goepfert RP, Phan J, Lai SY, Reddy JP, Rosenthal DI, Garden AS. Unilateral Radiotherapy for Tonsillar Cancer: Treatment Outcomes in the Era of Human Papilloma Virus (HPV), Positron-emission Tomography (PET) and Intensity-modulated Radiation Therapy (IMRT). Int J Radiat Oncol Biol Phys. e-Pub 2022. PMID: 35504500.
66. Contrera KJ, Chinn SB, Weber RS, Roberts D, Myers JN, Lai SY, Lewis CM, Hessel AC, Gillenwater AM, Mulcahy CF, Yu P, Hanasono MM, Fuller CD, Chambers MS, Zafereo ME. Outcomes after definitive surgery for mandibular osteoradionecrosis. Head Neck. e-Pub 2022. PMID: 35238096.
67. Mitcham TM, Nevozhay D, Chen Y, Nguyen LD, Pinton GF, Lai SY, Sokolov KV, Bouchard RR. Effect of perfluorocarbon composition on activation of phase-changing ultrasound contrast agents. Med Phys. e-Pub 2022. PMID: 35195908.
68. Aggarwal P, Hutcheson KA, Goepfert RP, Garden AS, Garg N, Mott FE, Fuller CD, Lai SY, Gunn GB, Chambers MS, Hanna EY, Sturgis EM, Shete S. Risk factors associated with patient-reported fatigue among long-term oropharyngeal carcinoma survivors. Head Neck. e-Pub 2022. PMID: 35084077.
69. Wahid KA, Ahmed S, He R, van Dijk LV, Teuwen J, McDonald BA, Salama V, Mohamed ASR, Salzillo T, Dede C, Taku N, Lai SY, Fuller CD, Naser MA. Evaluation of deep learning-based multiparametric MRI oropharyngeal primary tumor auto-segmentation and investigation of input channel effects: Results from a prospective imaging registry. Clin Transl Radiat Oncol 32:6-14, 2022. e-Pub 2022. PMID: 34765748.
70. Salzillo TC, Taku N, Wahid KA, McDonald BA, Wang J, van Dijk LV, Rigert JM, Mohamed ASR, Wang J, Lai SY, Fuller CD. Advances in Imaging for HPV-Related Oropharyngeal Cancer: Applications to Radiation Oncology. Semin Radiat Oncol 31(4):371-388, 2021. e-Pub 2021. PMID: 34455992.
71. Wahid KA, He R, McDonald BA, Anderson BM, Salzillo T, Mulder S, Wang J, Sharafi CS, McCoy LA, Naser MA, Ahmed S, Sanders KL, Mohamed ASR, Ding Y, Wang J, Hutcheson K, Lai SY, Fuller CD, van Dijk LV. Intensity standardization methods in magnetic resonance imaging of head and neck cancer. Phys Imaging Radiat Oncol 20:88-93, 2021. e-Pub 2021. PMID: 34849414.
72. Hutcheson, KA, McMillan, H, Warneke, C, Porsche, C, Savage, K, Buoy, S, Wang, J, Woodman, K, Lai, SY, Fuller, C. Manual Therapy for Fibrosis-Related Late Effect Dysphagia in head and neck cancer survivors. BMJ open 11(8), 2021. e-Pub 2021. PMID: 34348950.
73. Aggarwal P, Hutcheson KA, Garden AS, Mott FE, Lu C, Goepfert RP, Fuller CD, Lai SY, Gunn GB, Chambers MS, Sturgis EM, Hanna EY, Shete S. Determinants of patient-reported xerostomia among long-term oropharyngeal cancer survivors. Cancer. e-Pub 2021. PMID: 34358341.
74. Barbon CEA, CMKL Y, Alvarez CP, Goepfert RP, Fuller CD, Lai SY, Gross ND, Hutcheson KA. Dysphagia profiles after primary transoral robotic surgery or radiation for oropharyngeal cancer: A registry analysis. Head Neck. e-Pub 2021. PMID: 34080249.
75. Maniakas A, Henderson YC, Hei H, Peng S, Chen Y, Jiang Y, Ji S, Cardenas M, Chiu Y, Bell D, Williams MD, Hofmann MC, Scherer SE, Wheeler DA, Busaidy NL, Dadu R, Wang JR, Cabanillas ME, Zafereo M, Johnson FM, Lai SY. Novel anaplastic thyroid cancer PDXs and cell lines: Expanding preclinical models of genetic diversity. J Clin Endocrinol Metab. e-Pub 2021. PMID: 34147031.
76. Henderson YC, Mohamed ASR, Maniakas A, Chen Y, Powell RT, Peng S, Cardenas M, Williams MD, Bell D, Zafereo ME, Wang RJ, Scherer SE, Wheeler DA, Cabanillas ME, Hofmann MC, Johnson FM, Stephan CC, Sandulache V, Lai SY. A High-Throughput Approach to Identify Effective Systemic Agents for the Treatment of Anaplastic Thyroid Carcinoma. J Clin Endocrinol Metab. e-Pub 2021. PMID: 34120183.
77. Aggarwal P, Hutcheson KA, Garden AS, Mott FE, Goepfert RP, Duvall A, Fuller CD, Lai SY, Gunn GB, Sturgis EM, Hanna EY, Shete S. Association of Risk Factors With Patient-Reported Voice and Speech Symptoms Among Long-term Survivors of Oropharyngeal Cancer. JAMA Otolaryngol Head Neck Surg. e-Pub 2021. PMID: 33956062.
78. Gao R, Bai S, Henderson YC, Lin Y, Schalck A, Yan Y, Kumar T, Hu M, Sei E, Davis A, Wang F, Shaitelman SF, Wang JR, Chen K, Moulder S, Lai SY, Navin NE. Delineating copy number and clonal substructure in human tumors from single-cell transcriptomes. Nat Biotechnol 39(5):599-608, 2021. e-Pub 2021. PMID: 33462507.
79. Chen Y, Maniakas A, Tan L, Cui M, Le X, Niedzielski JS, Michel KA, Harlan CJ, Lu W, Henderson YC, Mohamed ASR, Lorenzi PL, Putluri N, Bankson JA, Sandulache VC, Lai SY. Development of a rational strategy for integration of lactate dehydrogenase A suppression into therapeutic algorithms for head and neck cancer. Br J Cancer 124(10):1670-1679, 2021. e-Pub 2021. PMID: 33742144.
80. van Dijk LV, Abusaif AA, Rigert J, Naser MA, Hutcheson KA, Lai SY, Fuller CD, Mohamed ASR, Working Group OBOTMAS. Normal Tissue Complication Probability (NTCP) prediction model for osteoradionecrosis of the mandible in head and neck cancer patients following radiotherapy: Large-scale observational cohort. Int J Radiat Oncol Biol Phys. e-Pub 2021. PMID: 33965514.
81. Michel KA, Ragavan M, Walker CM, Merritt ME, Lai SY, Bankson JA. Comparison of selective excitation and multi-echo chemical shift encoding for imaging of hyperpolarized [1-13C]pyruvate. J Magn Reson 325:106927, 2021. e-Pub 2021. PMID: 33607386.
82. van Dijk LV, Mohamed ASR, Ferrarotto R, McCoy LA, Sharafi CS, Jones E, Steele K, Moreno AC, Lai SY, Garden AS, Myers JN, Rosenthal DI, Fuller CD, Hutcheson KA, Working Group FMAS. The impact of induction and/or concurrent chemoradiotherapy on acute and late patient-reported symptoms in oropharyngeal cancer: Application of a mixed-model analysis of a prospective observational cohort registry. Cancer. e-Pub 2021. PMID: 33788956.
83. Aggarwal P, Goepfert RP, Garden AS, Garg N, Zaveri JS, Du XL, Swartz MD, Lai SY, Fuller CD, Ferrarotto R, Sturgis EM, Piller LB, Hutcheson KA. Risk and Clinical Risk Factors Associated With Late Lower Cranial Neuropathy in Long-term Oropharyngeal Squamous Cell Carcinoma Survivors. JAMA Otolaryngol Head Neck Surg. e-Pub 2021. PMID: 33538759.
84. Johnson, JM, Mohamed, AS, Ding, Y, Wang, J, Lai, SY, Fuller, C, Shah, R, Butler, RT, Weber, RS. Ultra-small superparamagnetic iron oxide (USPIO) magnetic resonance imaging in benign mixed tumor of the parotid gland. Clinical Case Reports 9(1):123-127, 2021. e-Pub 2021. PMID: 33489146.
85. Barua S, Elhalawani H, Volpe S, Al Feghali KA, Yang P, Ng SP, Elgohari B, Granberry RC, Mackin DS, Gunn GB, Hutcheson KA, Chambers MS, Court LE, Mohamed ASR, Fuller CD, Lai SY, Rao A. Computed Tomography Radiomics Kinetics as Early Imaging Correlates of Osteoradionecrosis in Oropharyngeal Cancer Patients. Front Artif Intell 4:618469, 2021. e-Pub 2021. PMID: 33898983.
86. Lai SY, Ferris RL. Evolving Evidence in Support of Sentinel Lymph Node Biopsy for Early-Stage Oral Cavity Cancer. J Clin Oncol 38(34):JCO2002716, 2020. e-Pub 2020. PMID: 33052758.
87. Liu W, Qdaisat A, Zhou S, Fuller CD, Ferrarotto R, Guo M, Lai SY, Cardoso R, Mohamed ASR, Lopez G, Narayanan S, van Dijk LV, Cohen L, Bruera E, Yeung SJ, Hanna EY. Hypomagnesemia and incidence of osteoradionecrosis in patients with head and neck cancers. Head Neck. e-Pub 2020. PMID: 33094893.
88. Elhalawani H, Mohamed ASR, Elgohari B, Lin TA, Sikora AG, Lai SY, Abusaif A, Phan J, Morrison WH, Gunn GB, Rosenthal DI, Garden AS, Fuller CD, Sandulache VC. Tobacco exposure as a major modifier of oncologic outcomes in human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma. BMC Cancer 20(1):912, 2020. e-Pub 2020. PMID: 32967643.
89. Tzeng CD, Teshome M, Katz MHG, Weinberg JS, Lai SY, Antonoff MB, Bird JE, Shafer A, Davis JW, Adelman DM, Moon B, Reece G, Prabhu SS, DeSnyder SM, Skibber JM, Mehran R, Schmeler K, Roland CL, Tran Cao HS, Aloia TA, Caudle AS, Swisher SG, Vauthey JN. Cancer Surgery Scheduling During and After the COVID-19 First Wave: The MD Anderson Cancer Center Experience. Ann Surg 272(2):e106-e111, 2020. e-Pub 2020. PMID: 32675511.
90. Maniakas A, Dadu R, Busaidy NL, Wang JR, Ferrarotto R, Lu C, Williams MD, Gunn GB, Hofmann MC, Cote G, Sperling J, Gross ND, Sturgis EM, Goepfert RP, Lai SY, Cabanillas ME, Zafereo M. Evaluation of Overall Survival in Patients With Anaplastic Thyroid Carcinoma, 2000-2019. JAMA Oncol. e-Pub 2020. PMID: 32761153.
91. Cardoso RC, Kamal M, Zaveri J, Chambers MS, Gunn GB, Fuller CD, Lai SY, Mott FE, McMillan H, Hutcheson KA. Self-Reported Trismus: prevalence, severity and impact on quality of life in oropharyngeal cancer survivorship: a cross-sectional survey report from a comprehensive cancer center. Support Care Cancer. e-Pub 2020. PMID: 32779007.
92. Mohamed ASR, He R, Ding Y, Wang J, Fahim J, Elgohari B, Elhalawani H, Kim AD, Ahmed H, Garcia JA, Johnson JM, Stafford RJ, Bankson JA, Chambers MS, Sandulache VC, Fuller CD, Lai SY. Quantitative Dynamic Contrast-Enhanced MRI Identify Radiation-Induced Vascular Damage in Patients with Advanced Osteoradionecrosis: Results of a Prospective Study. Int J Radiat Oncol Biol Phys. e-Pub 2020. PMID: 32712257.
93. Niedzielski JS, Wei X, Xu T, Gomez DR, Liao Z, Bankson JA, Lai SY, Court LE, Yang J. Development and application of an elastic net logistic regression model to investigate the impact of cardiac substructure dose on radiation-induced pericardial effusion in patients with NSCLC. Acta Oncol:1-8. e-Pub 2020. PMID: 32678696.
94. Mehanna H, Hardman JC, Shenson JA, Abou-Foul AK, Topf MC, AlFalasi M, Chan JYK, Chaturvedi P, Chow VLY, Dietz A, Fagan JJ, Godballe C, Golusinski W, Homma A, Hosal S, Iyer NG, Kerawala C, Koh YW, Konney A, Kowalski LP, Kraus D, Kuriakose MA, Kyrodimos E, Lai SY, Leemans CR, Lennon P, Licitra L, Lou PJ, Lyons B, Mirghani H, Nichols AC, Paleri V, Panizza BJ, Parente Arias P, Patel MR, Piazza C, Rischin D, Sanabria A, Takes RP, Thomson DJ, Uppaluri R, Wang Y, Yom SS, Zhu YM, Porceddu SV, de Almeida JR, Simon C, Holsinger FC. Recommendations for head and neck surgical oncology practice in a setting of acute severe resource constraint during the COVID-19 pandemic: an international consensus. Lancet Oncol 21(7):e350-e359, 2020. e-Pub 2020. PMID: 32534633.
95. Yu W, Chen Y, Putluri N, Coarfa C, Robertson MJ, Putluri V, Stossi F, Dubrulle J, Mancini MA, Pang JC, Nguyen T, Baluya D, Myers JN, Lai SY, Sandulache VC. Acquisition of Cisplatin Resistance Shifts Head and Neck Squamous Cell Carcinoma Metabolism toward Neutralization of Oxidative Stress. Cancers (Basel) 12(6), 2020. e-Pub 2020. PMID: 32599707.
96. Kiong KL, Guo T, CMKL Y, Gross ND, Hanasono MM, Ferrarotto R, Rosenthal DI, Myers JN, Hanna EY, Lai SY. Changing practice patterns in head and neck oncologic surgery in the early COVID-19 era. Head Neck 42(6):1179-1186, 2020. e-Pub 2020. PMID: 32459061.
97. Jozaghi Y, Zafereo ME, Perrier ND, Wang JR, Grubbs E, Gross ND, Fisher S, Sturgis EM, Goepfert RP, Lai SY, Best C, Busaidy NL, Cabanillas ME, Dadu R, Gagel RF, Habra MA, Hu MI, Jimenez C, Sherman SI, Thosani S, Varghese J, Waguespack SG, Weitzman S, Ying AK, Graham PH. Endocrine surgery in the Coronavirus disease 2019 pandemic: Surgical Triage Guidelines. Head Neck 42(6):1325-1328, 2020. e-Pub 2020. PMID: 32437031.
98. Cardenas CE, Mohamed ASR, Yang J, Gooding M, Veeraraghavan H, Kalpathy-Cramer J, Ng SP, Ding Y, Wang J, Lai SY, Fuller CD, Sharp G. Head and neck cancer patient images for determining auto-segmentation accuracy in T2-weighted magnetic resonance imaging through expert manual segmentations. Med Phys 47(5):2317-2322, 2020. e-Pub 2020. PMID: 32418343.
99. Piotrowski SL, Wilson L, Maldonado KL, Tailor R, Hill LR, Bankson JA, Lai S, Kasper FK, Young S. Effect of Radiation on DCE-MRI Pharmacokinetic Parameters in a Rabbit Model of Compromised Maxillofacial Wound Healing: A Pilot Study. J Oral Maxillofac Surg 78(6):1034.e1-1034.e10, 2020. e-Pub 2020. PMID: 32147226.
100. Cata JP, Patino M, Gorur A, Du KN, Uhelski ML, Myers J, Lai S, Rubin ML, Dougherty PM, Owusu-Agyemang P. Persistent and Chronic Postoperative Opioid Use in a Cohort of Patients with Oral Tongue Squamous Cell Carcinoma. Pain Med 21(5):1061-1067, 2020. e-Pub 2020. PMID: 31609416.
101. McCulloch M, Cazoulat G, Ford A, Elgohari BA, Bahig H, Kim AD, Elhalawani HM, He R, Wang J, Ding Y, Mohamed ASR, Polan DF, King J, Peterson CB, Ohrt AN, Fuller CD, Lai SY, Brock KK. Biomechanical modeling of radiation dose-induced volumetric changes of the parotid glands for deformable image registration. Phys Med Biol. e-Pub 2020. PMID: 32320955.
102. MD Anderson Head and Neck Surgery Treatment Guidelines Consortium, Maniakas A, Jozaghi Y, Zafereo ME, Sturgis EM, Su SY, Gillenwater AM, Gidley PW, Lewis CM, Diaz E, Goepfert RP, Kupferman ME, Gross ND, Hessel AC, Pytynia KB, Nader ME, Wang JR, Lango MN, Kiong KL, Guo T, Zhao X, CMKL Y, Appelbaum E, Alpard J, Garcia JA, Terry S, Flynn JE, Bauer S, Fournier D, Burgess CG, Wideman C, Johnston M, You C, De Luna R, Joseph L, Diersing J, Prescott K, Heiberger K, Mugartegui L, Rodriguez J, Zendehdel S, Sellers J, Friddell RA, Thomas A, Khanjae SJ, Schwarzlose KB, Chambers MS, Hofstede TM, Cardoso RC, Aponte Wesson R, Won A, Otun AO, Gombos DS, Al-Zubidi N, Hutcheson KA, Gunn GB, Rosenthal DI, Gillison ML, Ferrarotto R, Weber RS, Hanna EY, Myers JN, Lai SY. Head and neck surgical oncology in the time of a pandemic: Subsite-specific triage guidelines during the COVID-19 pandemic. Head Neck. e-Pub 2020. PMID: 32342541.
103. He R, Ding Y, Mohamed ASR, Ng SP, Ger RB, Elhalawani H, Elgohari BA, Young KH, Hutcheson KA, Fuller CD, Lai SY. Simultaneously spatial and temporal Higher-Order Total Variations for noise suppression and motion reduction in DCE and IVIM. SPIE Medical Imaging, 2020. e-Pub 2020.
104. Garden AS, Kamal M, Mohamed ASR, Frank SJ, Lewin JS, Lai SY, Morrison WH, Phan J, Ferrarotto R, Rosenthal DI, Hutcheson KA, Fuller CD, Gunn GB. Neurologic sequelae following radiation with and without chemotherapy for oropharyngeal cancer: Patient reported outcomes study. Head Neck. e-Pub 2020. PMID: 32212359.
105. Yang J, Mohamed ASR, Bahig H, Ding Y, Wang J, Ng SP, Lai S, Miller A, Hutcheson KA, Fuller CD, Head J. Automatic registration of 2D MR cine images for swallowing motion estimation. PLoS One 15(2):e0228652, 2020. e-Pub 2020. PMID: 32045464.
106. He R, Ding Y, Mohamed ASR, Ng SP, Ger RB, Elhalawani H, Elgohari BA, Young KH, Hutcheson KA, Fuller CD, Lai SY. Simultaneously spatial and temporal Higher-Order Total Variations for noise suppression and motion reduction in DCE and IVIM. Proc SPIE Int Soc Opt Eng 11313, 2020. e-Pub 2020. PMID: 32753776.
107. Elhalawani H, Awan MJ, Ding Y, Mohamed ASR, Elsayes AK, Abu-Gheida I, Wang J, Hazle J, Gunn GB, Lai SY, Frank SJ, Ginsberg LE, Rosenthal DI, Fuller CD. Data from a terminated study on iron oxide nanoparticle magnetic resonance imaging for head and neck tumors. Sci Data 7(1):63, 2020. e-Pub 2020. PMID: 32081849.
108. Kemnade JO, Elhalawani H, Castro P, Yu J, Lai S, Ittmann M, Mohamed ASR, Lai SY, Fuller CD, Sikora AG, Sandulache VC. CD8 infiltration is associated with disease control and tobacco exposure in intermediate-risk oropharyngeal cancer. Sci Rep 10(1):243, 2020. e-Pub 2020. PMID: 31937831.
109. Owen JL, Kibbi N, Worley B, Kelm RC, Wang JV, Barker CA, Behshad R, Bichakjian CK, Bolotin D, Bordeaux JS, Bradshaw SH, Cartee TV, Chandra S, Cho NL, Choi JN, Counci ML, Demirci H, Eisen DB, Esmaeli B, Golda N, Huang CC, Ibrahim SF, Jiang SB, Kim J, Kuzel TM, Lai SY, Lawrence N, Lee EH, Leitenberger JJ, Maher IA, Mann MW, Minkis K, Mittal BB, Nehal KS, Neuhaus IM Ozog DM, Petersen B, Rotemberg V, Samant S, Samie FH, Servaes S, Shields CL, Shin TM, Sobanko JF, A-K S, Stebbins WG, Thomas JR, Thomas VD, Tse DT, Waldman AH, Wong MK, Xu YG, Yu SS, Zeitouni NC, Ramsay T, Reynolds KA, Poon E, Alam M. Sebaceous carcinoma: evidence-based clinical practice guidelines. The Lancet Oncology 20(12):e699-e714, 2019. e-Pub 2019. PMID: 31797796.
110. CMKL Y, Chang EI, Lai SY. Contemporary Approach to Locally Advanced Oral Cavity Squamous Cell Carcinoma. Curr Oncol Rep 21(11):99, 2019. e-Pub 2019. PMID: 31701240.
111. Aggarwal P, Zaveri JS, Goepfert RP, Shi Q, Du XL, Swartz M, Lai SY, Fuller CD, Lewin JS, Piller LB, Hutcheson KA. Swallowing-related outcomes associated with late lower cranial neuropathy in long-term oropharyngeal cancer survivors: cross-sectional survey analysis. Head Neck 41(11):3880-3894, 2019. e-Pub 2019. PMID: 31441572.
112. Hutcheson KA, Warneke CL, CMKL Y, Zaveri J, Elgohari BE, Goepfert R, Hessel AC, Kupferman ME, Lai SY, Fuller CD, Gunn GB, Garden AS, Johnson F, Ferrarotto R, Lewin JS, Gross ND, Head MD, Working Group NCS. Dysphagia After Primary Transoral Robotic Surgery With Neck Dissection vs Nonsurgical Therapy in Patients With Low- to Intermediate-Risk Oropharyngeal Cancer. JAMA Otolaryngol Head Neck Surg. e-Pub 2019. PMID: 31556933.
113. MD Anderson Head and Neck Cancer Symptom Working Group, Spatial-Non-spatial Multi-Dimensional Analysis of Radiotherapy Treatment/Toxicity Team (SMART3), Christopherson KM, Ghosh A, Radwan Mohamed AS, Kamal M, Gunn G, Dale T, Kalpathy-Cramer J, Messer J, Garden AS, Elhalawani H, Frank SJ, Lewin J, Morrison WH, Phan J, Gross N, Ferrarotto R, Weber RS, Rosenthal DI, Lai SY, Hutcheson K, Fuller CD, Marai G, Canahuate G, Vock DM. Chronic radiation-associated dysphagia in oropharyngeal cancer survivors: Towards age-adjusted dose constraints for deglutitive muscles. Clin Transl Radiat Oncol 18:16-22, 2019. e-Pub 2019. PMID: 31341972.
114. Wang JR, Zafereo M, Dadu R, Ferrarotto R, Busaidy N, Lu C, Ahmed S, Gule-Monroe M, Williams MD, Sturgis E, Goepfert RP, Gross ND, Lai SY, Gunn B, Phan J, Rosenthal DI, Fuller C, Morrison WH, Iyer PC, Cabanillas M. Complete surgical resection following neoadjuvant dabrafenib plus trametinib in BRAFV600E-mutated anaplastic thyroid carcinoma. Thyroid. e-Pub 2019. PMID: 31319771.
115. Jethanandani A, Chen MM, Gule-Monroe MK, Morrison WH, Lai SY, Johnson JM. Incidental detection of oropharyngeal cancer with fluciclovine PET. Head Neck. e-Pub 2019. PMID: 31046173.
116. Chari NS, Ivan C, Le X, Li J, Mijiti A, Patel AA, Osman AA, Peterson CB, Williams MD, Pickering CR, Caulin C, Myers JN, Calin GA, Lai SY. Disruption of TP63-miR-27a* feedback loop by mutant TP53 in head and neck cancer. J Natl Cancer Inst. e-Pub 2019. PMID: 31124563.
117. Head J, Kiser K, Meheissen MAM, Mohamed ASR, Kamal M, Ng SP, Elhalawani H, Jethanandani A, He R, Ding Y, Rostom Y, Hegazy N, Bahig H, Garden A, Lai S, Phan J, Gunn GB, Rosenthal D, Frank S, Brock KK, Wang J, Fuller CD. Prospective quantitative quality assurance and deformation estimation of MRI-CT image registration in simulation of head and neck radiotherapy patients. Clin Transl Radiat Oncol 18:120-127, 2019. e-Pub 2019. PMID: 31341987.
118. Schilling C, Stoeckli SJ, Vigili MG, de Bree R, Lai SY, Alvarez J, Christensen A, Cognetti DM, D'Cruz AK, Frerich B, Garrel R, Kohno N, Klop WM, Kerawala C, Lawson G, McMahon J, Sassoon I, Shaw RJ, Tvedskov JF, von Buchwald C, McGurk M. Surgical consensus guidelines on sentinel node biopsy (SNB) in patients with oral cancer. Head Neck. e-Pub 2019. PMID: 30896058.
119. Piotrowski SL, Wilson L, Dharmaraj N, Hamze A, Clark A, Tailor R, Hill LR, Lai S, Kasper FK, Young S. Development and Characterization of a Rabbit Model of Compromised Maxillofacial Wound Healing. Tissue Eng Part C Methods 25(3):160-167, 2019. e-Pub 2019. PMID: 30747042.
120. Zhu Y, Mohamed ASR, Lai SY, Yang S, Kanwar A, Wei L, Kamal M, Sengupta S, Elhalawani H, Skinner H, Mackin DS, Shiao J, Messer J, Wong A, Ding Y, Zhang L, Court L, Ji Y, Fuller CD. Imaging-Genomic Study of Head and Neck Squamous Cell Carcinoma: Associations Between Radiomic Phenotypes and Genomic Mechanisms via Integration of The Cancer Genome Atlas and The Cancer Imaging Archive. JCO Clin Cancer Inform 3:1-9, 2019. e-Pub 2019. PMID: 30730765.
121. Landa I, Pozdeyev N, Korch C, Marlow LA, Smallridge RC, Copland JA, Henderson YC, Lai SY, Clayman GL, Onoda N, Tan AC, Garcia-Rendueles MER, Knauf JA, Haugen BR, Fagin JA, Schweppe RE. Comprehensive genetic characterization of human thyroid cancer cell lines: a validated panel for preclinical studies. Clin Cancer Res. e-Pub 2019. PMID: 30737244.
122. Ng SP, Pollard C, Berends J, Ayoub Z, Kamal M, Garden AS, Bahig H, Cantor SB, Schaefer AJ, Ajayi T, Gunn GB, Frank SJ, Skinner H, Phan J, Morrison WH, Ferrarotto R, Johnson JM, Mohamed ASR, Lai SY, Hessel AC, Sturgis EM, Weber RS, Fuller CD, Rosenthal DI. Usefulness of surveillance imaging in patients with head and neck cancer who are treated with definitive radiotherapy. Cancer. e-Pub 2019. PMID: 30748005.
123. Mohamed ASR, Smith BD, Smith JB, Sevak P, Malek JS, Kanwar A, Browne T, Gunn GB, Garden AS, Frank SJ, Morrison WH, Phan J, Zafereo M, Skinner H, Lai SY, Hutcheson KA, Lewin JS, Hessel AE, Thekdi AA, Weber RS, Fuller CD, Rosenthal DI. Outcomes of carotid-sparing IMRT for T1 glottic cancer: Comparison with conventional radiation. Laryngoscope. e-Pub 2019. PMID: 30756394.
124. Bharadwaj U, Eckols TK, Xu X, Kasembeli MM, Chen Y, Adachi M, Song Y, Mo Q, Lai SY, Tweardy DJ. Correction: Small-molecule inhibition of STAT3 in radioresistant head and neck squamous cell carcinoma. Oncotarget 10(16):1603, 2019. e-Pub 2019. PMID: 30899429.
125. MD Anderson Head and Neck Cancer Symptom Working Group, Grant S, Kamal M, Mohamed ASR, Zaveri J, Barrow MP, Gunn GB, Lai SY, Lewin JS, Rosenthal DI, Wang XS, Fuller CD, Hutcheson KA. Single-item discrimination of quality-of-life-altering dysphagia among 714 long-term oropharyngeal cancer survivors: Comparison of patient-reported outcome measures of swallowing. Cancer. e-Pub 2019. PMID: 30633325.
126. Ng SP, Pollard C, Kamal M, Ayoub Z, Garden AS, Bahig H, Gunn GB, Frank SJ, Skinner HD, Phan J, Berends J, Morrison WH, Johnson JM, Ferrarotto R, Sturgis EM, Mohamed ASR, Lai SY, Fuller CD, Rosenthal DI. Risk of second primary malignancies in head and neck cancer patients treated with definitive radiotherapy. NPJ Precis Oncol 3:22, 2019. e-Pub 2019. PMID: 31583278.
127. Bahig H, Yuan Y, Mohamed ASR, Brock KK, Ng SP, Wang J, Ding Y, Hutcheson K, McCulloch M, Balter PA, Lai SY, Al-Mamgani A, Sonke JJ, van der Heide UA, Nutting C, Li XA, Robbins J, Awan M, Karam I, Newbold K, Harrington K, Oelfke U, Bhide S, Philippens MEP, Terhaard CHJ, McPartlin AJ, Blanchard P, Garden AS, Rosenthal DI, Gunn GB, Phan J, Cazoulat G, Aristophanous M, McSpadden KK, Garcia JA, van den Berg CAT, Raaijmakers CPJ, Kerkmeijer L, Doornaert P, Blinde S, Frank SJ, Fuller CD. Magnetic Resonance-based Response Assessment and Dose Adaptation in Human Papilloma Virus Positive Tumors of the Oropharynx treated with Radiotherapy (MR-ADAPTOR): An R-IDEAL stage 2a-2b/Bayesian phase II trial. Clin Transl Radiat Oncol 13:19-23, 2018. e-Pub 2018. PMID: 30386824.
128. Amaria RN, Reddy SM, Tawbi HA, Davies MA, Ross MI, Glitza IC, Cormier JN, Lewis C, Hwu WJ, Hanna E, Diab A, Wong MK, Royal R, Gross N, Weber R, Lai SY, Ehlers R, Blando J, Milton DR, Woodman S, Kageyama R, Wells DK, Hwu P, Patel SP, Lucci A, Hessel A, Lee JE, Gershenwald J, Simpson L, Burton EM, Posada L, Haydu L, Wang L, Zhang S, Lazar AJ, Hudgens CW, Gopalakrishnan V, Reuben A, Andrews MC, Spencer CN, Prieto V, Sharma P, Allison J, Tetzlaff MT, Wargo JA. Publisher Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma. Nat Med. e-Pub 2018. PMID: 30361511.
129. Amaria RN, Reddy SM, Tawbi HA, Davies MA, Ross MI, Glitza IC, Cormier JN, Lewis C, Hwu WJ, Hanna E, Diab A, Wong MK, Royal R, Gross N, Weber R, Lai SY, Ehlers R, Blando J, Milton DR, Woodman S, Kageyama R, Wells DK, Hwu P, Patel SP, Lucci A, Hessel A, Lee JE, Gershenwald J, Simpson L, Burton EM, Posada L, Haydu L, Wang L, Zhang S, Lazar AJ, Hudgens CW, Gopalakrishnan V, Reuben A, Andrews MC, Spencer CN, Prieto V, Sharma P, Allison J, Tetzlaff MT, Wargo JA. Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable Melanoma. Nat Med. e-Pub 2018. PMID: 30297909.
130. MD Anderson Head and Neck Cancer Symptom Working Group, Cardoso RC, Qazali A, Zaveri J, Chambers MS, Gunn GB, Fuller CD, Lai SY, Mott FE, Hutcheson KA. Self-reported oral morbidities in long-term oropharyngeal cancer survivors: A cross-sectional survey of 906 survivors. Oral Oncol 84:88-94, 2018. e-Pub 2018. PMID: 30115482.
131. Aggarwal P, Zaveri JS, Goepfert RP, Shi Q, Du XL, Swartz M, Gunn GB, Lai SY, Fuller CD, Hanna EY, Rosenthal DI, Lewin JS, Piller LB, Hutcheson KA. Symptom Burden Associated With Late Lower Cranial Neuropathy in Long-term Oropharyngeal Cancer Survivors. JAMA Otolaryngol Head Neck Surg. e-Pub 2018. PMID: 30193299.
132. Ng SP, Bahig H, Wang J, Cardenas CE, Lucci A, Hall CS, Meas S, Sarli VN, Yuan Y, Urbauer DL, Ding Y, Ikner S, Dinh V, Elgohari BA, Johnson JM, Skinner HD, Gunn GB, Garden AS, Phan J, Rosenthal DI, Morrison WH, Frank SJ, Hutcheson KA, Mohamed ASR, Lai SY, Ferrarotto R, MacManus MP, Fuller CD. Predicting treatment Response based on Dual assessment of magnetic resonance Imaging kinetics and Circulating Tumor cells in patients with Head and Neck cancer (PREDICT-HN): matching 'liquid biopsy' and quantitative tumor modeling. BMC Cancer 18(1):903, 2018. e-Pub 2018. PMID: 30231854.
133. Joint Head and Neck Radiotherapy-MRI Development Cooperative, M Meheissen MA, R Mohamed AS, Kamal M, Hernandez M, Volpe S, Elhalawani H, Barrow MP, Ding Y, Wang J, Davuluri R, Rostom Y, Hegazy N, Gunn G, Lai SY, Garden AS, Lewin JS, Rosenthal DI, Frank SJ, Fuller CD, Hutcheson KA. A prospective longitudinal assessment of MRI signal intensity kinetics of non-target muscles in patients with advanced stage oropharyngeal cancer in relationship to radiotherapy dose and post-treatment radiation-associated dysphagia: Preliminary findings from a randomized trial. Radiother Oncol. e-Pub 2018. PMID: 30206020.
134. Ng SP, Dyer BA, Kalpathy-Cramer J, Mohamed ASR, Awan MJ, Gunn GB, Phan J, Zafereo M, Debnam JM, Lewis CM, Colen RR, Kupferman ME, Guha-Thakurta N, Canahuate G, Marai GE, Vock D, Hamilton B, Holland J, Cardenas CE, Lai S, Rosenthal D, Fuller CD. A prospective in silico analysis of interdisciplinary and interobserver spatial variability in post-operative target delineation of high-risk oral cavity cancers: Does physician specialty matter?. Clin Transl Radiat Oncol 12:40-46, 2018. e-Pub 2018. PMID: 30148217.
135. Mohamed ASR, Bahig H, Aristophanous M, Blanchard P, Kamal M, Ding Y, Cardenas CE, Brock KK, Lai SY, Hutcheson KA, Phan J, Wang J, Ibbott G, Gabr RE, Narayana PA, Garden AS, Rosenthal DI, Gunn GB, Fuller CD, Group MD. Prospective in silico study of the feasibility and dosimetric advantages of MRI-guided dose adaptation for human papillomavirus positive oropharyngeal cancer patients compared with standard IMRT. Clin Transl Radiat Oncol 11:11-18, 2018. e-Pub 2018. PMID: 30014042.
136. Sun CY, Walker CM, Michel KA, Venkatesan AM, Lai SY, Bankson JA. Influence of parameter accuracy on pharmacokinetic analysis of hyperpolarized pyruvate. Magn Reson Med 79(6):3239-3248, 2018. e-Pub 2018. PMID: 29090487.
137. Tam S, Amit M, Boonsripitayanon M, Busaidy N, Cabanillas M, Waguespack SG, Gross ND, Grubbs EG, Williams MD, Lai SY, Sturgis E, Zafereo M. The Effect of Tumor Size and Minimal Extrathyroidal Extension in Patients with Differentiated Thyroid Cancer. Thyroid. e-Pub 2018. PMID: 29936892.
138. Kamal M, Mohamed ASR, Volpe S, Zaveri J, Barrow MP, Gunn GB, Lai SY, Ferrarotto R, Lewin JS, Rosenthal DI, Jethanandani A, Meheissen MAM, Mulder SL, Cardenas CE, Fuller CD, Hutcheson KA, Head MD, Working Group NCS. Radiotherapy dose-volume parameters predict videofluoroscopy-detected dysphagia per DIGEST after IMRT for oropharyngeal cancer: Results of a prospective registry. Radiother Oncol. e-Pub 2018. PMID: 29961581.
139. Tam S, Sandulache VC, Metwalli KA, Rock CD, Eraj SA, Sheu T, El-Naggar AK, Fuller CD, Weber RS, Lai SY. Incompletely treated malignancies of the major salivary gland: Toward evidence-based care. Head Neck. e-Pub 2018. PMID: 29734482.
140. Hutcheson KA, Barrow MP, Plowman EK, Lai SY, Fuller CD, Barringer DA, Eapen G, Wang Y, Hubbard R, Jimenez SK, Little LG, Lewin JS. Expiratory Muscle Strength Training for Radiation-associated Aspiration After Head and Neck Cancer: A Case-series. Laryngoscope 128(5):1044-1051, 2018. e-Pub 2018. PMID: 28833185.
141. Multidisciplinary Larynx Cancer Working Group, Mulcahy CF, Mohamed ASR, Kanwar A, Hutcheson KA, Ghosh A, Vock D, Weber RS, Lai SY, Gunn GB, Zafereo M, Morrison WH, Ferrarotto R, Garden AS, Rosenthal DI, Fuller CD. Age-adjusted comorbidity and survival in locally advanced laryngeal cancer. Head Neck. e-Pub 2018. PMID: 29756307.
142. Goepfert RP, Lewin JS, Barrow MP, Warneke CL, Fuller CD, Lai SY, Weber RS, Hutcheson KA. Grading Dysphagia as a Toxicity of Head and Neck Cancer: Differences in Severity Classification Based on MBS DIGEST and Clinical CTCAE Grades. Dysphagia 33(2):185-191, 2018. e-Pub 2018. PMID: 28836005.
143. Frank SJ, Blanchard P, Lee JJ, Sturgis EM, Kies MS, Machtay M, Vikram B, Garden AS, Rosenthal DI, Gunn GB, Fuller CD, Hutcheson K, Lai S, Busse PM, Lee NY, Lin A, Foote RL. Comparing Intensity-Modulated Proton Therapy With Intensity-Modulated Photon Therapy for Oropharyngeal Cancer: The Journey From Clinical Trial Concept to Activation. Semin Radiat Oncol 28(2):108-113, 2018. e-Pub 2018. PMID: 29735186.
144. Kamal M, Ng SP, Eraj SA, Rock CD, Pham B, Messer JA, Garden AS, Morrison WH, Phan J, Frank SJ, El-Naggar AK, Johnson JM, Ginsberg LE, Ferrarotto R, Lewin JS, Hutcheson KA, Cardenas CE, Zafereo ME, Lai SY, Hessel AC, Weber RS, Gunn GB, Fuller CD, Mohamed ASR, Rosenthal DI. Three-dimensional imaging assessment of anatomic invasion and volumetric considerations for chemo/radiotherapy-based laryngeal preservation in T3 larynx cancer. Oral Oncol 79:1-8, 2018. e-Pub 2018. PMID: 29598944.
145. Yu W, Chen Y, Dubrulle J, Stossi F, Putluri V, Sreekumar A, Putluri N, Baluya D, Lai SY, Sandulache VC. Cisplatin generates oxidative stress which is accompanied by rapid shifts in central carbon metabolism. Sci Rep 8(1):4306, 2018. e-Pub 2018. PMID: 29523854.
146. Joint Head and Neck Radiotherapy-MRI Development Cooperative, Elhalawani H, Ger RB, R Mohamed AS, Awan MJ, Ding Y, Li K, Fave XJ, Beers AL, Driscoll B, Hormuth Ii DA, van Houdt PJ, He R, Zhou S, Mathieu KB, Li H, Coolens C, Chung C, Bankson JA, Huang W, Wang J, Sandulache VC, Lai SY, Howell RM, Stafford R, Yankeelov TE, der Heide UAV, Frank SJ, Barboriak DP, Hazle JD, Court LE, Kalpathy-Cramer J, Fuller CD. Erratum: Dynamic contrast-enhanced magnetic resonance imaging for head and neck cancers. Sci Data 5:180041, 2018. e-Pub 2018. PMID: 29557974.
147. Joint Head and Neck Radiotherapy-MRI Development Cooperative, Ger RB, R Mohamed AS, Awan MJ, Ding Y, Li K, Fave XJ, Beers AL, Driscoll B, Elhalawani H, Hormuthnd DA, van Houdt PJ, He R, Zhou S, Mathieu KB, Li H, Coolens C, Chung C, Bankson JA, Huang W, Wang J, Sandulache VC, Lai SY, Howell RM, Stafford R, Yankeelov TE, der Heide UAV, Frank SJ, Barboriak DP, Hazle JD, Court LE, Kalpathy-Cramer J, Fuller CD. Publisher Correction: A Multi-Institutional Comparison of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Parameter Calculations. Sci Rep 8(1):4422, 2018. e-Pub 2018. PMID: 29520065.
148. . Dynamic contrast-enhanced magnetic resonance imaging for head and neck cancers. Sci Data 5:180008, 2018. e-Pub 2018. PMID: 29437167.
149. Amit M, Tam S, Boonsripitayanon M, Cabanillas ME, Busaidy NL, Grubbs EG, Lai SY, Gross ND, Sturgis EM, Zafereo ME. Association of Lymph Node Density With Survival of Patients With Papillary Thyroid Cancer. JAMA Otolaryngol Head Neck Surg 144(2):108-114, 2018. e-Pub 2018. PMID: 29192312.
150. M.D. Anderson Cancer Center Head and Neck Quantitative Imaging Working Group, Elhalawani H, Kanwar A, R Mohamed AS, White A, Zafereo J, Wong A, Berends J, Abohashem S, Williams B, Aymard JM, Perni S, Messer J, Warren B, Youssef B, Yang P, M Meheissen MA, Kamal M, Elgohari B, Ger RB, Cardenas CE, Fave X, Zhang L, Mackin D, Marai G, Vock DM, Canahuate GM, Lai SY, Gunn G, Garden AS, Rosenthal DI, Court L, Fuller CD. Investigation of radiomic signatures for local recurrence using primary tumor texture analysis in oropharyngeal head and neck cancer patients. Sci Rep 8(1):1524, 2018. e-Pub 2018. PMID: 29367653.
151. Pena I, Clayman GL, Grubbs EG, Bergeron JM, Waguespack SG, Cabanillas ME, Dadu R, Hu MI, Fellman BM, Li Y, Gross ND, Lai SY, Sturgis EM, Zafereo ME. Management of the lateral neck compartment in patients with sporadic medullary thyroid cancer. Head Neck 40(1):79-85, 2018. e-Pub 2018. PMID: 29044788.
152. Elhalawani H, Lin TA, Volpe S, Mohamed ASR, White AL, Zafereo J, Wong AJ, Berends JE, AboHashem S, Williams B, Aymard JM, Kanwar A, Perni S, Rock CD, Cooksey L, Campbell S, Yang P, Nguyen K, Ger RB, Cardenas CE, Fave XJ, Sansone C, Piantadosi G, Marrone S, Liu R, Huang C, Yu K, Li T, Yu Y, Zhang Y, Zhu H, Morris JS, Baladandayuthapani V, Shumway JW, Ghosh A, Pöhlmann A, Phoulady HA, Goyal V, Canahuate G, Marai GE, Vock D, Lai SY, Mackin DS, Court LE, Freymann J, Farahani K, Kaplathy-Cramer J, Fuller CD. Machine Learning Applications in Head and Neck Radiation Oncology: Lessons From Open-Source Radiomics Challenges. Front Oncol 8:294, 2018. e-Pub 2018. PMID: 30175071.
153. Tam S, Amit M, Boonsripitayanon M, Cabanillas ME, Busaidy NL, Gunn GB, Lai SY, Gross ND, Sturgis EM, Zafereo ME. Adjuvant External Beam Radiotherapy in Locally Advanced Differentiated Thyroid Cancer. JAMA Otolaryngol Head Neck Surg. e-Pub 2017. PMID: 29098272.
154. Hutcheson KA, Barrow MP, Warneke CL, Wang Y, Eapen G, Lai SY, Barringer DA, Plowman EK, Lewin JS. Cough strength and expiratory force in aspirating and nonaspirating postradiation head and neck cancer survivors. Laryngoscope. e-Pub 2017. PMID: 29114887.
155. Walker CM, Chen Y, Lai SY, Bankson JA. Erratum: "A novel perfused Bloch-McConnell simulator for analyzing the accuracy of dynamic hyperpolarized MRS" [Med. Phys. V43, 854-864(2016)]. Med Phys 44(10):5539, 2017. e-Pub 2017. PMID: 29027239.
156. Hansen CC, Smith JB, Mohamed ASR, Mulcahy CF, Wefel JS, Hutcheson KA, Chrane K, Phan J, Frank SJ, Garden AS, Smith BD, Eichelberger H, Anderson C, McCoy C, Horiates M, Patrick C, Floris S, French C, Beadle BM, Morrison WH, Su SY, Lewis CM, Kupferman ME, Johnson JM, Skinner HD, Lai SY, Hanna EY, Rosenthal DI, Fuller CD, Gunn GB, Head MD, Working Group NCS. Cognitive function and patient-reported memory problems after radiotherapy for cancers at the skull base: A cross-sectional survivorship study using the Telephone Interview for Cognitive Status and the MD Anderson Symptom Inventory-Head and Neck Module. Head Neck 39(10):2048-2056, 2017. e-Pub 2017. PMID: 28763137.
157. Joint Head and Neck Radiotherapy-MRI Development Cooperative, Ger RB, Mohamed ASR, Awan MJ, Ding Y, Li K, Fave XJ, Beers AL, Driscoll B, Elhalawani H, Hormuth DA, Houdt PJV, He R, Zhou S, Mathieu KB, Li H, Coolens C, Chung C, Bankson JA, Huang W, Wang J, Sandulache VC, Lai SY, Howell RM, Stafford RJ, Yankeelov TE, Heide UAV, Frank SJ, Barboriak DP, Hazle JD, Court LE, Kalpathy-Cramer J, Fuller CD. A Multi-Institutional Comparison of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Parameter Calculations. Sci Rep 7(1):11185, 2017. e-Pub 2017. PMID: 28894197.
158. Quinlan-Davidson SR, Mohamed ASR, Myers JN, Gunn GB, Johnson FM, Skinner H, Beadle BM, Gillenwater AM, Phan J, Frank SJ, William WN, Wong AJ, Lai SY, Fuller CD, Morrison WH, Rosenthal DI, Garden AS. Outcomes of oral cavity cancer patients treated with surgery followed by postoperative intensity modulated radiation therapy. Oral Oncol 72:90-97, 2017. e-Pub 2017. PMID: 28797467.
159. MD Anderson Head and Neck Cancer Symptom Working Group, Eraj SA, Jomaa MK, Rock CD, Mohamed ASR, Smith BD, Smith JB, Browne T, Cooksey LC, Williams B, Temple B, Preston KE, Aymar JM, Gross ND, Weber RS, Hessel AC, Ferrarotto R, Phan J, Sturgis EM, Hanna EY, Frank SJ, Morrison WH, Goepfert RP, Lai SY, Rosenthal DI, Mendoza TR, Cleeland CS, Hutcheson KA, Fuller CD, Garden AS, Gunn GB. Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients =65 years old. Radiat Oncol 12(1):150, 2017. e-Pub 2017. PMID: 28888224.
160. Shiao JC, Mohamed ASR, Messer JA, Hutcheson KA, Johnson JM, Enderling H, Kamal M, Warren BW, Pham B, Morrison WH, Zafereo ME, Hessel AC, Lai SY, Kies MS, Ferrarotto R, Garden AS, Schomer DF, Gunn GB, Phan J, Frank SJ, Beadle BM, Weber RS, Lewin JS, Rosenthal DI, Fuller CD. Quantitative pretreatment CT volumetry: Association with oncologic outcomes in patients with T4a squamous carcinoma of the larynx. Head Neck 39(8):1609-1620, 2017. e-Pub 2017. PMID: 28464542.
161. Mohamed ASR, Cardenas CE, Garden AS, Awan MJ, Rock CD, Westergaard SA, Brandon Gunn G, Belal AM, El-Gowily AG, Lai SY, Rosenthal DI, Fuller CD, Aristophanous M. Patterns-of-failure guided biological target volume definition for head and neck cancer patients: FDG-PET and dosimetric analysis of dose escalation candidate subregions. Radiother Oncol 124(2):248-255, 2017. e-Pub 2017. PMID: 28774596.
162. MD Anderson Head and Neck Cancer Symptom Working Group, Mohamed ASR, Hobbs BP, Hutcheson KA, Murri MS, Garg N, Song J, Brandon Gunn G, Sandulache V, Beadle BM, Phan J, Morrison WH, Frank SJ, Blanchard P, Garden AS, El-Halawani H, Kamal M, Chambers MS, Lewin JS, Ferrarotto R, Ronald Zhu X, Zhang X, Hofstede TM, Cardoso RC, Gillenwater AM, Sturgis EM, Weber RS, Rosenthal DI, Fuller CD, Lai SY. Dose-volume correlates of mandibular osteoradionecrosis in Oropharynx cancer patients receiving intensity-modulated radiotherapy: Results from a case-matched comparison. Radiother Oncol 124(2):232-239, 2017. e-Pub 2017. PMID: 28733053.
163. Mohamed ASR, Wong AJ, Fuller CD, Kamal M, Gunn GB, Phan J, Morrison WH, Beadle BM, Skinner H, Lai SY, Quinlan-Davidson SR, Belal AM, El-Gowily AG, Frank SJ, Rosenthal DI, Garden AS. Patterns of locoregional failure following post-operative intensity-modulated radiotherapy to oral cavity cancer: quantitative spatial and dosimetric analysis using a deformable image registration workflow. Radiat Oncol 12(1):129, 2017. e-Pub 2017. PMID: 28806994.
164. Hutcheson KA, Yuk M, Hubbard R, Gunn GB, Fuller CD, Lai SY, Lin H, Garden AS, Rosenthal DI, Hanna EY, Kies MS, Lewin JS. Delayed lower cranial neuropathy after oropharyngeal intensity-modulated radiotherapy: A cohort analysis and literature review. Head Neck 39(8):1516-1523, 2017. e-Pub 2017. PMID: 28452175.
165. MICCAI/M.D. Anderson Cancer Center Head and Neck Quantitative Imaging Working Group, Mohamed ASR, White AL, Zafereo J, Wong AJ, Berends JE, AboHashem S, Williams B, Aymard JM, Kanwar A, Perni S, Rock CD, Cooksey L, Campbell S, Ding Y, Lai SY, Marai EG, Vock D, Canahuate GM, Freymann J, Farahani K, Kalpathy-Cramer J, Fuller CD. Matched computed tomography segmentation and demographic data for oropharyngeal cancer radiomics challenges. Sci Data 4:170077, 2017. e-Pub 2017. PMID: 28675381.
166. Cabanillas ME, Williams MD, Gunn GB, Weitzman SP, Burke L, Busaidy NL, Ying AK, Yiin YH, William WN, Lu C, Lai SY. Facilitating anaplastic thyroid cancer specialized treatment: A model for improving access to multidisciplinary care for patients with anaplastic thyroid cancer. Head Neck 39(7):1291-1295, 2017. e-Pub 2017. PMID: 28452157.
167. Zhang W, Zhang X, Yang P, Blanchard P, Garden AS, Gunn B, Fuller CD, Chambers M, Hutcheson KA, Ye R, Lai SY, Radwan MAS, Zhu XR, Frank SJ. Intensity-modulated proton therapy and osteoradionecrosis in oropharyngeal cancer. Radiother Oncol 123(3):401-405, 2017. e-Pub 2017. PMID: 28549794.
168. Rao SN, Zafereo M, Dadu R, Busaidy NL, Hess K, Cote GJ, Williams MD, William WN, Sandulache V, Gross N, Gunn GB, Lu C, Ferrarotto R, Lai SY, Cabanillas ME. Patterns of Treatment Failure in Anaplastic Thyroid Carcinoma. Thyroid 27(5):672-681, 2017. e-Pub 2017. PMID: 28068873.
169. Pezzi TA, Mohamed ASR, Sheu T, Blanchard P, Sandulache VC, Lai SY, Cabanillas ME, Williams MD, Pezzi CM, Lu C, Garden AS, Morrison WH, Rosenthal DI, Fuller CD, Gunn GB. Radiation therapy dose is associated with improved survival for unresected anaplastic thyroid carcinoma: Outcomes from the National Cancer Data Base. Cancer 123(9):1653-1661, 2017. e-Pub 2017. PMID: 28026871.
170. Goepfert RP, Lewin JS, Barrow MP, Fuller CD, Lai SY, Song J, Hobbs BP, Gunn GB, Beadle BM, Rosenthal DI, Garden AS, Kies MS, Papadimitrakopoulou VA, Schwartz DL, Hutcheson KA. Predicting two-year longitudinal MD Anderson dysphagia inventory outcomes after intensity modulated radiotherapy for locoregionally advanced oropharyngeal carcinoma. Laryngoscope 127(4):842-848, 2017. e-Pub 2017. PMID: 27440393.
171. Multidisciplinary Larynx Cancer Working Group, Vock D, Mohamed ASR, Gross N, Mulcahy C, Zafereo M, Gunn GB, Garden A, Sevak P, Phan J, Lewin J, Frank S, Beadle B, Morrison W, Lai SY, Hutcheson KA, G Marai E, Canahuate G, Kies M, El-Naggar A, Rosenthal D, Weber RS, Fuller C. Conditional Survival Analysis of Patients with Locally Advanced Laryngeal Cancer: Construction of a Dynamic Risk Model and Clinical Nomogram. Sci Rep 7:43928, 2017. e-Pub 2017. PMID: 28276466.
172. Wong AT, Lai SY, Gunn GB, Beadle BM, Fuller CD, Barrow MP, Hofstede TM, Chambers MS, Sturgis EM, Mohamed AS, Lewin JS, Hutcheson KA. Symptom burden and dysphagia associated with osteoradionecrosis in long-term oropharynx cancer survivors: a cohort analysis. Oral Oncol 66:75-80, 2017. e-Pub 2017. PMID: 28249651.
173. Sandulache VC, Chen Y, Feng L, William WN, Skinner HD, Myers JN, Meyn RE, Li J, Mijiti A, Bankson JA, Fuller CD, Konopleva MY, Lai SY. Metabolic interrogation as a tool to optimize chemotherapeutic regimens. Oncotarget 8(11):18154-18165, 2017. e-Pub 2017. PMID: 28184025.
174. Goepfert RP, Lewin JS, Barrow MP, Gunn GB, Fuller CD, Beadle BM, Garden AS, Rosenthal DI, Kies MS, Papadimitrakopoulou V, Lai SY, Gross ND, Schwartz DL, Hutcheson KA. Long-Term, Prospective Performance of the MD Anderson Dysphagia Inventory in "Low-Intermediate Risk" Oropharyngeal Carcinoma After Intensity Modulated Radiation Therapy. Int J Radiat Oncol Biol Phys 97(4):700-708, 2017. e-Pub 2017. PMID: 27485284.
175. Beadle BM, Liao KP, Giordano SH, Garden AS, Hutcheson KA, Lai SY, Guadagnolo BA. Reduced feeding tube duration with intensity-modulated radiation therapy for head and neck cancer: A Surveillance, Epidemiology, and End Results-Medicare Analysis. Cancer 123(2):283-293, 2017. e-Pub 2017. PMID: 27662641.
176. Chen DW, Lewin JS, Xu L, Lai SY, Gunn GB, Fuller CD, Mohamed AS, Kanwar A, Sturgis EM, Hutcheson KA. Feeding tube utilization in patients with salivary gland malignancies. Otolaryngol Head Neck Surg 156(1):109-117, 2017. e-Pub 2017. PMID: 27576681.
177. Hutcheson KA, Barrow MP, Barringer DA, Knott JK, Lin HY, Weber RS, Fuller CD, Lai SY, Alvarez CP, Raut J, Lazarus CL, May A, Patterson J, Roe JW, Starmer HM, Lewin JS. Dynamic imaging grade of swallowing toxicity (DIGEST): Scale Development and Validation. Cancer 123(1):62-70, 2017. e-Pub 2017. PMID: 27564246.
178. Sandulache VC, Williams MD, Lai SY, Lu C, William WN, Busaidy NL, Cote GJ, Singh RR, Luthra R, Cabanillas ME. Real-Time Genomic Characterization Utilizing Circulating Cell-Free DNA in Patients with Anaplastic Thyroid Carcinoma. Thyroid 27(1):81-87, 2017. e-Pub 2017. PMID: 27785980.
179. Fuller CD, Mohamed AS, Garden AS, Gunn GB, Mulcahy CF, Zafereo M, Phan J, Lai SY, Lewin JS, Hutcheson KA, Frank SJ, Beadle BM, Morrison WH, El-Naggar AK, Kocak-Uzel E, Ginsberg LE, Kies MS, Weber RS, Rosenthal DI. Long-term outcomes after multidisciplinary management of T3 laryngeal squamous cell carcinomas: Improved functional outcomes and survival with modern therapeutic approaches. Head Neck 38(12):1739-1751, 2016. e-Pub 2016. PMID: 27466789.
180. Shiao JC, Mohamed AS, Gunn GB, Hutcheson KA, Kanwar A, Garden AS, Smith J, Phan J, Morrison WH, Lai SY, Beadle BM, Weber RS, Kies MS, Rosenthal DI, Fuller CD. Nontarget Swallowing Muscles Dose-Volume Correlates of Patient-Reported Outcomes After Oropharyngeal Intensity Modulated Radiation Therapy (IMRT). Int J Radiat Oncol Biol Phys 96(2S):E335-E336, 2016. e-Pub 2016. PMID: 27674409.
181. Mohamed AS, Pham BH, Messer JA, Morrison WH, Zafereo M, Hessel AC, Lai SY, Garden AS, Weber RS, Rosenthal DI, Fuller CD. Identification of Anatomic Correlates of Failure in Patients With T4a Larynx Cancer. Int J Radiat Oncol Biol Phys 96(2S):E343, 2016. e-Pub 2016. PMID: 27674433.
182. Pezzi TA, Mohamed AS, Sheu T, Blanchard P, Sandulache VC, Lai SY, Cabanillas ME, Williams MD, Pezzi CM, Lu C, Garden AS, Morrison WH, Rosenthal DI, Fuller CD, Gunn GB. Relationship Between Radiation Therapy Dose and Overall Survival in Anaplastic Thyroid Cancer: Analysis of the National Cancer Data Base. Int J Radiat Oncol Biol Phys 96(2S):E361, 2016. e-Pub 2016. PMID: 27674482.
183. Mohamed AS, Browne TS, Kies MS, Gunn GB, Garden AS, Beadle BM, Phan J, Morrison WH, William WN, Lai SY, Weber RS, Rosenthal DI, Fuller CD. Predictive Significance of Early Response to Induction Chemotherapy in Advanced Larynx Cancer. Int J Radiat Oncol Biol Phys 96(2S):E371-E372, 2016. e-Pub 2016. PMID: 27674512.
184. Mohamed AS, Lai SY, Murri M, Hutcheson KA, Sandulache VC, Hobbs B, Gunn GB, Garg N, Chambers MS, Frank SJ, Rosenthal DI, Garden AS, Fuller CD. Dose-Volume Correlates of Osteoradionecrosis of the Mandible in Oropharynx Patients Receiving Intensity Modulated Radiation Therapy. Int J Radiat Oncol Biol Phys 96(2S):S220-S221, 2016. e-Pub 2016. PMID: 28733053.
185. Joint Head and Neck Radiotherapy-MRI Development Cooperative, Sandulache VC, Hobbs BP, Mohamed AS, Frank SJ, Song J, Ding Y, Ger R, Court LE, Kalpathy-Cramer J, Hazle JD, Wang J, Awan MJ, Rosenthal DI, Garden AS, Gunn GB, Colen RR, Elshafeey N, Elbanan M, Hutcheson KA, Lewin JS, Chambers MS, Hofstede TM, Weber RS, Lai SY, Fuller CD. Dynamic contrast-enhanced MRI detects acute radiotherapy-induced alterations in mandibular microvasculature: prospective assessment of imaging biomarkers of normal tissue injury. Sci Rep 6:29864, 2016. e-Pub 2016. PMID: 27499209.
186. Wang J, Weygand J, Hwang KP, Mohamed AS, Ding Y, Fuller CD, Lai SY, Frank SJ, Zhou J. Magnetic resonance imaging of glucose uptake and metabolism in patients with head and neck cancer. Sci Rep 6:30618, 2016. e-Pub 2016. PMID: 27461165.
187. Jiang W, Mohamed AS, Fuller CD, Kim BY, Tang C, Gunn GB, Hanna EY, Frank SJ, Su SY, Diaz E, Kupferman ME, Beadle BM, Morrison WH, Skinner H, Lai SY, El-Naggar AK, DeMonte F, Rosenthal DI, Garden AS, Phan J. The role of elective nodal irradiation for esthesioneuroblastoma patients with clinically negative neck. Pract Radiat Oncol 6(4):241-7, 2016. e-Pub 2016. PMID: 26979544.
188. Tucker JR, Xu L, Sturgis EM, Mohamed AS, Hofstede TM, Chambers MS, Lai SY, Fuller CD, Beadle B, Gunn GB, Hutcheson KA. Osteoradionecrosis in patients with salivary gland malignancies. Oral Oncol 57:1-5, 2016. e-Pub 2016. PMID: 27208837.
189. Pezzi TA, Sandulache VC, Pezzi CM, Turkeltaub AE, Feng L, Cabanillas ME, Williams MD, Lai SY. Treatment and survival of patients with insular thyroid carcinoma: 508 cases from the National Cancer Data Base. Head Neck 38(6):906-12, 2016. e-Pub 2016. PMID: 26843481.
190. Bharadwaj U, Eckols TK, Xu X, Kasembeli MM, Chen Y, Adachi M, Song Y, Mo Q, Lai SY, Tweardy DJ. Small-molecule inhibition of STAT3 in radioresistant head and neck squamous cell carcinoma. Oncotarget 7(18):26307-30, 2016. e-Pub 2016. PMID: 27027445.
191. Sandulache VC, Vandelaar LJ, Skinner HD, Cata J, Hutcheson K, Fuller CD, Phan J, Siddiqui Z, Lai SY, Weber RS, Zafereo ME. Salvage total laryngectomy after external-beam radiotherapy: a 20-year experience. Head Neck 38 Suppl 1:E1962-8, 2016. e-Pub 2016. PMID: 26879395.
192. Lewis CM, Nurgalieva Z, Sturgis EM, Lai SY, Weber RS. Improving patient outcomes through multidisciplinary treatment planning conference. Head Neck 38 Suppl 1:E1820-5, 2016. e-Pub 2016. PMID: 26690552.
193. Lewis CM, Aloia TA, Shi W, Martin I, Lai SY, Selber JC, Hessel AC, Hanasono MM, Hutcheson KA, Robb GL, Weber RS. Development and feasibility of a specialty-specific National Surgical Quality Improvement Program (NSQIP): the head and neck - reconstructive surgery NSQIP. JAMA Otolaryngol Head Neck Surg 142(4):321-7, 2016. e-Pub 2016. PMID: 26892756.
194. Shoultz-Henley S, Garden AS, Mohamed AS, Sheu T, Kroll MH, Rosenthal DI, Gunn GB, Hayes AJ, French C, Eichelberger H, Kalpathy-Cramer J, Smith BD, Phan J, Ayoub Z, Lai SY, Pham B, Kies M, Gold KA, Sturgis E, Fuller CD. Prognostic value of pre-therapy platelet elevation in oropharyngeal cancer patients treated with chemoradiation. Int J Cancer 138(5):1290-7, 2016. e-Pub 2016. PMID: 26414107.
195. MD Anderson Head and Neck Cancer Symptom Working Group, Dale T, Hutcheson K, Mohamed AS, Lewin JS, Gunn GB, Rao AU, Kalpathy-Cramer J, Frank SJ, Garden AS, Messer JA, Warren B, Lai SY, Beadle BM, Morrison WH, Phan J, Skinner H, Gross N, Ferrarotto R, Weber RS, Rosenthal DI, Fuller CD. Beyond mean pharyngeal constrictor dose for beam path toxicity in non-target swallowing muscles: dose-volume correlates of chronic radiation-associated dysphagia (RAD) after oropharyngeal intensity modulated radiotherapy. Radiother Oncol 118(2):304-14, 2016. e-Pub 2016. PMID: 26897515.
196. Redis RS, Vela LE, Lu W, Ferreira de Oliveira J, Ivan C, Rodriguez-Aguayo C, Adamoski D, Pasculli B, Taguchi A, Chen Y, Fernandez AF, Valledor L, Van Roosbroeck K, Chang S, Shah M, Kinnebrew G, Han L, Atlasi Y, Cheung LH, Huang GY, Monroig P, Ramirez MS, Catela Ivkovic T, Van L, Ling H, Gafà R, Kapitanovic S, Lanza G, Bankson JA, Huang P, Lai SY, Bast RC, Rosenblum MG, Radovich M, Ivan M, Bartholomeusz G, Liang H, Fraga MF, Widger WR, Hanash S, Berindan-Neagoe I, Lopez-Berestein G, Ambrosio AL, Gomes Dias SM, Calin GA. Allele-specific reprogramming of cancer metabolism by the long non-coding RNA CCAT2. Mol Cell 61(4):520-34, 2016. e-Pub 2016. PMID: 26853146.
197. Messer JA, Mohamed AS, Hutcheson KA, Ding Y, Lewin JS, Wang J, Lai SY, Frank SJ, Garden AS, Sandulache V, Eichelberger H, French CC, Colen RR, Phan J, Kalpathy-Cramer J, Hazle JD, Rosenthal DI, Gunn GB, Fuller CD. Magnetic resonance imaging of swallowing-related structures in nasopharyngeal carcinoma patients receiving IMRT: longitudinal dose-response characterization of quantitative signal kinetics. Radiother Oncol 118(2):315-22, 2016. e-Pub 2016. PMID: 26830697.
198. Walker CM, Chen Y, Lai SY, Bankson JA. A novel perfused Bloch-McConnell simulator for analyzing the accuracy of dynamic hyperpolarized MRS. Med Phys 43(2):854-64, 2016. e-Pub 2016. PMID: 26843246.
199. Bennett CL, Lai SY, Sartor O, Georgantopoulos P, Hrushesky WJ, Henke M, Armitage JO. Consensus on the existence of functional erythropoietin receptors on cancer cells. JAMA Oncol 2(1):1-3, 2016. e-Pub 2016. PMID: 26606114.
200. George JR, Henderson YC, Williams MD, Roberts DB, Hei H, Lai SY, Clayman GL. Association of TERT promoter mutation, but not BRAF mutation, with increased mortality in PTC. (*Co-Senior/corresponding authors) J Clin Endocrinol Metab 100(12):E1550-9, 2015. e-Pub 2015. PMID: 26461266.
201. Sandulache VC, Chen Y, Skinner HD, Lu T, Feng L, Court LE, Myers JN, Meyn RE, Fuller CD, Bankson JA, Lai SY. Acute tumor lactate perturbations as a biomarker of genotoxic stress: development of a biochemical model. Mol Cancer Ther 14(12):2901-8, 2015. e-Pub 2015. PMID: 26376962.
202. Ding Y, Hazle JD, Mohamed AS, Frank SJ, Hobbs BP, Colen RR, Gunn GB, Wang J, Kalpathy-Cramer J, Garden AS, Lai SY, Rosenthal DI, Fuller CD. Intravoxel incoherent motion imaging kinetics during chemoradiotherapy for human papillomavirus-associated squamous cell carcinoma of the oropharynx: preliminary results from a prospective pilot study. NMR Biomed 28(12):1645-54, 2015. e-Pub 2015. PMID: 26451969.
203. Bankson JA, Walker CM, Ramirez MS, Stefan W, Fuentes D, Merritt ME, Lee J, Sandulache VC, Chen Y, Phan L, Chou PC, Rao A, Yeung SC, Lee MH, Schellingerhout D, Conrad CA, Malloy C, Sherry AD, Lai SY, Hazle JD. Kinetic modeling and constrained reconstruction of hyperpolarized [1-13C]-pyruvate offers improved metabolic imaging of tumors. Cancer Res 75(22):4708-17, 2015. e-Pub 2015. PMID: 26420214.
204. Lee J, Ramirez MS, Walker CM, Chen Y, Yi S, Sandulache VC, Lai SY, Bankson JA. High-throughput hyperpolarized (13)C metabolic investigations using a multi-channel acquisition system. J Magn Reson 260:20-7, 2015. e-Pub 2015. PMID: 26397217.
205. Agrawal A, Civantos FJ, Brumund KT, Chepeha DB, Hall NC, Carroll WR, Smith RB, Zitsch RP, Lee WT, Shnayder Y, Cognetti DM, Pitman KT, King DW, Christman LA, Lai SY. [(99m)Tc]Tilmanocept accurately detects sentinel lymph nodes and predicts node pathology status in patients with oral squamous cell carcinoma of the head and neck: results of a phase III multi-institutional trial. Ann Surg Oncol 22(11):3708-15, 2015. e-Pub 2015. PMID: 25670018.
206. Ding Y, Mohamed AS, Yang J, Colen RR, Frank SJ, Wang J, Wassal EY, Wang W, Kantor ME, Balter PA, Rosenthal DI, Lai SY, Hazle JD, Fuller CD. Prospective observer and software-based assessment of magnetic resonance imaging quality in head and neck cancer: should standard positioning and immobilization be required for radiation therapy applications?. Pract Radiat Oncol 5(4):e299-308, 2015. e-Pub 2015. PMID: 25544553.
207. Bhayani MK, Acharya V, Kongkiatkamon S, Farah S, Roberts DB, Sterba J, Chambers MS, Lai SY. Sialendoscopy for patients with radioiodine-induced sialadenitis and xerostomia. Thyroid 25(7):834-8, 2015. e-Pub 2015. PMID: 25860842.
208. Zhou M, Chen Y, Adachi M, Wen X, Erwin B, Mawlawi O, Lai SY, Li C. Single agent nanoparticle for radiotherapy and radio-photothermal therapy in anaplastic thyroid cancer. (*Co-corresponding authors) Biomaterials 57:41-49, 2015. e-Pub 2015. PMID: 25913249.
209. Lewis CM, Monroe MM, Roberts DB, Hessel AC, Lai SY, Weber RS. An audit and feedback system for effective quality improvement in head and neck surgery: can we become better surgeons?. Cancer 121(10):1581-7, 2015. e-Pub 2015. PMID: 25639485.
210. Ramirez MS, Lee J, Walker CM, Chen Y, Kingsley CV, De La Cerda J, Maldonado KL, Lai SY, Bankson JA. Feasibility of multianimal hyperpolarized (13) C MRS. Magn Reson Med 73(5):1726-32, 2015. e-Pub 2015. PMID: 24903532.
211. Smith BG, Hutcheson KA, Little LG, Skoracki RJ, Rosenthal DI, Lai SY, Lewin JS. Lymphedema outcomes in patients with head and neck cancer. Otolaryngol Head Neck Surg 152(2):284-91, 2015. e-Pub 2015. PMID: 25389318.
212. Henderson YC, Ahn SH, Ryu J, Chen Y, Williams MD, El-Naggar AK, Gagea M, Schweppe RE, Haugen BR, Lai SY, Clayman GL. Development and characterization of six new human papillary thyroid carcinoma cell lines. (*Co-senior/corresponding authors) J Clin Endocrinol Metab 100(2):E243-52, 2015. e-Pub 2015. PMID: 25427145.
213. Le X, Huang AT, Chen Y, Lai SY. Regulation of receptor tyrosine kinases by miRNA: overexpression of miRNA using lentiviral inducible expression vectors. Methods Mol Biol 1233:135-47, 2015. e-Pub 2015. PMID: 25319896.
214. Pickering CR, Zhou JH, Lee JJ, Drummond JA, Peng SA, Saade RE, Tsai KY, Curry JL, Tetzlaff MT, Lai SY, Yu J, Muzny DM, Doddapaneni H, Shinbrot E, Covington KR, Zhang J, Seth S, Caulin C, Clayman GL, El-Naggar AK, Gibbs RA, Weber RS, Myers JN, Wheeler DA, Frederick MJ. Mutational landscape of aggressive cutaneous squamous cell carcinoma. Clin Cancer Res 20(24):6582-92, 2014. e-Pub 2014. PMID: 25303977.
215. Ramirez MS, Lee J, Walker CM, Sandulache VC, Hennel F, Lai SY, Bankson JA. Radial spectroscopic MRI of hyperpolarized [1-(13) C] pyruvate at 7 tesla. Magn Reson Med 72(4):986-95, 2014. e-Pub 2014. PMID: 24186845.
216. Monroe MM, Lai SY. Sentinel lymph node biopsy for oral cancer: supporting evidence and recent novel developments. Curr Oncol Rep 16(5):385, 2014. e-Pub 2014. PMID: 24633882.
217. Henderson YC, Toro-Serra R, Chen Y, Ryu J, Frederick MJ, Zhou G, Gallick GE, Lai SY, Clayman GL. Src inhibitors in suppression of papillary thyroid carcinoma growth. (*Co-senior/corresponding authors) Head Neck 36(3):375-84, 2014. e-Pub 2014. PMID: 23729178.
218. Thomas L, Lai SY, Dong W, Feng L, Dadu R, Regone RM, Cabanillas ME. Sorafenib in metastatic thyroid cancer: a systematic review. Oncologist 19(3):251-8, 2014. e-Pub 2014. PMID: 24563075.
219. Ahn SH, Henderson YC, Williams MD, Lai SY, Clayman GL. Detection of thyroid cancer stem cells in papillary thyroid carcinoma. (*co-senior/corresponding authors) J Clin Endocrinol Metab 99(2):536-44, 2014. e-Pub 2014. PMID: 24302752.
220. Sandulache VC, Chen Y, Lee J, Rubinstein A, Ramirez MS, Skinner HD, Walker CM, Williams MD, Tailor R, Court LE, Bankson JA, Lai SY. Evaluation of hyperpolarized [1-13C]- pyruvate by magnetic resonance to detect ionizing radiation effects in real time. PLoS One 9(1):e87031, 2014. e-Pub 2014. PMID: 24475215.
221. El-Sawy T, Frank SJ, Hanna E, Sniegowski M, Lai SY, Nasser QJ, Myers J, Esmaeli B. Multidisciplinary management of lacrimal sac/nasolacrimal duct carcinomas. Ophthal Plast Reconstr Surg 29(6):454-7, 2013. e-Pub 2013. PMID: 24195987.
222. Bhayani MK, Hutcheson KA, Barringer DA, Lisec A, Alvarez CP, Roberts DB, Lai SY, Lewin JS. Gastrostomy tube placement in patients with oropharyngeal carcinoma treated with radiotherapy or chemoradiotherapy: factors affecting placement and dependence. Head Neck 35(11):1634-40, 2013. e-Pub 2013. PMID: 23322563.
223. Hutcheson KA, Bhayani MK, Beadle BM, Gold KA, Shinn EH, Lai SY, Lewin J. Eat and exercise during radiotherapy or chemoradiotherapy for pharyngeal cancers: Use it or lose it. JAMA Otolaryngol Head Neck Surg 139(11):1127-34, 2013. e-Pub 2013. PMID: 24051544.
224. Bhayani MK, Hutcheson KA, Barringer DA, Roberts DB, Lewin JS, Lai SY. Gastrostomy tube placement in patients with hypopharyngeal cancer treated with radiotherapy or chemoradiotherapy: Factors affecting placement and dependence. Head Neck 35(11):1641-6, 2013. e-Pub 2013. PMID: 23322545.
225. Wu X, Bhayani MK, Dodge CT, Nicoloso MS, Chen Y, Yan X, Adachi M, Thomas L, Galer CE, Jiffar T, Pickering CR, Kupferman ME, Myers JN, Calin GA, Lai SY. Coordinated targeting of the EGFR signaling axis by microRNA-27a*. Oncotarget 4(9):1388-98, 2013. e-Pub 2013. PMID: 23963114.
226. Fatani HA, Sunbuli M, Lai SY, Bell D. Phosphaturic mesenchymal tumor: a report of 6 patients treated at a single institution and comparison with reported series. Ann Diagn Pathol 17(4):319-21, 2013. e-Pub 2013. PMID: 22981782.
227. Peng S, Creighton CJ, Zhang Y, Sen B, Mazumdar T, Myers JN, Lai SY, Woolfson A, Lorenzi MV, Bell D, Williams MD, Johnson FM. Tumor grafts derived from patients with head and neck squamous carcinoma authentically maintain the molecular and histologic characteristics of human cancers. J Transl Med 11(198), 2013. e-Pub 2013. PMID: 24621392.
228. Adachi M, Mitsudo K, Yamamoto N, Hagiwara S, Shigetomi T, Fujimoto Y, Lai SY, Tohnai I. Chemoradiotherapy for maxillary sinus adenoid cystic carcinoma using superselective intra-arterial infusion via a superficial temporal artery. Head Neck 35(3):E89-93, 2013. e-Pub 2013. PMID: 21953943.
229. Ramirez MS, Lai SY, Bankson JA. A throughput-optimized array system for multiple-mouse MRI. NMR Biomed 26(3):237-47, 2013. e-Pub 2013. PMID: 22887122.
230. Adachi M, Cui C, Dodge CT, Bhayani MK, Lai SY. Targeting STAT3 inhibits growth and enhances radiosensitivity in head and neck squamous cell carcinoma. Oral Oncol 48(12):1220-6, 2012. e-Pub 2012. PMID: 22770899.
231. Hamilton JD, Lai SY, Ginsberg LE. Superimposed infection in mandibular osteoradionecrosis: diagnosis and outcomes. J Comput Assist Tomogr 36(6):725-31, 2012. e-Pub 2012. PMID: 23192211.
232. Bennett CL, Spiegel DM, Macdougall IC, Norris L, Qureshi ZP, Sartor O, Lai SY, Tallman MS, Raisch DW, Smith SW, Silver S, Murday AS, Armitage JO, Goldsmith D. A review of safety, efficacy, and utilization of erythropoietin, darbepoetin, and peginesatide for patients with cancer or chronic kidney disease: a report from the Southern Network on Adverse Reactions (SONAR). Semin Thromb Hemost 38(8):783-96, 2012. e-Pub 2012. PMID: 23111861.
233. Sandulache VC, Skinner HD, Wang Y, Chen Y, Dodge CT, Ow TJ, Bankson JA, Myers JN, Lai SY. Glycolytic inhibition alters anaplastic thyroid carcinoma tumor metabolism and improves response to conventional chemotherapy and radiation. Mol Cancer Ther 11(6):1373-80, 2012. e-Pub 2012. PMID: 22572813.
234. Sen B, Peng SH, Woods DM, Wistuba I, Bell D, El-Naggar AK, Lai SY, Johnson FM. STAT5A-mediated SOCS2 expression regulates Jak2 and STAT3 activity following c-Src inhibition in head and neck squamous carcinoma. Clin Cancer Res 18(1):127-39, 2012. e-Pub 2012. PMID: 22090359.
235. Argiris A, Karamouzis MV, Smith R, Kotsakis A, Gibson MK, Lai SY, Kim S, Branstetter BF, Shuai Y, Romkes M, Wang L, Grandis JR, Ferris RL, Johnson JT, Heron DE. Phase I trial of pemetrexed in combination with cetuximab and concurrent radiotherapy in patients with head and neck cancer. Ann Oncol 22(11):2482-8, 2011. e-Pub 2011. PMID: 21363880.
236. Murata S, Adachi M, Kioi M, Torigoe S, Ijichi K, Hasegawa Y, Ogawa T, Bhayani MK, Lai SY, Mitsudo K, Tohnai I. Etodolac improves 5-FU sensitivity of head and neck cancer cells through inhibition of thymidylate synthase. Anticancer Res 31(9):2893-8, 2011. e-Pub 2011. PMID: 21868535.
237. Ragan DK, Lai SY, Bankson JA. Fast, reproducible measurement of the vascular input function in mice using constrained reconstruction and cardiac sampling. NMR Biomed 24(4):373-84, 2011. e-Pub 2011. PMID: 20862661.
238. Feinstein TM, Lai SY, Lenzner D, Gooding W, Ferris RL, Grandis JR, Myers EN, Johnson JT, Heron DE, Argiris A. Prognostic factors in patients with high-risk locally advanced salivary gland cancers treated with surgery and postoperative radiotherapy. Head Neck 33(3):318-23, 2011. e-Pub 2011. PMID: 21284048.
239. Schwartz DL, Bankson J, Bidaut L, He Y, Williams R, Lemos R, Thitai AK, Oh J, Volgin A, Soghomonyan S, Yeh HH, Nishii R, Mukhopadhay U, Alauddin M, Mushkudiani I, Kuno N, Krishnan S, Bornman W, Lai SY, Powis G, Hazle J, Gelovani J. HIF-1-dependent stromal adaptation to ischemia mediates in vivo tumor radiation resistance. Mol Cancer Res 9(3):259-70, 2011. e-Pub 2011. PMID: 21364021.
240. Gule MK, Chen Y, Sano D, Frederick MJ, Zhou G, Zhao M, Milas ZL, Galer CE, Henderson YC, Jasser SA, Schwartz DL, Bankson JA, Myers JN, Lai SY. Targeted therapy of VEGFR2 and EGFR significantly inhibits growth of anaplastic thyroid cancer in an orthotopic murine model. Clin Cancer Res 17(8):2281-91, 2011. e-Pub 2011. PMID: 21220477.
241. Weber RS, Lewis CM, Eastman SD, Hanna EY, Akiwumi O, Hessel AC, Lai SY, Kian L, Kupferman ME, Roberts DB. Quality and performance indicators in an academic department of head and neck surgery. Arch Otolaryngol Head Neck Surg 136(12):1212-8, 2010. e-Pub 2010. PMID: 21173370.
242. Argiris A, Heron DE, Smith RP, Kim S, Gibson MK, Lai SY, Branstetter BF, Posluszny DM, Wang L, Seethala RR, Dacic S, Gooding W, Grandis JR, Johnson JT, Ferris RL. Induction docetaxel, cisplatin, and cetuximab followed by concurrent radiotherapy, cisplatin, and cetuximab and maintenance cetuximab in patients with locally advanced head and neck cancer. J Clin Oncol 28(36):5294-300, 2010. e-Pub 2010. PMID: 21079141.
243. Passero VA, Branstetter BF, Shuai Y, Heron DE, Gibson MK, Lai SY, Kim SW, Grandis JR, Ferris RL, Johnson JT, Argiris A. Response assessment by combined PET-CT versus CT scan alone using RECIST in patients with locally advanced head and neck cancer treated with chemoradiotherapy. Ann Oncol 21(11):2278-83, 2010. e-Pub 2010. PMID: 20430907.
244. Wheeler SE, Suzuki S, Thomas SM, Sen M, Leeman-Neill RJ, Chiosea SI, Kuan CT, Bigner DD, Gooding WE, Lai SY, Grandis JR. Epidermal growth factor receptor variant III mediates head and neck cancer cell invasion via STAT3 activation. Oncogene 29(37):5135-45, 2010. e-Pub 2010. PMID: 20622897.
245. Lewis CM, Bell DM, Lai SY. Pathology quiz case: calcifying fibrous pseudotumor (CFT) of the oral cavity. Arch Otolaryngol Head Neck Surg 136(8):841, 843-4, 2010. e-Pub 2010. PMID: 20713769.
246. Henderson YC, Chen Y, Frederick MJ, Lai SY, Clayman GL. MEK inhibitor PD0325901 significantly reduces the growth of papillary thyroid carcinoma cells in vitro and in vivo. (*Co-senior/corresponding authors). Mol Cancer Ther 9(7):1968-76, 2010. e-Pub 2010. PMID: 20587665.
247. Schwartz DL, Bankson JA, Lemos R, Lai SY, Thittai AK, He Y, Hostetter G, Demeure MJ, Von Hoff DD, Powis G. Radiosensitization and stromal imaging response correlates for the HIF-1 inhibitor PX-478 given with or without chemotherapy in pancreatic cancer. Mol Cancer Ther 9(7):2057-67, 2010. e-Pub 2010. PMID: 20587661.
248. Bennett CL, McKoy JM, Henke M, Silver SM, MacDougall IC, Birgegaard G, Luminari S, Casadevall N, Schellekens H, Sartor O, Lai SY, Armitage JO. Reassessments of ESAs for cancer treatment in the US and Europe. Oncology (Williston Park) 24(3):260-8, 2010. e-Pub 2010. PMID: 20394138.
249. Epperly MW, Lai SY, Kanai AJ, Mason N, Lopresi B, Dixon T, Franicola D, Niu Y, Wilson WR, Greenberger JS. Effectiveness of combined modality radiotherapy of orthotopic human squamous cell carcinomas in Nu/Mu mice using cetuximab, tirapazamine and MnSOD-plasmid liposome gene therapy. In Vivo 24(1):1-8, 2010. e-Pub 2010.
250. Heron DE, Ferris RL, Karamouzis M, Andrade RS, Deeb EL, Burton S, Gooding WE, Branstetter BF, Mountz JM, Johnson JT, Argiris A, Grandis JR, Lai SY. Stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: results of a phase 1-dose-escalation trial. Int J Radiat Oncol Biol Phys 75(5):1493-500, 2009. e-Pub 2009. PMID: 19464819.
251. Ward BK, Seethala RR, Barnes EL, Lai SY. Basal cell adenocarcinoma of a hard palate minor salivary gland: case report and review of the literature. Head Neck Oncol 1:41, 2009. e-Pub 2009.
252. Cano ER, Lai SY, Caylakli F, Johnson JT, Ferris RL, Carrau RL, Snyderman CH, Gooding WE, Jr SA, Myers EN. Management of squamous cell carcinoma of the base of tongue with chemoradiation and brachytherapy. (*Co-first authors). Head Neck 31(11):1431-8, 2009. e-Pub 2009. PMID: 19405086.
253. Lai SY, Koppikar P, Thomas SM, Childs EE, Egloff AM, Seethala RR, Branstetter BF, Gooding WE, Muthukrishnan A, Mountz JM, Lui VW, Shin DM, Agarwala SS, Johnson R, Couture LA, Myers EN, Johnson JT, Mills G, Argiris A, Grandis JR. Intratumoral epidermal growth factor receptor antisense DNA therapy in head and neck cancer: first human application and potential antitumor mechanisms. J Clin Oncol 27(8):1235-42, 2009. e-Pub 2009.
254. Lai SY, Walvekar RR, Ferris RL. Minimally invasive video-assisted thyroidectomy: expanded indications and oncologic completeness. Head Neck 30(11):1403-7, 2008. e-Pub 2008.
255. Nance MA, Seethala RR, Wang Y, Chiosea SI, Myers EN, Johnson JT, Lai SY. Treatment and survival outcomes based on histologic grading in patients with head and neck mucoepidermoid carcinoma. Cancer 113(8):2082-9, 2008. e-Pub 2008.
256. Deleyiannis FW, Rogers C, Ferris RL, Lai SY, Kim S, Johnson J. Reconstruction of the through-and-through anterior mandibulectomy defect: indications and limitations of the double-skin paddle fibular free flap. Laryngoscope 118(8):1329-34, 2008. e-Pub 2008. PMID: 18438259.
257. Lai SY, Ziober AF, Lee MN, Cohen NA, Falls EM, Ziober BL. Activated Vav2 modulates cellular invasion through Rac1 and Cdc42 in oral squamous cell carcinoma. Oral Oncol 44(7):683-8, 2008. e-Pub 2008. PMID: 17996485.
258. Chiosea SI, Barnes EL, Lai SY, Egloff AM, Sargent RL, Hunt JL, Seethala RR. Mucoepidermoid carcinoma of upper aerodigestive tract: clinicopathologic study of 78 cases with immunohistochemical analysis of dicer expression. Virchows Arch 452(6):629-35, 2008. e-Pub 2008. PMID: 18239938.
259. Deleyiannis FW, Dunklebarger J, Lee E, Gastman B, Lai SY, Ferris R, Myers EN, Johnson J. Reconstruction of the marginal mandibulectomy defect: an update. Am J Otolaryngol 28(6):363-6, 2007. e-Pub 2007. PMID: 17980765.
260. Nayak JV, Walvekar RR, Andrade RS, Branstetter BF, Daamen N, Lai SY, Argiris A, Smith RP, Heron DE, Ferris RL, Johnson JT. Deferring planned neck dissection following chemoradiation for stage IV head and neck cancer: the utility of PET-CT. Laryngoscope 117(12):2129-34, 2007. e-Pub 2007. PMID: 17921898.
261. Deleyiannis FW, Rogers C, Lee E, Russavage J, Gastman B, Dunklebarger J, Lai SY, Ferris R, Myers EN, Johnson J. Reconstruction of the lateral mandibulectomy defect: management based on prognosis and location and volume of soft tissue resection. Laryngoscope 116(11):2071-80, 2006. e-Pub 2006. PMID: 17075408.
262. Lai SY, Childs EE, Xi S, Coppelli FM, Gooding WE, Wells A, Ferris RL, Grandis JR. Erythropoietin-mediated activation of JAK-STAT signaling contributes to cellular invasion in head and neck squamous cell carcinoma. Oncogene 24(27):4442-9, 2005. e-Pub 2005. PMID: 15856028.
263. Mohyeldin A, Lu H, Dalgard C, Lai SY, Cohen N, Acs G, Verma A. Erythropoietin signaling promotes invasiveness of human head and neck squamous cell carcinoma. Neoplasia 7(5):537-43, 2005. e-Pub 2005.
264. Cohen NA, Lai SY, Ziober AF, Ziober BL. Dysregulation of hypoxia inducible factor-1alpha in head and neck squamous cell carcinoma cell lines correlates with invasive potential. Laryngoscope 114(3):418-23, 2004. e-Pub 2004. PMID: 15091212.
265. Lai SY, Kennedy DW, Bolger WE. Sphenoid encephaloceles: disease management and identification of lesions within the lateral recess of the sphenoid sinus. Laryngoscope 112(10):1800-5, 2002. e-Pub 2002. PMID: 12368619.
266. Lai SY, Deffenderfer OF, Hanson W, Phillips MP, Thaler ER. Identification of upper respiratory bacterial pathogens with the electronic nose. Laryngoscope 112(6):975-9, 2002. e-Pub 2002. PMID: 12160294.
267. Wolfe SG, Lai SY, Bigelow DC. Bilateral squamous cell carcinoma of the external auditory canals. Laryngoscope 112(6):1003-5, 2002. e-Pub 2002. PMID: 12160263.
268. Lai SY, Weinstein GS, Chalian AA, Rosenthal DI, Weber RS. Parotidectomy in the treatment of aggressive cutaneous malignancies. Arch Otolaryngol Head Neck Surg 128(5):521-6, 2002. e-Pub 2002. PMID: 12003582.
269. Gendron KM, Lai SY, Weinstein GS, Chalian AA, Husbands JM, Wolf PF, DiDonato L, Weber RS. Clinical care pathway for head and neck cancer: a valuable tool for decreasing resource utilization. Arch Otolaryngol Head Neck Surg 128(3):258-262, 2002. e-Pub 2002. PMID: 11886340.
270. Shah SS, Lai SY, Ruchelli E, Kazahaya K, Mahboubi S. Retropharyngeal aberrant thymus. Pediatrics 108(5):E94, 2001. e-Pub 2001. PMID: 11694678.
271. Lai SY, Kelleher K, Sataloff RT. Vocal fold granuloma: The "ball-valve" phenomenon. Ear Nose Throat J 79(11):836, 2000. e-Pub 2000. PMID: 11107684.
272. Gaffen SL, Lai SY, Longmore GD, Liu KD, Goldsmith MA. Genetic evidence for an additional factor required for erythropoietin-induced signal transduction. Blood 94(1):74-86, 1999. e-Pub 1999. PMID: 10381500.
273. Watowich SS, Liu KD, Xie X, Lai SY, Mikami A, Longmore GD, Goldsmith MA. Oligomerization and scaffolding functions of the erythropoietin receptor cytoplasmic tail. J Biol Chem 274(9):5415-21, 1999. e-Pub 1999. PMID: 10026152.
274. Bauer JH, Liu KD, You Y, Lai SY, Goldsmith MA. Heteromerization of the gamma-c chain with the interleukin-9 receptor alpha subunit leads to STAT activation and prevention of apoptosis. J Biol Chem 273(15):9255-60, 1998. e-Pub 1998. PMID: 9535918.
275. Longmore GD, You Y, Molden J, Liu KD, Mikami A, Lai SY, Pharr P, Goldsmith MA. Redundant and selective roles for erythropoietin receptor tyrosines in erythropoiesis in vivo. Blood 91(3):870-8, 1998. e-Pub 1998. PMID: 9446647.
276. Lai SY, Molden J, Goldsmith MA. Shared gamma(-c) subunit within the human interleukin-7 receptor complex. A molecular basis for the pathogenesis of X-linked severe combined immunodeficiency. J Clin Invest 99(2):169-77, 1997. e-Pub 1997.
277. Lai SY, Molden J, Liu KD, Puck JM, White MD, Goldsmith MA. Interleukin-4-specific signal transduction events are driven by homotypic interactions of the interleukin-4 receptor alpha subunit. EMBO J 15(17):4506-14, 1996. e-Pub 1996. PMID: 8887542.
278. Gaffen SL, Lai SY, Ha M, Liu X, Hennighausen L, Greene WC, Goldsmith MA. Distinct tyrosine residues within the interleukin-2 receptor beta chain drive signal transduction specificity, redundancy, and diversity. J Biol Chem 271(35):21381-90, 1996. e-Pub 1996. PMID: 8702919.
279. Lai SY, Xu W, Gaffen SL, Liu KD, Longmore GD, Greene WC, Goldsmith MA. The molecular role of the common gamma-c subunit in signal transduction reveals functional asymmetry within multimeric cytokine receptor complexes. Proc Natl Acad Sci U S A 93(1):231-5, 1996. e-Pub 1996.
280. Goldsmith MA, Lai SY, Xu W, Amaral MC, Kuczek ES, Parent LJ, Mills GB, Tarr KL, Longmore GD, Greene WC. Growth signal transduction by the human interleukin-2 receptor requires cytoplasmic tyrosines of the beta chain and non-tyrosine residues of the gamma-c chain. J Biol Chem 270(37):21729-37, 1995. e-Pub 1995. PMID: 7665592.
281. Liu KD, Lai SY, Goldsmith MA, Greene WC. Identification of a variable region within the cytoplasmic tail of the IL-2 receptor beta chain that is required for growth signal transduction. J Biol Chem 270(38):22176-81, 1995. e-Pub 1995. PMID: 7545674.
282. Gaffen SL, Lai SY, Xu W, Gouilleux F, Groner B, Goldsmith MA, Greene WC. Signaling through the interleukin 2 receptor beta chain activates a STAT-5-like DNA-binding activity. Proc Natl Acad Sci U S A 92(16):7192-6, 1995. e-Pub 1995. PMID: 7543676.

Invited Articles

1. Hamza A, Yao CMKL, Lai SY, Bell D. Clear Cell Tumor of the Maxilla with MAML2 and EWSR1 Gene Rearrangements: A True Hybrid or a FISH Fumble?. AJSP Rev Rep, 2019.
2. Cabanillas ME, Dadu R, Hu MI, Lu C, Gunn GB, Grubbs EG, Lai SY, Williams MD. Thyroid gland malignancies. Hematol Oncol Clin North Am 29(6):1123-43, 2015. e-Pub 2015. PMID: 26568552.
3. Lai SY, Fuller CD, Bhattacharya PK, Frank SJ. Metabolic imaging as a biomarker of early radiation response in tumors. Clin Cancer Res 21(22):4996-8, 2015. e-Pub 2015. PMID: 26232369.
4. Bhayani MK, Holsinger FC, Lai SY. A shifting paradigm for patients with head and neck cancer: transoral robotic surgery (TORS). Oncology (Williston Park) 24(11):1010-5, 2010. e-Pub 2010. PMID: 21155450.
5. Lai SY, Johnson FM. Defining the role of the JAK-STAT pathway in head and neck and thoracic malignancies: implications for future therapeutic approaches. Drug Resist Updat 13(3):67-78, 2010. e-Pub 2010. PMID: 20471303.
6. Bennett CL, Samaras AT, Lai SY. Erythropoietin therapy for cancer patients: a review of scientific findings and policy decisions. Healthcare Bulletin, 2008. e-Pub 2008.
7. Lai SY. Book Review: Voice conservation surgery for laryngeal and hypopharyngeal cancer. Laryngoscope 117:385, 2007. e-Pub 2007.
8. Grandis JR, Battey JF, Califf RM, Chole RA, Gantz BJ, Gates GA, Gorelic L, Hannley MT, Hardwick KS, Harris JP, Kapoor WN, Lai SY, Lalwani AK, Minor LB, Nadol JP, Post JC, Roland PS, Schechter AM, Schuller DE, Sklare DA, Wackym PA, Weber RS, Jr WE, Wolf GT, Woodson GE. Research education and training in otolaryngology: meeting summary and research opportunities. Otolaryngol Head Neck Surg 135(3):361-7, 2006. e-Pub 2006. PMID: 16949965.
9. Lai SY. Book Review: Principles and practice of head and neck oncology. Head Neck 28:477, 2006. e-Pub 2006.
10. Lai SY, Grandis JR. Treating head and neck cancer. Coping With Cancer 19(2):38, 2005. e-Pub 2005.
11. Lai SY. Erythropoietin therapy in patients with head and neck squamous cell carcinoma may worsen locoregional control and survival. Abstr Hematol Oncol 7:5-7, 2004. e-Pub 2004.
12. Lai SY, Weber RS. Cutaneous malignancies of the head and neck. Oper Tech Gen Surg 6:132-42, 2004. e-Pub 2004.
13. Becker DG, Lai SY, Schipor I, Becker SS. Analysis in otoplasty. Facial Plast Surg Clin North Am 11(3):297-305, 2003. e-Pub 2003. PMID: 15062258.
14. Lai SY, Weinstein GS. Supracricoid partial laryngectomy with cricohyoidoepiglottopexy. Oper Tech Otolayngol Head Neck Surg 14:34-39, 2003.
15. Lai SY, Weinstein GS. Supracricoid partial laryngectomy with cricohyoidoepiglottopexy. Oper Tech Otolaryngol Head Neck Surg 14:34-9, 2003. e-Pub 2003.
16. Lai SY, Weinstein GS. Tracheostomy: a safe and expeditious method. Oper Tech Otolaryngol Head Neck Surg 14:51-4, 2003. e-Pub 2003.
17. Lai SY, Tom LWC. Allergic rhinitis in children. Curr Opin Otolaryngol Head Neck Surg 9(6):359, 2001. e-Pub 2001.

Review Articles

1. Chegini, S, Schilling, C, Walgama, E, Yu, KM, Thankappan, K, Iyer, S, Cariati, P, Balasubramanian, D, Kanatas, A, Lai, SY, McGurk, M. Neck failure following pathologically node-negative neck dissection (pN0) in oral squamous cell carcinoma. British Journal of Oral and Maxillofacial Surgery 59(10):1157-1165, 2021. e-Pub 2021. PMID: 34281738.
2. Johnson JM, Lai SY, Cotzia P, Cognetti D, Luginbuhl A, Pribitkin EA, Zhan T, Mollaee M, Domingo-Vidal M, Chen Y, Campling B, Bar-Ad V, Birbe R, Tuluc M, Martinez Outschoorn U, Curry J. Mitochondrial metabolism as a treatment target in anaplastic thyroid cancer. Semin Oncol 42(6):915-22, 2015. e-Pub 2015. PMID: 26615136.
3. Bhayani MK, Calin GA, Lai SY. Functional relevance of miRNA* sequences in human disease. Mutat Res 731(1-2):14-9, 2012. e-Pub 2012. PMID: 22085809.
4. Bennett CL, Lai SY, Henke M, Barnato SE, Armitage JO, Sartor O. Association between pharmaceutical support and basic science research on erythropoiesis-stimulating agents. Arch Intern Med 170(16):1490-8, 2010. e-Pub 2010. PMID: 20837837.
5. Cognetti DM, Weber RS, Lai SY. Head and neck cancer: an evolving treatment paradigm. Cancer 113(7 Suppl):1911-32, 2008. e-Pub 2008.
6. Bennett CL, Silver SM, Djulbegovic B, Samaras AT, Blau CA, Gleason KJ, Barnato SE, Elverman KM, Courtney DM, McKoy JM, Edwards BJ, Tigue CC, Raisch DW, Yarnold PR, Dorr DA, Kuzel TM, Tallman MS, Trifilio SM, West DP, Lai SY, Henke M. Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia. JAMA 299(8):914-24, 2008. e-Pub 2008. PMID: 18314434.
7. Lin CJ, Grandis JR, Carey TE, Gollin SM, Whiteside TL, Koch WM, Ferris RL, Lai SY. Head and neck squamous cell carcinoma cell lines: established models and rationale for selection. Head Neck 29(2):163-88, 2007. e-Pub 2007. PMID: 17312569.
8. Lai SY, Weber RS. High-risk non-melanoma skin cancer of the head and neck. Curr Oncol Rep 7(2):154-8, 2005. e-Pub 2005. PMID: 15717950.
9. Gadiparthi S, Lai SY, Ferris RL, Branstetter BF. Radiology quiz case 2. Parapharyngeal second branchial cleft cyst. Arch Otolaryngol Head Neck Surg 130(9):1121, 1124-5, 2004. e-Pub 2004. PMID: 15381605.

Other Articles

1. Amaria RN, Reddy SM, Tawbi HA, Davies MA, Ross MI, Glitza IC, Cormier JN, Lewis C, Hwu WJ, Hanna E, Diab A, Wong MK, Royal R, Gross N, Weber R, Lai SY, Ehlers R, Blando J, Milton DR, Woodman S, Kageyama R, Wells DK, Hwu P, Patel SP, Lucci A, Hessel A, Lee JE, Gershenwald J, Simpson L, Burton EM, Posada L, Haydu L, Wang L, Zhang S, Lazar AJ, Hudgens CW, Gopalakrishnan V, Reuben A, Andrews MC, Spencer CN, Prieto V, Sharma P, Allison J, Tetzlaff MT, Wargo JA Author Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma. Nat Med 24(12):1941, 2018. PMID: 30361510.
2. Lai SY Advances in diagnostic options for patients with head and neck cancer. Support for People with Oral and Head and Neck Cancer, Inc, 2014.
3. Lai SY Sialendoscopy: treating patients with salivary gland dysfunction following radioiodine therapy. Endoperspectives, Department of Endocrine Neoplasia & HD Newsletter, The University of Texas MD Anderson Cancer Center, 2013.
4. Samaras AT, Bennett CL, Lai SY Anemia drugs pose risks for cancer and chronic kidney disease patients: usage guidelines become increasingly restrictive. Consumer Reports, 2009.
5. Lai SY Protectionism: a threat to individual freedom. The Freeman 12:9-11, 1987.

Editorials

1. Lai SY, Ferris RL. Evolving Evidence in Support of Sentinel Lymph Node Biopsy for Early-Stage Oral Cavity Cancer. J Clin Oncol 38(34):3983-3986, 2020. PMID: 33052758.
2. Lai SY, Grandis JR. Understanding the presence and function of erythropoietin receptors on cancer cells. J Clin Oncol 24(29):4675-6, 2006. PMID: 17028292.

Abstracts

1. Choi, KY, Hao, Q, Carlisle, K, Hollenbeak, CS, Lai, SY. ASO Visual Abstract. Annals of surgical oncology 30(12):7699, 2023. e-Pub 2023. PMID: 37592087.
2. MD Anderson Head and Neck Cancer Symptom Working Group, Grant S, Kamal M, Mohamed ASR, Zaveri J, Barrow MP, Gunn GB, Lai SY, Lewin JS, Rosenthal DI, Wang XS, Fuller CD, Hutcheson KA. Single-item discrimination of quality-of-life-altering dysphagia among 714 long-term oropharyngeal cancer survivors: Comparison of patient-reported outcome measures of swallowing. Cancer. e-Pub 2019. PMID: 30633325.
3. Hutcheson K, McMillan H, Porsche-Bockeloh C, Savage K, Buoy S, Fuller D, Lai SY, Woodman K, Warneke C, Lewin JS. Manual Therapy for Fibrosis-Related Late Effect Dysphagia in Head and Neck Cancer Survivors: Preliminary Results of the Pilot MANTLE trial. AHNS 10th International Conference on Head and Neck Cancer - “Survivorship through Quality and Innovation", 2019. e-Pub 2019.
4. Head MD, Working Group NCS, Grant S, Kamal M, Mohamed ASR, Zaveri J, Barrow MP, Gunn GB, Lai SY, Lewin JS, Rosenthal DI, Wang XS, Fuller CD, Hutcheson KA. Single-item discrimination of quality-of-life-altering dysphagia among 714 long-term oropharyngeal cancer survivors: Comparison of patient-reported outcome measures of swallowing. Cancer. e-Pub 2019. PMID: 30633325.
5. Hutcheson K, McMillan H, Porsche-Bockeloh C, Savage K, Buoy S, Fuller D, Lai SY, Woodman K, Warneke C, Lewin JS. Manual Therapy for Fibrosis-Related Late Effect Dysphagia in Head and Neck Cancer Survivors: Preliminary Results of the Pilot MANTLE trial. AHNS 10th International Conference on Head and Neck Cancer - “Survivorship through Quality and Innovation", 2019. e-Pub 2019.
6. Elhalawani H, Mohamed AS, Eraj S, Meheissen MAM, Rock CD, Batra AD, Ferrarotto R, William WN, Lai SY, Gunn GB, Morrison WH, Phan J, Skinner HD, Frank SJ, Garden AS, Kies MS, Rosenthal DI, Fuller CD. Primary and Nodal Tumor Regression Rates: Towards CT-Based 3D Volumetric Characterization of Response to Induction Chemotherapy in Oropharynx Cancer patients. Int J Radiat Oncol Biol Phys 99(2 (Suppli. 1)):E335, 2017. e-Pub 2017.
7. Kamal M, Mohamed AS, Ng SP, Gunn GB, Rosenthal DI, Cardenas C, Lai SY, Morrison WH, Aristophanous M, Frank SJ, Phan J, Fuller CD, Garden AS. Patterns of Failure After Radiation Therapy in Head and Neck Squamous Cell Carcinoma of Unknown Primary: Implication of Elective Nodal and Mucosal Dose Coverage. Int J Radiat Oncol Biol Phys 99(2 (Suppli. 1)):E345, 2017. e-Pub 2017.
8. Rock CD, Jomaa M, Eraj S, Mohamed AS, Meheissen MAM, Elhalawani H, Morrison WH, Phan J, Lai SY, Sturgis EM, Hutcheson KA, Ferrarotto R, Frank SJ, Rosenthal DI, Fuller CD. Long-Term Patient Reported Symptoms and Quality of Life in Patients >65 Following Radiation Therapy for Early Stage Glottic Carcinoma. Int J Radiat Oncol Biol Phys 99(2 (Suppli. 1)):E367-E368, 2017. e-Pub 2017.
9. Rock CD, Jomaa M, Eraj S, Mohamed AS, Meheissen MAM, Elhalawani H, Morrison WH, Phan J, Lai SY, Sturgis EM, Hutcheson KA, Ferrarotto R, Frank SJ, Rosenthal DI, Fuller CD, Garden AS, Gunn GB. Long-Term Patient Reported Outcomes Following Treatment for Locally Advanced Oropharyngeal Carcinoma: Results from a Symptom Assessment Study. Int J Radiat Oncol Biol Phys 99(2 (Suppli. 1)):E368, 2017. e-Pub 2017.
10. Kamal M, Meheissen MAM, Mohamed AS, Ding Y, Rostom Y, Hegazy N, Wang J, Elhalawani H, Phan J, Rosenthal DI, Lai SY, Hutcheson KA, Frank SJ, Garden AS, Gunn GB, Fuller CD. Prospective MRI Assessment of Longitudinal Signal Kinetics of Salivary Glands in Head and Neck Cancer Patients Treated With Radiation Therapy. Int J Radiat Oncol Biol Phys 99(2 (Suppl. 1)):E345, 2017. e-Pub 2017.
11. Rock CD, Jomaa M, Eraj S, Mohamed AS, Meheissen MAM, Elhalawani H, Morrison WH, Phan J, Lai SY, Sturgis EM, Hutcheson KA, Ferrarotto R, Frank SJ, Rosenthal DI, Fuller CD, Garden AS, Gunn GB. Long-Term Patient Reported Outcomes Following Treatment for Locally Advanced Oropharyngeal Carcinoma: Results from a Symptom Assessment Study. Int J Radiat Oncol Biol Phys 99(2 (Suppli. 1)):E368, 2017. e-Pub 2017.
12. Ng SP, Jomaa M, Pollard C, Berends J, Ayoub Z, Mohamed AS, Gunn GB, Frank SJ, Garden AS, Rosenthal DI, Skinner HD, Phan J, Morrison WH, Johnson JM, Ferrarotto R, Lai SY, Sturgis EM, Fuller CD. Second Primary Malignancies in Head and Neck Cancer Patients Treated with Definitive Radiotherapy. Int J Radiat Oncol Biol Phys 99(2 (Suppli. 1)):S122, 2017. e-Pub 2017.
13. Kamal M, Meheissen MAM, Mohamed AS, Ding Y, Rostom Y, Hegazy N, Wang J, Elhalawani H, Phan J, Rosenthal DI, Lai SY, Hutcheson KA, Frank SJ, Garden AS, Gunn GB, Fuller CD. Prospective MRI Assessment of Longitudinal Signal Kinetics of Salivary Glands in Head and Neck Cancer Patients Treated With Radiation Therapy. Int J Radiat Oncol Biol Phys 99(2 (Suppl. 1)):E345, 2017. e-Pub 2017.
14. Rock CD, Jomaa M, Eraj S, Mohamed AS, Meheissen MAM, Elhalawani H, Morrison WH, Phan J, Lai SY, Sturgis EM, Hutcheson KA, Ferrarotto R, Frank SJ, Rosenthal DI, Fuller CD. Long-Term Patient Reported Symptoms and Quality of Life in Patients >65 Following Radiation Therapy for Early Stage Glottic Carcinoma. Int J Radiat Oncol Biol Phys 99(2 (Suppli. 1)):E367-E368, 2017. e-Pub 2017.
15. Kamal M, Mohamed AS, Ng SP, Gunn GB, Rosenthal DI, Cardenas C, Lai SY, Morrison WH, Aristophanous M, Frank SJ, Phan J, Fuller CD, Garden AS. Patterns of Failure After Radiation Therapy in Head and Neck Squamous Cell Carcinoma of Unknown Primary: Implication of Elective Nodal and Mucosal Dose Coverage. Int J Radiat Oncol Biol Phys 99(2 (Suppli. 1)):E345, 2017. e-Pub 2017.
16. Elhalawani H, Mohamed AS, Eraj S, Meheissen MAM, Rock CD, Batra AD, Ferrarotto R, William WN, Lai SY, Gunn GB, Morrison WH, Phan J, Skinner HD, Frank SJ, Garden AS, Kies MS, Rosenthal DI, Fuller CD. Primary and Nodal Tumor Regression Rates: Towards CT-Based 3D Volumetric Characterization of Response to Induction Chemotherapy in Oropharynx Cancer patients. Int J Radiat Oncol Biol Phys 99(2 (Suppli. 1)):E335, 2017. e-Pub 2017.
17. Ng SP, Jomaa M, Pollard C, Berends J, Ayoub Z, Mohamed AS, Gunn GB, Frank SJ, Garden AS, Rosenthal DI, Skinner HD, Phan J, Morrison WH, Johnson JM, Ferrarotto R, Lai SY, Sturgis EM, Fuller CD. Second Primary Malignancies in Head and Neck Cancer Patients Treated with Definitive Radiotherapy. Int J Radiat Oncol Biol Phys 99(2 (Suppli. 1)):S122, 2017. e-Pub 2017.
18. Mohamed ASR, Davuluri R, Frank S, Ding Y, Lai SY, Wang J, Fuller C, Hutcheson KA. Prospective MRI Assessment of dose-response kinetics of non-target muscles in head and neck cancer. European Society for Radiotherapy and Oncology - ESTRO 36 - Vienna, Austria, 2017. e-Pub 2017.
19. Mohamed ASR, Davuluri R, Frank S, Ding Y, Lai SY, Wang J, Fuller C, Hutcheson KA. Prospective MRI Assessment of dose-response kinetics of non-target muscles in head and neck cancer. European Society for Radiotherapy and Oncology - ESTRO 36 - Vienna, Austria, 2017. e-Pub 2017.
20. Ng SP, Jomaa MK, Pollard C, Ayoub Z, Mohamed A, Garden AS, Berends J, Gunn GB, Frank SJ, Skinner HD, Phan J, Rosenthal DI, Morrison WH, Johnson JM, Sturgis EM, Lai SY, Fuller CD. Cost of surveillance imaging in head and neck cancer. American Society of Clinical Oncology 2017 Annual Meeting, Chicago, IL, 2017. e-Pub 2017.
21. Ng SP, Jomaa MK, Pollard C, Ayoub Z, Mohamed A, Garden AS, Berends J, Gunn GB, Frank SJ, Skinner HD, Phan J, Rosenthal DI, Morrison WH, Johnson JM, Sturgis EM, Lai SY, Fuller CD. Cost of surveillance imaging in head and neck cancer. American Society of Clinical Oncology 2017 Annual Meeting, Chicago, IL, 2017. e-Pub 2017.
22. Nichols AC, Lai SY, Prokopec S, Wheeler D, Pinto N, Barrett JW, Copland JA, Smallridge R, Scherer S, Agrawal N, Ball D, Nelkin B, Yoo J, Fung K, Nikiforov Y, Giordano T, Faquin WC, Williams MD, Rivera M, Gill A, Garnis C, Rocco JW, Weinberger P, Xi L, Lam A, Carling T, Korah R, Clifton-Bligh R, Clayman G, Bishop J, Howlett C, Boutros PC. Analysis of the genomic landscape of anaplastic thyroid cancer provides insight into thyroid cancer progression. American Head & Neck Society, American Head & Neck Society 2017 Annual Meeting, San Diego, CA, 2017. e-Pub 2017.
23. Hutcheson, KA, Barrow MP, Plowman EK, Lai SY, Eapen GA, Wang Y. Expiratory Function by Aspiration Status in Post-Radiation Head and Neck Cancer Survivors. The American Laryngological Association 138th Annual Meeting - San Diego, CA, 2017. e-Pub 2017.
24. Tam S, Sandulache VC, Metwalli KA, Rock CD, Eraj S, Fuller CD, Weber RS, Lai SY. Failure to Achieve Gross Total Disease Resection During Initial Surgery of Major Salivary Gland Carcinoma Affects Disease Free Survival. American Head & Neck Society, American Head & Neck Society 2017 Annual Meeting, San Diego, CA, 2017. e-Pub 2017.
25. Nichols AC, Lai SY, Prokopec S, Wheeler D, Pinto N, Barrett JW, Copland JA, Smallridge R, Scherer S, Agrawal N, Ball D, Nelkin B, Yoo J, Fung K, Nikiforov Y, Giordano T, Faquin WC, Williams MD, Rivera M, Gill A, Garnis C, Rocco JW, Weinberger P, Xi L, Lam A, Carling T, Korah R, Clifton-Bligh R, Clayman G, Bishop J, Howlett C, Boutros PC. Analysis of the genomic landscape of anaplastic thyroid cancer provides insight into thyroid cancer progression. American Head & Neck Society, American Head & Neck Society 2017 Annual Meeting, San Diego, CA, 2017. e-Pub 2017.
26. Tam S, Sandulache VC, Metwalli KA, Rock CD, Eraj S, Fuller CD, Weber RS, Lai SY. Failure to Achieve Gross Total Disease Resection During Initial Surgery of Major Salivary Gland Carcinoma Affects Disease Free Survival. American Head & Neck Society, American Head & Neck Society 2017 Annual Meeting, San Diego, CA, 2017. e-Pub 2017.
27. Hutcheson, KA, Barrow MP, Plowman EK, Lai SY, Eapen GA, Wang Y. Expiratory Function by Aspiration Status in Post-Radiation Head and Neck Cancer Survivors. The American Laryngological Association 138th Annual Meeting - San Diego, CA, 2017. e-Pub 2017.
28. Sandulache VC, Chen Y, William WN, Skinner HD, Meyn RE, Fuller CD, Bankson JA, Lai SY. Interrogation of Tumor Metabolism to Assess Treatment Response. Symposium and Training XXIV: Dynamic Imaging of Metabolism in Health and Disease - UT Southwestern Medical Center Advanced Imaging Research Center and The National Center for Research Sources - Dallas, TX, 2017. e-Pub 2017.
29. Sandulache VC, Chen Y, William WN, Skinner HD, Meyn RE, Fuller CD, Bankson JA, Lai SY. Interrogation of Tumor Metabolism to Assess Treatment Response. Symposium and Training XXIV: Dynamic Imaging of Metabolism in Health and Disease - UT Southwestern Medical Center Advanced Imaging Research Center and The National Center for Research Sources - Dallas, TX, 2017. e-Pub 2017.
30. Sandulache V, Hobbs B, Mohamed A, Frank S, Hazle J, Awan M, Rosenthal D, Garden A, Gunn G, Ding Y, Wang J, Colen R, Hutcheson K, Lewin J, Chambers M, Hofstede T, Weber R, Lai SY, Fuller C. Dynamic contrast-enhanced MRI detects acute radiotherapy-induced alterations in mandibular microvasculature: prospective assessment of imaging biomarkers of normal tissue injury. American Head and Neck Society (AHNS) International Conference on Head and Neck Cancer, Seattle, WA, 2016. e-Pub 2016.
31. Hutcheson KA, Barrow MP, Hubbard RM, Plowman EK, Lai SY, Eapen GA, Fuller CD, Barringer DA, Jiminez SB, Little LG, Lewin JS. Expiratory muscle strength training in chronic radiation-associated aspirators. American Head and Neck (AHNS) 9th International Conference on Head and Neck Cancer, 2016. e-Pub 2016.
32. Sandulache V, Hobbs B, Mohamed A, Frank S, Hazle J, Awan M, Rosenthal D, Garden A, Gunn G, Ding Y, Wang J, Colen R, Hutcheson K, Lewin J, Chambers M, Hofstede T, Weber R, Lai SY, Fuller C. Dynamic contrast-enhanced MRI detects acute radiotherapy-induced alterations in mandibular microvasculature: prospective assessment of imaging biomarkers of normal tissue injury. American Head and Neck Society (AHNS) International Conference on Head and Neck Cancer, Seattle, WA, 2016. e-Pub 2016.
33. Hutcheson KA, Barrow MP, Hubbard RM, Plowman EK, Lai SY, Eapen GA, Fuller CD, Barringer DA, Jiminez SB, Little LG, Lewin JS. Expiratory muscle strength training in chronic radiation-associated aspirators. American Head and Neck (AHNS) 9th International Conference on Head and Neck Cancer, 2016. e-Pub 2016.
34. Sandulache V, Williams MD, Lai SY, Lu C, William WN, Busaidy NL, Cabanillas ME. Clinical genomic testing of anaplastic thyroid carcinoma (ATC) and need for integration into future prospective clinical trials. 2016 ASCO Annual Meeting, Chicago, IL, 2016. e-Pub 2016.
35. Mulcahy CF, Mohamed A, Rosenthal DI, Hutcheson KA, Weber RS, Lai SY, Garden AS, Zafereo M, Morrison WH, Lewin JS, Kies MS, El-Naggar AK, Fuller CD. Comorbidity and survival in locally advanced laryngeal cancer. ASCO Annual Meeting, Chicago, IL, 2016. e-Pub 2016.
36. Mulcahy CF, Mohamed A, Rosenthal DI, Hutcheson KA, Weber RS, Lai SY, Garden AS, Zafereo M, Morrison WH, Lewin JS, Kies MS, El-Naggar AK, Fuller CD. Comorbidity and survival in locally advanced laryngeal cancer. ASCO Annual Meeting, Chicago, IL, 2016. e-Pub 2016.
37. Sandulache V, Williams MD, Lai SY, Lu C, William WN, Busaidy NL, Cabanillas ME. Clinical genomic testing of anaplastic thyroid carcinoma (ATC) and need for integration into future prospective clinical trials. 2016 ASCO Annual Meeting, Chicago, IL, 2016. e-Pub 2016.
38. Li K, Mohamed ASR, Ding Y, Awan MJ, Frank SJ, Wang J, Hazle JD, Hutcheson K, Lai SY, Kalpathy-Cramer J, Li X, Fuller CD, Huang W. DCE-MRI evidence of biological changes in irradiated healthy muscle following chemoradiotherapy treatment of head and neck cancer. ISMRM - 2016 Annual Meeting & Exhibition, Singapore, 2016. e-Pub 2016.
39. Li K, Mohamed ASR, Ding Y, Awan MJ, Frank SJ, Wang J, Hazle JD, Hutcheson K, Lai SY, Kalpathy-Cramer J, Li X, Fuller CD, Huang W. DCE-MRI evidence of biological changes in irradiated healthy muscle following chemoradiotherapy treatment of head and neck cancer. ISMRM - 2016 Annual Meeting & Exhibition, Singapore, 2016. e-Pub 2016.
40. Rao SN, Busaidy NL, Dadu R, Hess K, Zafereo M, William W, Lai SY, Sandulache V, Gunn B, Lu C, Cabanillas ME. Patterns of failure in anaplastic thyroid cancer patients. Endocrine Society's 98th Annual Meeting and Expo, Boston, MA, 2016. e-Pub 2016.
41. Rao SN, Busaidy NL, Dadu R, Hess K, Zafereo M, William W, Lai SY, Sandulache V, Gunn B, Lu C, Cabanillas ME. Patterns of failure in anaplastic thyroid cancer patients. Endocrine Society's 98th Annual Meeting and Expo, Boston, MA, 2016. e-Pub 2016.
42. Tucker JR, Xu L, Sturgis EM, Mohamed ASR, Hofstede TM, Chambers MS, Lai SY, Fuller CD, Beadle BM, Gunn GB, Hutcheson KA. Osteoradionecrosis in salivary gland malignancies. 2016 Multidisciplinary Head and Neck Cancer Symposium, Scottsdale, AZ, 2016. e-Pub 2016.
43. Hutcheson KA, Lin HY, Yuk MM, Hubbard RM, Portwood MB, Gunn GB, Fuller DC, Garden AS, Lai SY, Schwartz DL, Kies MS, Hanna EY, Goepfert RP, Lewin JS. Delayed lower cranial neuropathy after oropharyngeal IMRT: a prospective study and literature review. 2016 Multidisciplinary Head and Neck Cancer Symposium, Scottsdale, AZ, 2016. e-Pub 2016.
44. Warren BW, Mohamed ASR, Hutcheson KA, Gunn GB, Lewin JS, Lai SY, Rosenthal DI, Garden AS, Fuller CD. Trismus dose-response assessment using quantitative volumetric measures in head and neck radiotherapy. 2016 Multidisciplinary Head and Neck Cancer Symposium, Scottsdale, AZ, 2016. e-Pub 2016.
45. Chen D, Xu L, Gunn GB, Fuller CD, Mohamed ASR, Lai SY, Kanwar A, Lewin JS, Sturgis EM, Hutcheson KA. Feeding tube utilization in patients with salivary gland malignancy. 2016 Multidisciplinary Head and Neck Cancer Symposium, Scottsdale, AZ, 2016. e-Pub 2016.
46. Sandulache V, Hobbs B, Mohamed A, Frank S, Hazle J, Awan M, Rosenthal D, Garden A, Gunn G, Ding Y, Wang J, Colen R, Hutcheson K, Lewin J, Chambers M, Hofstede T, Weber R, Lai SY, Fuller C. Dynamic contrast-enhanced MRI detects acute radiotherapy-induced alterations in mandibular microvasculature: prospective assessment of imaging biomarkers of normal tissue injury. 2016 Multidisciplinary Head and Neck Cancer Symposium, Scottsdale, AZ, 2016. e-Pub 2016.
47. Cabanillas M, Gunn G, Williams M, Busaidy N, Jr WW, Lu C, Lai SY. Facilitating Anaplastic Thyroid Cancer Specialized Treatment (FAST): a multidisciplinary Anaplastic Thyroid Cancer (ATC) Team. 2016 Multidisciplinary Head and Neck Cancer Symposium, Scottsdale, AZ, 2016. e-Pub 2016.
48. Goepfert RP, Lewin JS, Barrow MP, Gunn GB, Fuller CD, Beadle B, Rosenthal DI, Garden AS, Kies M, Papadimitrikopolou V, Lai SY, Schwartz DL, Hutcheson KA. Long-term performance of the MD Anderson dysphagia inventory in "low-intermediate risk" oropharyngeal carcinoma after intensity modulated radiation therapy. 2016 Multidisciplinary Head and Neck Cancer Symposium, Scottsdale, AZ, 2016. e-Pub 2016.
49. Tucker JR, Xu L, Sturgis EM, Mohamed ASR, Hofstede TM, Chambers MS, Lai SY, Fuller CD, Beadle BM, Gunn GB, Hutcheson KA. Osteoradionecrosis in salivary gland malignancies. 2016 Multidisciplinary Head and Neck Cancer Symposium, Scottsdale, AZ, 2016. e-Pub 2016.
50. Sandulache V, Hobbs B, Mohamed A, Frank S, Hazle J, Awan M, Rosenthal D, Garden A, Gunn G, Ding Y, Wang J, Colen R, Hutcheson K, Lewin J, Chambers M, Hofstede T, Weber R, Lai SY, Fuller C. Dynamic contrast-enhanced MRI detects acute radiotherapy-induced alterations in mandibular microvasculature: prospective assessment of imaging biomarkers of normal tissue injury. 2016 Multidisciplinary Head and Neck Cancer Symposium, Scottsdale, AZ, 2016. e-Pub 2016.
51. Hutcheson KA, Lin HY, Yuk MM, Hubbard RM, Portwood MB, Gunn GB, Fuller DC, Garden AS, Lai SY, Schwartz DL, Kies MS, Hanna EY, Goepfert RP, Lewin JS. Delayed lower cranial neuropathy after oropharyngeal IMRT: a prospective study and literature review. 2016 Multidisciplinary Head and Neck Cancer Symposium, Scottsdale, AZ, 2016. e-Pub 2016.
52. Goepfert RP, Lewin JS, Barrow MP, Gunn GB, Fuller CD, Beadle B, Rosenthal DI, Garden AS, Kies M, Papadimitrikopolou V, Lai SY, Schwartz DL, Hutcheson KA. Long-term performance of the MD Anderson dysphagia inventory in "low-intermediate risk" oropharyngeal carcinoma after intensity modulated radiation therapy. 2016 Multidisciplinary Head and Neck Cancer Symposium, Scottsdale, AZ, 2016. e-Pub 2016.
53. Cabanillas M, Gunn G, Williams M, Busaidy N, Jr WW, Lu C, Lai SY. Facilitating Anaplastic Thyroid Cancer Specialized Treatment (FAST): a multidisciplinary Anaplastic Thyroid Cancer (ATC) Team. 2016 Multidisciplinary Head and Neck Cancer Symposium, Scottsdale, AZ, 2016. e-Pub 2016.
54. Warren BW, Mohamed ASR, Hutcheson KA, Gunn GB, Lewin JS, Lai SY, Rosenthal DI, Garden AS, Fuller CD. Trismus dose-response assessment using quantitative volumetric measures in head and neck radiotherapy. 2016 Multidisciplinary Head and Neck Cancer Symposium, Scottsdale, AZ, 2016. e-Pub 2016.
55. Chen D, Xu L, Gunn GB, Fuller CD, Mohamed ASR, Lai SY, Kanwar A, Lewin JS, Sturgis EM, Hutcheson KA. Feeding tube utilization in patients with salivary gland malignancy. 2016 Multidisciplinary Head and Neck Cancer Symposium, Scottsdale, AZ, 2016. e-Pub 2016.
56. Huang A, Tang C, Hutcheson K, Beadle B, Lewin J, Lai SY. Gastrostomy tube placement in patients with laryngeal carcinoma treated with full-field radiotherapy: factors affecting placement and dependence. ASTRO 56th Annual Meeting, San Francisco, CA, 2015. e-Pub 2015.
57. Huang A, Tang C, Hutcheson K, Beadle B, Lewin J, Lai SY. Gastrostomy tube placement in patients with laryngeal carcinoma treated with full-field radiotherapy: factors affecting placement and dependence. ASTRO 56th Annual Meeting, San Francisco, CA, 2015. e-Pub 2015.
58. Sandulache VC, Chen Y, Skinner HD, Walker CM, Court LE, Bankson JA, Myers JN, Lai SY. Acute tumor lactate perturbations act as a biomarker of genotoxic stress. Keystone's Symposia 2015 Conference, Vancouver, BC, 2015. e-Pub 2015.
59. Bharadwaj U, Lai SY, Dobrolecki L, Eckols TK, Lewis MT, Tweardy DJ. Targeting STAT3 with an oral small-molecule inhibitor to reverse chemotherapy and radiation resistance. Worldwide Innovative Networking (WIN) Symposium 2015, Paris, France, 2015. e-Pub 2015.
60. Bankson JA, Walker CM, Chen Y, Lai SY, Hazle JD. Metabolic imaging with hyperpolarized [1-13C]-pyruvate and DCE-MRI. 2015 AACR Special Conference on Metabolism and Cancer, Bellevue, WA, 2015. e-Pub 2015.
61. Huang A, Lai SY. Identification and management of laryngeal carcinoma patients with risk factors for gastrostomy tube placement. ASTRO 56th Annual Conference, San Francisco, CA, 2015. e-Pub 2015.
62. Sandulache VC, Chen Y, Skinner HD, Walker CM, Court LE, Bankson JA, Myers JN, Lai SY. Acute tumor lactate perturbations act as a biomarker of genotoxic stress. Keystone's Symposia 2015 Conference, Vancouver, BC, 2015. e-Pub 2015.
63. Bharadwaj U, Lai SY, Dobrolecki L, Eckols TK, Lewis MT, Tweardy DJ. Targeting STAT3 with an oral small-molecule inhibitor to reverse chemotherapy and radiation resistance. Worldwide Innovative Networking (WIN) Symposium 2015, Paris, France, 2015. e-Pub 2015.
64. Bankson JA, Walker CM, Chen Y, Lai SY, Hazle JD. Metabolic imaging with hyperpolarized [1-13C]-pyruvate and DCE-MRI. 2015 AACR Special Conference on Metabolism and Cancer, Bellevue, WA, 2015. e-Pub 2015.
65. Huang A, Lai SY. Identification and management of laryngeal carcinoma patients with risk factors for gastrostomy tube placement. ASTRO 56th Annual Conference, San Francisco, CA, 2015. e-Pub 2015.
66. Lewis CM, Nurgalieva Z, Lai SY, Weber RS. Adherence to head and neck cancer guidelines: setting the stage for continual quality improvement. ASCO Quality Care Symposium, 2014. e-Pub 2014.
67. Agrawal A, Civantos F, Lai SY. [99mTc]Tilmanocept accurately detects sentinel lymph nodes and predicts pathologic nodal status in patients with squamous cell carcinoma of the head and neck: results of a phase 3 multi-institutional trial. Annual Congress of the European Association of Nuclear Medicine (EANM), Gothenburg, Sweden, 2014. e-Pub 2014.
68. Agrawal A, Civantos F, Lai SY. [99mTc]Tilmanocept accurately detects sentinel lymph nodes and predicts pathologic nodal status in patients with squamous cell carcinoma of the head and neck: results of a phase 3 multi-institutional trial. Annual Congress of the European Association of Nuclear Medicine (EANM), Gothenburg, Sweden, 2014. e-Pub 2014.
69. Lewis CM, Nurgalieva Z, Lai SY, Weber RS. Adherence to head and neck cancer guidelines: setting the stage for continual quality improvement. ASCO Quality Care Symposium, 2014. e-Pub 2014.
70. Lai SY, Huang AT, Tang C, Hutcheson KA, Bender M, Beadle BM, Gold KA, Lewin JS. Identification and management of laryngeal carcinoma patients with risk factors for gastrostomy tube placement. ASTRO 56th Annual Meeting, San Francisco, CA, 2014. e-Pub 2014.
71. Lai SY, Huang AT, Tang C, Hutcheson KA, Bender M, Beadle BM, Gold KA, Lewin JS. Identification and management of laryngeal carcinoma patients with risk factors for gastrostomy tube placement. ASTRO 56th Annual Meeting, San Francisco, CA, 2014. e-Pub 2014.
72. Bhayani MK, Wu X, Chen Y, Calin GA, Lai SY. MIR-27A* targets the EGFR signaling axis in HNSCC. IFHNOS 5th World Congress and AHNS Annual Meeting, New York, NY, 2014. e-Pub 2014.
73. Kwak PE, Monroe MM, Hessel AC, Lai SY, Lewin J, Sturgis EM. Subclavian mobilization and primary reanastomosis of the right recurrent laryngeal nerve in the management of aggressive thyroid carcinoma. IFHNOS 5th World Congress and AHNS Annual Meeting, New York, NY, 2014. e-Pub 2014.
74. Kwak PE, Monroe MM, Hessel AC, Lai SY, Lewin J, Sturgis EM. Subclavian mobilization and primary reanastomosis of the right recurrent laryngeal nerve in the management of aggressive thyroid carcinoma. IFHNOS 5th World Congress and AHNS Annual Meeting, New York, NY, 2014. e-Pub 2014.
75. Bhayani MK, Wu X, Chen Y, Calin GA, Lai SY. MIR-27A* targets the EGFR signaling axis in HNSCC. IFHNOS 5th World Congress and AHNS Annual Meeting, New York, NY, 2014. e-Pub 2014.
76. Lai SY, Agrawal A, Civantos FJ, Brumund KT, Chepeha DB, Williams MD, Chasen BA, Rohren EM, Edeiken-Monroe BS, Chambers MS, Weber RS. Receptor-targeted 99m Tc-tilmanocept for sentinel lymph node biopsy (SLNB) in HNSCC: Predictive utility vs. elective neck dissection. The 6th European Congress on Head & Neck Oncology, Liverpool, UK, 2014. e-Pub 2014.
77. Wu X, Bhayani MK, Chen Y, Calin GA, Lai SY. MiR-27a* targets the EGFR signaling axis to inhibit HNSCC disease progression. The 6th European Congress on Head and Neck Oncology, Liverpool, UK, 2014. e-Pub 2014.
78. Lai SY, Agrawal A, Civantos FJ, Brumund KT, Chepeha DB, Williams MD, Chasen BA, Rohren EM, Edeiken-Monroe BS, Chambers MS, Weber RS. Receptor-targeted 99m Tc-tilmanocept for sentinel lymph node biopsy (SLNB) in HNSCC: Predictive utility vs. elective neck dissection. The 6th European Congress on Head & Neck Oncology, Liverpool, UK, 2014. e-Pub 2014.
79. Wu X, Bhayani MK, Chen Y, Calin GA, Lai SY. MiR-27a* targets the EGFR signaling axis to inhibit HNSCC disease progression. The 6th European Congress on Head and Neck Oncology, Liverpool, UK, 2014. e-Pub 2014.
80. Ramirez MS, Lee J, Chen Y, Walker CM, Lai SY, Bankson JA. Multi gradient and spin-echo radial acquisition for hyperpolarized 13C MRSI. ISMRM Annual Meeting, Milan, Italy, 2014. e-Pub 2014.
81. Ramirez MS, Lee J, Chen Y, Walker CM, Lai SY, Bankson JA. Multi gradient and spin-echo radial acquisition for hyperpolarized 13C MRSI. ISMRM Annual Meeting, Milan, Italy, 2014. e-Pub 2014.
82. Sandulache VC, Chen Y, Lee J, Ramirez MS, Skinner HD, Court LE, Bankson JA, Lai SY. Using hyperpolarized magnetic resonance (HP-MR) to monitor solid tumor progression, metastasis, and response to treatment. AACR Translational Impact of Model Organisms in Cancer, San Diego, CA, 2013. e-Pub 2013.
83. Sandulache VC, Chen Y, Lee J, Ramirez MS, Skinner HD, Court LE, Bankson JA, Lai SY. Using hyperpolarized magnetic resonance (HP-MR) to monitor solid tumor progression, metastasis, and response to treatment. AACR Translational Impact of Model Organisms in Cancer, San Diego, CA, 2013. e-Pub 2013.
84. Civantos F, Agrawal A, Cope F, Blue M, Abbruzzese B, Metz W, Lai SY. Comparison of false negative rates and overall accuracy of sentinel lymph node biopsy in phase-3 99mTc-sulfur colloid in head/neck squamous cell carcinoma. 99th Annual Clinical Congress, American College of Surgeons (ACS), Washington, D.C, 2013. e-Pub 2013.
85. Agrawal A, Lai SY, Civantos F, Brumund K, Chepeha D, Carroll W, Smith R, Zitsch R, Lee W. Results from a prospective phase-3 multi-institutional trial of 99mTc-tilmanocept, a CD206-targeted molecular sentinel node mapping agent, in head/neck squamous cell carcinoma. 99th Annual Clinical Congress, American College of Surgeons (ACS), Washington, D.C, 2013. e-Pub 2013.
86. Lai SY, Rashmi R, Lewis CM, Hessel A, Gidley P, Skoracki R, Jordan V, Weber RS. Ensuring quality of care for head and neck cancer patients: longitudinal analysis of morbidity and mortality conference data. 99th Annual Clinical Congress, American College of Surgeons (ACS), Washington, D.C, 2013. e-Pub 2013.
87. Agrawal A, Lai SY, Civantos F, Brumund K, Chepeha D, Carroll W, Smith R, Zitsch R, Lee W. Results from a prospective phase-3 multi-institutional trial of 99mTc-tilmanocept, a CD206-targeted molecular sentinel node mapping agent, in head/neck squamous cell carcinoma. 99th Annual Clinical Congress, American College of Surgeons (ACS), Washington, D.C, 2013. e-Pub 2013.
88. Lai SY, Rashmi R, Lewis CM, Hessel A, Gidley P, Skoracki R, Jordan V, Weber RS. Ensuring quality of care for head and neck cancer patients: longitudinal analysis of morbidity and mortality conference data. 99th Annual Clinical Congress, American College of Surgeons (ACS), Washington, D.C, 2013. e-Pub 2013.
89. Civantos F, Agrawal A, Cope F, Blue M, Abbruzzese B, Metz W, Lai SY. Comparison of false negative rates and overall accuracy of sentinel lymph node biopsy in phase-3 99mTc-sulfur colloid in head/neck squamous cell carcinoma. 99th Annual Clinical Congress, American College of Surgeons (ACS), Washington, D.C, 2013. e-Pub 2013.
90. Yi S, Chen Y, Lee J, Rubinstein A, Lai SY, Bankson JA. Optimization of real-time metabolic scanning in anaplastic thyroid cancer cells. CPRIT/CURE Summer Training Program, 2013. e-Pub 2013.
91. Lai SY, Rashmi R, Lewis CM, Hessel AC, Gidley PW, Skoracki R, Weber RS. Longitudinal analysis of morbidity and mortality conference data for head and neck cancer patients. Oral Presentation. 2013 AAO-HNSF Annual Meeting & OTO Expo, Vancouver, BC, 2013. e-Pub 2013.
92. Lai SY, Acharya V, Kongkiatkamon S, Farrah S, Roberts DB, Sterba J, Chambers MS. Quantitative assessment of outcomes for sialendoscopy in patients with radioiodine-induced sialadenitis. Oral Presentation. 2013 AAO-HNSF Annual Meeting & OTO Expo, Vancouver, BC, 2013. e-Pub 2013.
93. Ramirez MS, Lee J, Walker CM, Sandulache VC, Lai SY, Bankson JA. Improved throughput for preclinical hyperpolarized 13C MRS. Proceedings of the 6th Annual World Molecular Imaging Conference, Savannah, GA, 2013. e-Pub 2013.
94. Ramirez MS, Walker CM, Lee J, Sandulache VC, Chen Y, Lai SY, Bankson JA. A robust, semi-quantitative imaging strategy for hyperpolarized MRI. Proceedings of the 6th Annual World Molecular Imaging Conference, Savannah, GA, 2013. e-Pub 2013.
95. Yi S, Chen Y, Lee J, Rubinstein A, Lai SY, Bankson JA. Optimization of real-time metabolic scanning in anaplastic thyroid cancer cells. CPRIT/CURE Summer Training Program, 2013. e-Pub 2013.
96. Ramirez MS, Lee J, Walker CM, Sandulache VC, Lai SY, Bankson JA. Improved throughput for preclinical hyperpolarized 13C MRS. Proceedings of the 6th Annual World Molecular Imaging Conference, Savannah, GA, 2013. e-Pub 2013.
97. Ramirez MS, Walker CM, Lee J, Sandulache VC, Chen Y, Lai SY, Bankson JA. A robust, semi-quantitative imaging strategy for hyperpolarized MRI. Proceedings of the 6th Annual World Molecular Imaging Conference, Savannah, GA, 2013. e-Pub 2013.
98. Lai SY, Rashmi R, Lewis CM, Hessel AC, Gidley PW, Skoracki R, Weber RS. Longitudinal analysis of morbidity and mortality conference data for head and neck cancer patients. Oral Presentation. 2013 AAO-HNSF Annual Meeting & OTO Expo, Vancouver, BC, 2013. e-Pub 2013.
99. Lai SY, Acharya V, Kongkiatkamon S, Farrah S, Roberts DB, Sterba J, Chambers MS. Quantitative assessment of outcomes for sialendoscopy in patients with radioiodine-induced sialadenitis. Oral Presentation. 2013 AAO-HNSF Annual Meeting & OTO Expo, Vancouver, BC, 2013. e-Pub 2013.
100. Hutcheson K, Bhayani M, Beadle B, Gold K, Shinn E, Lai SY, Lewin J. Use it or lose it: swallowing exercise and maintenance of oral intake during radiotherapy or chemoradiotherapy for oropharyngeal cancers. Oral Presentation. 2013 AHNS Annual Meeting, Orlando, FL, 2013. e-Pub 2013.
101. Civantos F, Lai SY, Agrawal A, Chepeha DB, Brumund KT, Cope FO, Blue M, Metz W, Abbruzzese BC. The CD206-targeted, molecular sentinel node mapping agent Tc99m-tilmanocept accurately stages Head/Neck Squamous Cell Carcinomas (HNSCC): prospective interim analysis results from a phase-3 multi-institutional study. 2nd International Symposium on Thoracic and Upper Aerodigestive Malignancies, Athens, Greece, 2013. e-Pub 2013.
102. Smith BG, Hutcheson KA, Little LG, Rosenthal DI, Lai SY, Skoracki RJ, Lewin JS. Management of lymphedema in patients with head and neck cancer. 2013 AHNS Annual Meeting, Orlando, FL, 2013. e-Pub 2013.
103. Ramirez MS, Lee J, Sandulache V, Walker CM, Chen Y, Lai SY, Bankson JA. Projection acquisitions for dynamic hyperpolarized 13C MRI. International Society for Magnetic Resonance in Medicine (ISMRM) 21st Annual Meeting and Exhibition, Salt Lake City, UT, 2013. e-Pub 2013.
104. Sandulache VC, Skinner HD, Chen Y, Lee J, Walker CM, Bankson JA, Lai SY. Optimization of radiosensitizing strategies using real-time magnetic resonance imaging (MRI) in anaplastic thyroid cancer. 2013 AHNS Annual Meeting, Orlando, FL, 2013. e-Pub 2013.
105. Civantos F, Lai SY, Agrawal A, Chepeha DB, Brumund KT, Cope FO, Blue M, Metz W, Abbruzzese BC. The CD206-targeted, molecular sentinel node mapping agent Tc99m-tilmanocept accurately stages Head/Neck Squamous Cell Carcinomas (HNSCC): prospective interim analysis results from a phase-3 multi-institutional study. 2nd International Symposium on Thoracic and Upper Aerodigestive Malignancies, Athens, Greece, 2013. e-Pub 2013.
106. Smith BG, Hutcheson KA, Little LG, Rosenthal DI, Lai SY, Skoracki RJ, Lewin JS. Management of lymphedema in patients with head and neck cancer. 2013 AHNS Annual Meeting, Orlando, FL, 2013. e-Pub 2013.
107. Hutcheson K, Bhayani M, Beadle B, Gold K, Shinn E, Lai SY, Lewin J. Use it or lose it: swallowing exercise and maintenance of oral intake during radiotherapy or chemoradiotherapy for oropharyngeal cancers. Oral Presentation. 2013 AHNS Annual Meeting, Orlando, FL, 2013. e-Pub 2013.
108. Sandulache VC, Skinner HD, Chen Y, Lee J, Walker CM, Bankson JA, Lai SY. Optimization of radiosensitizing strategies using real-time magnetic resonance imaging (MRI) in anaplastic thyroid cancer. 2013 AHNS Annual Meeting, Orlando, FL, 2013. e-Pub 2013.
109. Ramirez MS, Lee J, Sandulache V, Walker CM, Chen Y, Lai SY, Bankson JA. Projection acquisitions for dynamic hyperpolarized 13C MRI. International Society for Magnetic Resonance in Medicine (ISMRM) 21st Annual Meeting and Exhibition, Salt Lake City, UT, 2013. e-Pub 2013.
110. Lai SY, Agrawal A, Civantos FJ. Utilization of Tc99m-tilmanocept to assess sentinel lymph node status in HNSCC patients. 4th ICHNO Conference, Barcelona, Spain, 2013. e-Pub 2013.
111. De Bree R, Buscombe J, Lai SY, Agrawal A, Reininger C, Civantos F. Pivotal trial results and EU comparison of 99mTc-tilmanocept in sentinel node biopsy in head and neck cancer patients. 4th ICHNO Conference, Barcelona, Spain, 2013. e-Pub 2013.
112. Sandulache VC, Chen Y, Lee J, Walker CM, Bankson JA, Lai SY. Optimizing radiosensitization with metabolic imaging in anaplastic thyroid cancer. 4th ICHNO Conference, Barcelona, Spain, 2013. e-Pub 2013.
113. Lai SY, Agrawal A, Civantos FJ. Utilization of Tc99m-tilmanocept to assess sentinel lymph node status in HNSCC patients. 4th ICHNO Conference, Barcelona, Spain, 2013. e-Pub 2013.
114. Sandulache VC, Chen Y, Lee J, Walker CM, Bankson JA, Lai SY. Optimizing radiosensitization with metabolic imaging in anaplastic thyroid cancer. 4th ICHNO Conference, Barcelona, Spain, 2013. e-Pub 2013.
115. De Bree R, Buscombe J, Lai SY, Agrawal A, Reininger C, Civantos F. Pivotal trial results and EU comparison of 99mTc-tilmanocept in sentinel node biopsy in head and neck cancer patients. 4th ICHNO Conference, Barcelona, Spain, 2013. e-Pub 2013.
116. Hutcheson K, Bhayani M, Beadle B, Gold K, Shinn E, Lai SY, Lewin J. Use it or lose it: swallowing during radiotherapy or chemoradiotherapy for pharyngeal cancers. Dysphagia Research Society Meeting, Seattle, WA, 2013. e-Pub 2013.
117. Lai SY, Agrawal A, Civantos F. Utilization of receptor targeted technetium Tc 99m tilmanocept (Lymphoseek Injection) to identify and evaluate the pathological status of sentinel lymph nodes vs. elective neck dissection in patients with intraoral squamous cell carcinoma: a preliminary performance evaluation against technetium Tc 99m sulfur colloid in the ACOSOG-Z0360 study. Society of Surgical Oncology (SSO) 66th Annual Cancer Symposium, National Harbor, MD, 2013. e-Pub 2013.
118. Lai SY, Sandulache V. Using magnetic resonance and hyperpolarized tracers to monitor solid tumor progression, metastasis and response to treatment. AACR Special Conference - The translational impact of Model eOrganisms in eCancer, San Diego, CA, 2013. e-Pub 2013.
119. Lai SY, Sandulache V. Using magnetic resonance and hyperpolarized tracers to monitor solid tumor progression, metastasis and response to treatment. AACR Special Conference - The translational impact of Model eOrganisms in eCancer, San Diego, CA, 2013. e-Pub 2013.
120. Hutcheson K, Bhayani M, Beadle B, Gold K, Shinn E, Lai SY, Lewin J. Use it or lose it: swallowing during radiotherapy or chemoradiotherapy for pharyngeal cancers. Dysphagia Research Society Meeting, Seattle, WA, 2013. e-Pub 2013.
121. Lai SY, Agrawal A, Civantos F. Utilization of receptor targeted technetium Tc 99m tilmanocept (Lymphoseek Injection) to identify and evaluate the pathological status of sentinel lymph nodes vs. elective neck dissection in patients with intraoral squamous cell carcinoma: a preliminary performance evaluation against technetium Tc 99m sulfur colloid in the ACOSOG-Z0360 study. Society of Surgical Oncology (SSO) 66th Annual Cancer Symposium, National Harbor, MD, 2013. e-Pub 2013.
122. Nurgalieva Z, Weber RS, Lai SY, Sturgis EM, Beadle BM, William Jr W, Lewis CM. Adherence to head and neck cancer guidelines: multidisciplinary conference recommendations and care delivered. ASCO Quality Care Symposium, San Diego, CA, 2012. e-Pub 2012.
123. Nurgalieva Z, Weber RS, Lai SY, Sturgis EM, Beadle BM, William Jr W, Lewis CM. Adherence to head and neck cancer guidelines: setting the stage for continual quality improvement. ASCO Quality Care Symposium, San Diego, CA, 2012. e-Pub 2012.
124. Nurgalieva Z, Weber RS, Lai SY, Sturgis EM, Beadle BM, William Jr W, Lewis CM. Adherence to head and neck cancer guidelines: multidisciplinary conference recommendations and care delivered. ASCO Quality Care Symposium, San Diego, CA, 2012. e-Pub 2012.
125. Nurgalieva Z, Weber RS, Lai SY, Sturgis EM, Beadle BM, William Jr W, Lewis CM. Adherence to head and neck cancer guidelines: setting the stage for continual quality improvement. ASCO Quality Care Symposium, San Diego, CA, 2012. e-Pub 2012.
126. Williams MD, Lai SY, Cabanillas ME, Hale KS. Aggressive follicular thyroid carcinoma: a heterogenic diagnosis by molecular analysis. 8th International Conference on Head and Neck Cancer, Toronto, Ontario, Canada, 2012. e-Pub 2012.
127. Williams MD, Lai SY, Cabanillas ME, Hale KS. Aggressive follicular thyroid carcinoma: a heterogenic diagnosis by molecular analysis. 8th International Conference on Head and Neck Cancer, Toronto, Ontario, Canada, 2012. e-Pub 2012.
128. Sandulache VC, Bankson JA, Skinner H, Wang Y, Chen Y, Dodge C, Ow T, Hazle JD, Myers JN, Lai SY. In vivo monitoring of metabolic inhibition in anaplastic thyroid carcinoma. AACR Annual Meeting, Chicago, IL, 2012. e-Pub 2012.
129. Lai SY, Williams MD, Chasen BA, Lewis CM, Hessel AC, Rohren EM, Myers JN, Weber RS. 99m-Tc-tilmanocept in the detection of sentinel lymph nodes in head and neck cutaneous and intraoral squamous cell carcinoma: initial experience. 65th Society of Surgical Oncology Annual Cancer Symposium, Orlando, FL, 2012. e-Pub 2012.
130. Lai SY, Williams MD, Chasen BA, Lewis CM, Hessel AC, Rohren EM, Myers JN, Weber RS. 99m-Tc-tilmanocept in the detection of sentinel lymph nodes in head and neck cutaneous and intraoral squamous cell carcinoma: initial experience. 65th Society of Surgical Oncology Annual Cancer Symposium, Orlando, FL, 2012. e-Pub 2012.
131. Sandulache VC, Bankson JA, Skinner H, Wang Y, Chen Y, Dodge C, Ow T, Hazle JD, Myers JN, Lai SY. In vivo monitoring of metabolic inhibition in anaplastic thyroid carcinoma. AACR Annual Meeting, Chicago, IL, 2012. e-Pub 2012.
132. Adachi M, Cui C, Dodge CT, Byahani MK, Chen Y, Lai SY. Targeting STAT3 inhibits head and neck squamous cell carcinoma growth in vitro and in vivo. Oral Presentation. AHNS 8th International Conference on Head and Neck Cancer, Toronto, Ontario, Canada, 2012. e-Pub 2012.
133. Ramirez MS, Chen Y, Lai SY, Bankson JA. A six-fold throughput improvement for preclinical cancer studies. International Society for Magnetic Resonance in Medicine (ISMRM), Melbourne, Australia, 2012. e-Pub 2012.
134. Chen Y, Gule MK, Adachi M, Dodge CT, Henderson Y, Lai SY. Targeting focal adhesion kinase in anaplastic and papillary thyroid cancer inhibits tumor function and growth. Oral Presentation. AHNS 8th International Conference on Head and Neck Cancer, Toronto, Ontario, Canada, 2012. e-Pub 2012.
135. Bhayani MK, Hutcheson KA, Barringer DA, Lisec A, Alvarez C, Roberts DB, Lewin JS, Lai SY. Identification and management of oropharyngeal and hypopharyngeal carcinoma patients with risk factors for gastrostomy tube placement and dependence. Oral Presentation. AHNS 8th International Conference on Head and Neck Cancer, Toronto, Ontario, Canada, 2012. e-Pub 2012.
136. Sandulache VC, Skinner HD, Wang Y, Chen Y, Dodge CT, Ow TJ, Bankson JA, Myers JN, Lai SY. Glycolytic inhibition alters anaplastic thyroid carcinoma tumor metabolism and improves response to conventional chemotherapy and radiation. AHNS 8th International Conference on Head and Neck Cancer, Toronto, Ontario, Canada, 2012. e-Pub 2012.
137. Lai SY, Williams MD, Chasen BA, Lewis CM, Hessel AC, Gillenwater AM, Rohren EM, Myers JN, Weber RS. 99m-Tc-tilmanocept-identified sentinel lymph nodes relative to the pathological status of non-sentinel lymph nodes in an elective neck dissection in cutaneous and intraoral head and neck squamous cell carcinoma: a single institutional experience. Oral Presentation. AHNS 8th International Conference on Head and Neck Cancer, Toronto, Ontario, Canada, 2012. e-Pub 2012.
138. Bankson JA, Sandulache V, Merritt M, Elliott A, Chen Y, Priebe W, Schellingerhout D, Lai SY, Conrad C, Hazle JD. Dynamic spectroscopy and modeling of response to 2-deoxyglucose using hyperpolarized [1-13C]-pyruvate - Oral Presentation. CPRIT Annual Conference, Austin, TX, 2012. e-Pub 2012.
139. Sandulache VC, Skinner HD, Wang Y, Chen Y, Dodge CT, Ow TJ, Bankson JA, Myers JN, Lai SY. Glycolytic inhibition alters anaplastic thyroid carcinoma tumor metabolism and improves response to conventional chemotherapy and radiation. AHNS 8th International Conference on Head and Neck Cancer, Toronto, Ontario, Canada, 2012. e-Pub 2012.
140. Bhayani MK, Hutcheson KA, Barringer DA, Lisec A, Alvarez C, Roberts DB, Lewin JS, Lai SY. Identification and management of oropharyngeal and hypopharyngeal carcinoma patients with risk factors for gastrostomy tube placement and dependence. Oral Presentation. AHNS 8th International Conference on Head and Neck Cancer, Toronto, Ontario, Canada, 2012. e-Pub 2012.
141. Chen Y, Gule MK, Adachi M, Dodge CT, Henderson Y, Lai SY. Targeting focal adhesion kinase in anaplastic and papillary thyroid cancer inhibits tumor function and growth. Oral Presentation. AHNS 8th International Conference on Head and Neck Cancer, Toronto, Ontario, Canada, 2012. e-Pub 2012.
142. Adachi M, Cui C, Dodge CT, Byahani MK, Chen Y, Lai SY. Targeting STAT3 inhibits head and neck squamous cell carcinoma growth in vitro and in vivo. Oral Presentation. AHNS 8th International Conference on Head and Neck Cancer, Toronto, Ontario, Canada, 2012. e-Pub 2012.
143. Lai SY, Williams MD, Chasen BA, Lewis CM, Hessel AC, Gillenwater AM, Rohren EM, Myers JN, Weber RS. 99m-Tc-tilmanocept-identified sentinel lymph nodes relative to the pathological status of non-sentinel lymph nodes in an elective neck dissection in cutaneous and intraoral head and neck squamous cell carcinoma: a single institutional experience. Oral Presentation. AHNS 8th International Conference on Head and Neck Cancer, Toronto, Ontario, Canada, 2012. e-Pub 2012.
144. Bankson JA, Sandulache V, Merritt M, Elliott A, Chen Y, Priebe W, Schellingerhout D, Lai SY, Conrad C, Hazle JD. Dynamic spectroscopy and modeling of response to 2-deoxyglucose using hyperpolarized [1-13C]-pyruvate - Oral Presentation. CPRIT Annual Conference, Austin, TX, 2012. e-Pub 2012.
145. Ramirez MS, Chen Y, Lai SY, Bankson JA. A six-fold throughput improvement for preclinical cancer studies. International Society for Magnetic Resonance in Medicine (ISMRM), Melbourne, Australia, 2012. e-Pub 2012.
146. Henderson YC, Chen Y, Toro-Serra R, Frederick MJ, Zhou G, Lai SY, Clayman GL. Src inhibition produces growth suppression in papillary thyroid carcinoma cells without altering survival. AHNS COSM Annual Meeting, Chicago, IL, 2011. e-Pub 2011.
147. Bankson JA, Merritt M, Elliott A, Ramirez M, Chen Y, Lai SY. Dynamic spectroscopy and modelling of hyperpolarized [1-13C]-pyruvate in an orthotopic model of thyroid cancer. World Molecular Imaging Congress, San Diego, CA, 2011. e-Pub 2011.
148. Jr WW, Weber R, Lee JJ, Myers JN, Ginsberg L, El-Naggar A, Sturgis E, Sabichi A, Kies M, Hanna E, Hessel A, Lu C, Lai SY, Ayuste R, Lippman S, Kim E. Randomized trial of a short course of erlotinib 150 to 300 mg daily prior to surgery for squamous cell carcinomas of the head and neck (SCCHN) in current, former and never smokers: objective responses and clinical outcomes. ASCO Annual Meeting, Chicago, IL, 2011. e-Pub 2011.
149. Ramirez MS, Chen Y, Lai SY, Bankson JA. A 20 coil array system for parallel imaging-accelerated multiple mouse MRI. International Society for Magnetic Resonance in Medicine (ISMRM), Montreal, Quebec, Canada, 2011. e-Pub 2011.
150. Bhayani MK, Hutcheson KA, Barringer DA, Roberts DB, Lewin JS, Lai SY. Gastrostomy tube placement in patients with hypopharyngeal cancer treated with chemoradiotherapy: factors affecting placement and dependence. Dysphagia Research Society, San Antonio, TX, 2011. e-Pub 2011.
151. Bhayani MK, Hutcheson KA, Barringer DA, Lisec A, Roberts DB, Lai SY, Lewin JS. Identification and management of oropharyngeal carcinoma patients with risk factors for gastrostomy tube placement and dependence. ASTRO, Miami, FL, 2011. e-Pub 2011.
152. Bhayani MK, Hutcheson KA, Barringer DA, Roberts DB, Lewin JS, Lai SY. Gastrostomy tube placement in patients with hypopharyngeal cancer treated with chemoradiotherapy: factors affecting placement and dependence. Dysphagia Research Society, San Antonio, TX, 2011. e-Pub 2011.
153. Bankson JA, Merritt M, Elliott A, Ramirez M, Chen Y, Lai SY. Dynamic spectroscopy and modelling of hyperpolarized [1-13C]-pyruvate in an orthotopic model of thyroid cancer. World Molecular Imaging Congress, San Diego, CA, 2011. e-Pub 2011.
154. Jr WW, Weber R, Lee JJ, Myers JN, Ginsberg L, El-Naggar A, Sturgis E, Sabichi A, Kies M, Hanna E, Hessel A, Lu C, Lai SY, Ayuste R, Lippman S, Kim E. Randomized trial of a short course of erlotinib 150 to 300 mg daily prior to surgery for squamous cell carcinomas of the head and neck (SCCHN) in current, former and never smokers: objective responses and clinical outcomes. ASCO Annual Meeting, Chicago, IL, 2011. e-Pub 2011.
155. Bhayani MK, Hutcheson KA, Barringer DA, Lisec A, Roberts DB, Lai SY, Lewin JS. Identification and management of oropharyngeal carcinoma patients with risk factors for gastrostomy tube placement and dependence. ASTRO, Miami, FL, 2011. e-Pub 2011.
156. Henderson YC, Chen Y, Toro-Serra R, Frederick MJ, Zhou G, Lai SY, Clayman GL. Src inhibition produces growth suppression in papillary thyroid carcinoma cells without altering survival. AHNS COSM Annual Meeting, Chicago, IL, 2011. e-Pub 2011.
157. Ramirez MS, Chen Y, Lai SY, Bankson JA. A 20 coil array system for parallel imaging-accelerated multiple mouse MRI. International Society for Magnetic Resonance in Medicine (ISMRM), Montreal, Quebec, Canada, 2011. e-Pub 2011.
158. Weber RS, Eastman S, Hanna EY, Akiwumi O, Hessel A, Lai SY, Kian L, Roberts D. Quality and performance indicators for an academic head and neck surgical oncology department. AHNS Annual Meeting, Las Vegas, NV. e-Pub 2010.
159. Norris L, Qureshi Z, Barnato S, Lai SY, Bennett C. Serious adverse drug reactions (sADRS) associated with hematopoietic growth factors: A systematic review from the southern network on adverse reactions (SONAR) program. 52nd ASH Annual Meeting and Exposition, Orlando, FL, 2010. e-Pub 2010.
160. Wu X, Nicoloso MS, Chen Y, Calin GA, Lai SY. Regulation of the EGFR signaling axis by microRNA in HNSCC. AHNS Research Workshop, Arlington, VA, 2010. e-Pub 2010.
161. Lai SY, Chen Y, Gule M, Lemos R, Myers, NH, Schwartz DL, Bankson JA. Comparing response to therapy using a multi-animal dual-tracer DCE-MRI platform. World Molecular Imaging Congress (WMIC), Kyoto, Japan, 2010. e-Pub 2010.
162. Ragan DK, Lai SY, Bankson JA. In vivo measurement of pharmacokinetic parameters in small animal DCE-MRI using cardiac sampling of the vascular input function. International Society for Magnetic Resonance in Medicine (ISMRM), Stockholm, Sweden, 2010. e-Pub 2010.
163. Chen Y, Gule M, Lemos R, Myers JN, Schwartz DL, Bankson J, Lai SY. Evaluation of vandetanib (ZD6474) and radiation therapy in an orthotopic xenograft model of anaplastic thyroid carcinoma. AACR Annual Meeting, Washington, D.C, 2010. e-Pub 2010.
164. Lai SY, Chen Y, Gule M, Lemos R, Myers JN, Schwartz DL, Bankson J. A preclinical model for the assessment of targeted therapy efficacy in thyroid cancer. ASTRO-AHNS-ASCO Multidisciplinary Head and Neck Cancer Symposium, Chandler, AZ, 2010. e-Pub 2010.
165. Lai SY, Chen Y, Lemos R, Myers JN, Schwartz D, Bankson J. Preclinical assessment of therapeutic agents for thyroid cancer using dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI). Discussed Poster. 14th International Thyroid Congress (ITC), Paris, France, 2010. e-Pub 2010.
166. Wu X, Nicoloso MS, Chen Y, Calin GA, Lai SY. Regulation of the EGFR signaling axis by microRNA in HNSCC. AHNS Research Workshop, Arlington, VA, 2010. e-Pub 2010.
167. Lai SY, Chen Y, Lemos R, Myers JN, Schwartz D, Bankson J. Preclinical assessment of therapeutic agents for thyroid cancer using dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI). Discussed Poster. 14th International Thyroid Congress (ITC), Paris, France, 2010. e-Pub 2010.
168. Lai SY, Chen Y, Gule M, Lemos R, Myers, NH, Schwartz DL, Bankson JA. Comparing response to therapy using a multi-animal dual-tracer DCE-MRI platform. World Molecular Imaging Congress (WMIC), Kyoto, Japan, 2010. e-Pub 2010.
169. Ragan DK, Lai SY, Bankson JA. In vivo measurement of pharmacokinetic parameters in small animal DCE-MRI using cardiac sampling of the vascular input function. International Society for Magnetic Resonance in Medicine (ISMRM), Stockholm, Sweden, 2010. e-Pub 2010.
170. Weber RS, Eastman S, Hanna EY, Akiwumi O, Hessel A, Lai SY, Kian L, Roberts D. Quality and performance indicators for an academic head and neck surgical oncology department. AHNS Annual Meeting, Las Vegas, NV. e-Pub 2010.
171. Chen Y, Gule M, Lemos R, Myers JN, Schwartz DL, Bankson J, Lai SY. Evaluation of vandetanib (ZD6474) and radiation therapy in an orthotopic xenograft model of anaplastic thyroid carcinoma. AACR Annual Meeting, Washington, D.C, 2010. e-Pub 2010.
172. Lai SY, Chen Y, Gule M, Lemos R, Myers JN, Schwartz DL, Bankson J. A preclinical model for the assessment of targeted therapy efficacy in thyroid cancer. ASTRO-AHNS-ASCO Multidisciplinary Head and Neck Cancer Symposium, Chandler, AZ, 2010. e-Pub 2010.
173. Norris L, Qureshi Z, Barnato S, Lai SY, Bennett C. Serious adverse drug reactions (sADRS) associated with hematopoietic growth factors: A systematic review from the southern network on adverse reactions (SONAR) program. 52nd ASH Annual Meeting and Exposition, Orlando, FL, 2010. e-Pub 2010.
174. Zang Y, Velosa-Ramirez C, Thomas SM, Childs EE, Gooding WE, Johnson DE, Grandis JR, Lai SY. STAT3 is critical for the regulation of HIF-1 in head and neck squamous cell carcinoma. AACR Annual Meeting, 2009. e-Pub 2009.
175. Henderson Y, He Y, Clayman G, Schwartz D, Lai SY. Src inhibition and radiosensitivity in papillary thyroid carcinoma. World Congress on Thyroid Carcinoma, 2009. e-Pub 2009.
176. Samaras AY, Lai SY, Kim B, West DP, McKoy JM, Henke M, Silver SM, Bennett CL. Erythropoiesis stimulating agents for cancer patients: increasingly restrictive guidelines and policies in the United States and Europe. ASCO Annual Meeting, 2009. e-Pub 2009.
177. Zang Y, Velosa-Ramirez C, Thomas SM, Childs EE, Gooding WE, Johnson DE, Grandis JR, Lai SY. STAT3 is critical for the regulation of HIF-1 in head and neck squamous cell carcinoma. AACR Annual Meeting, 2009. e-Pub 2009.
178. Samaras AY, Lai SY, Kim B, West DP, McKoy JM, Henke M, Silver SM, Bennett CL. Erythropoiesis stimulating agents for cancer patients: increasingly restrictive guidelines and policies in the United States and Europe. ASCO Annual Meeting, 2009. e-Pub 2009.
179. Henderson Y, He Y, Clayman G, Schwartz D, Lai SY. Src inhibition and radiosensitivity in papillary thyroid carcinoma. World Congress on Thyroid Carcinoma, 2009. e-Pub 2009.
180. Barnato SE, Boyle SN, Kuykendal A, Lai SY, Wagner R, Goldstein C, Samaras AT, West DP, Tallman J, Henke M, Sartor O, Bennett CL. Evaluation of conflicts of interest in basic science studies evaluating erythropoietin and erythropoietin effects in solid cancer cell lines. ASH Annual Meeting, 2008. e-Pub 2008.
181. Kim B, Samaras AT, Nissenson AR, Sartor AO, Courtney DM, Liem RI, West DP, Boyle SN, Wagner RL, Goldstein CE, McKoy JM, Edwards BJ, Spiegel DM, Lai SY, Bennett CL. Erythropoiesis stimulating agent (ESA) use for anemic cancer and chronic kidney disease (CKD) patients in 2008: A revolution has occurred. ASH Annual Meeting, 2008. e-Pub 2008.
182. Samaras AT, Barnatio SE, Kim B, Sartor OA, Sauer BC, Djulbegovic B, Henke M, Edwards BJ, McKoy JM, Lai SY, Bennett CL. Evaluating mortality with erythropoietin stimulating agents (ESAs) in the oncology setting: The importance of selecting trials that include survival or locoregional tumor control as a primary endpoint. ASH Annual Meeting, 2008. e-Pub 2008.
183. Barnato SE, Boyle SN, Kuykendal A, Lai SY, Wagner R, Goldstein C, Samaras AT, West DP, Tallman J, Henke M, Sartor O, Bennett CL. Evaluation of conflicts of interest in basic science studies evaluating erythropoietin and erythropoietin effects in solid cancer cell lines. ASH Annual Meeting, 2008. e-Pub 2008.
184. Samaras AT, Barnatio SE, Kim B, Sartor OA, Sauer BC, Djulbegovic B, Henke M, Edwards BJ, McKoy JM, Lai SY, Bennett CL. Evaluating mortality with erythropoietin stimulating agents (ESAs) in the oncology setting: The importance of selecting trials that include survival or locoregional tumor control as a primary endpoint. ASH Annual Meeting, 2008. e-Pub 2008.
185. Kim B, Samaras AT, Nissenson AR, Sartor AO, Courtney DM, Liem RI, West DP, Boyle SN, Wagner RL, Goldstein CE, McKoy JM, Edwards BJ, Spiegel DM, Lai SY, Bennett CL. Erythropoiesis stimulating agent (ESA) use for anemic cancer and chronic kidney disease (CKD) patients in 2008: A revolution has occurred. ASH Annual Meeting, 2008. e-Pub 2008.
186. Childs EE, Wilkinson EC, Freilino M, Seethala RR, Grandis JR, Lai SY. Regulation of epithelial-mesenchymal transition by HIF-1 contributes to HNSCC invasion and metastasis. CORLAS Annual Meeting, 2008. e-Pub 2008.
187. Childs EE, Wilkinson EC, Freilino M, Seethala RR, Grandis JR, Lai SY. Regulation of epithelial-mesenchymal transition by HIF-1 contributes to HNSCC invasion and metastasis. CORLAS Annual Meeting, 2008. e-Pub 2008.
188. Gibson MK, Smith R, Heron DE, Ferris RL, Lai SY, Kim S, Boyer T, Johnson JT, Grandis JR, Argiris A. Phase-I trial of pemetrexed, cetuximab and concurrent radiotherapy (RT) in head and neck cancer (HNC). ASCO Annual Meeting, 2008. e-Pub 2008.
189. Kuykendal A, Bennett CL, McKoy JM, Boyle S, West DP, Edwards B, Courtney M, Sartor AO, Lai SY, Henke, M. Tumor progression and mortality associated with administration of erythropoiesis stimulating agents (ESAs) to cancer patients: Is toxicity due to ESAs or elevated hemoglobin (Hgb) levels?. ASCO Annual Meeting, 2008. e-Pub 2008.
190. Deleyiannis FWB, Rogers C, Ferris RL, Lai SY, Kim, SW, Johnson JT. Reconstruction of the through-and-through anterior mandible defect with a double-skin paddle fibular free flap. 7th International Conference on Head and Neck Cancer, 2008. e-Pub 2008.
191. Lai SY, Grandis JR. EGFR-Targeted Therapy: Antitumor mechanisms of intratumoral EGFR antisense DNA therapy in advanced head and neck squamous cell carcinoma. CORLAS Annual Meeting, 2008. e-Pub 2008.
192. Cano ER, Caylakli F, Johnson JT, Ferris RL, Carrau RL, Snyderman CH, Gooding WE, Jr SA, Lai SY, Myers EN. Management of squamous cell carcinoma of the base of the tongue with chemoradiation and brachytherapy. American Radium Society, 2008. e-Pub 2008.
193. Argiris A, Gibson M, Heron DE, Smith R, Ferris RL, Lai SY, Kim S, Branstetter BF, Johnson JT, Grandis JR. Phase-II trial of neoadjuvant docetaxel (T), cisplatin (P), and cetuximab (E) followed by concurrent radiation (X), P, and E in locally advanced head and neck cancer (HNC). ASCO Annual Meeting, 2008. e-Pub 2008.
194. Passero VA, Branstetter BF, Heron DE, Gibson MK, Lai SY, Kim SW, Ferris RL, Grandis JR, Johnson JT, Argiris A. How to best assess tumor response after curative chemoradiotherapy (CRT) for head and neck squamous cell carcinomas (HNSCC): RECIST or PET/CT?. ASCO Annual Meeting, 2008. e-Pub 2008.
195. Lai SY, Feinstein TM, Seethala RR, Heron DE, Ferris RL, Grandis JR, Myers EN, Johnson JT, Argiris A. Prognostic factors in patients with locally advanced salivary gland cancers treated with surgery and postoperative radiotherapy (RT). ASCO Annual Meeting, 2008. e-Pub 2008.
196. Grandis JR, Lai SY, Esteve F, Kim S, Ferris RL, Gibson M, Johnson R, Heron DE, Johnson JT, Argiris A. Erlotinib (E) as adjuvant treatment for patients (pts) with resected head and neck squamous cell carcinoma (HNSCC) with evaluation of neoadjuvant biomarker modulation with E with or without sulindac (S): a feasibility report. ASCO Annual Meeting, 2008. e-Pub 2008.
197. Mountz JM, Regiane A, Muthukrishnan A, Heron D, Bencherif B, Ferris R, Lai SY, Grandis JR. FDG PET in patients undergoing stereotactic body radiotherapy (SBRT) for recurrent squamous cell carcinoma of the head and neck (SCCHN). Society of Nuclear Medicine Annual Meeting, 2008. e-Pub 2008.
198. Mountz JM, Regiane A, Muthukrishnan A, Heron D, Bencherif B, Ferris R, Lai SY, Grandis JR. FDG PET in patients undergoing stereotactic body radiotherapy (SBRT) for recurrent squamous cell carcinoma of the head and neck (SCCHN). Society of Nuclear Medicine Annual Meeting, 2008. e-Pub 2008.
199. Kuykendal A, Bennett CL, McKoy JM, Boyle S, West DP, Edwards B, Courtney M, Sartor AO, Lai SY, Henke, M. Tumor progression and mortality associated with administration of erythropoiesis stimulating agents (ESAs) to cancer patients: Is toxicity due to ESAs or elevated hemoglobin (Hgb) levels?. ASCO Annual Meeting, 2008. e-Pub 2008.
200. Passero VA, Branstetter BF, Heron DE, Gibson MK, Lai SY, Kim SW, Ferris RL, Grandis JR, Johnson JT, Argiris A. How to best assess tumor response after curative chemoradiotherapy (CRT) for head and neck squamous cell carcinomas (HNSCC): RECIST or PET/CT?. ASCO Annual Meeting, 2008. e-Pub 2008.
201. Lai SY, Grandis JR. EGFR-Targeted Therapy: Antitumor mechanisms of intratumoral EGFR antisense DNA therapy in advanced head and neck squamous cell carcinoma. CORLAS Annual Meeting, 2008. e-Pub 2008.
202. Cano ER, Caylakli F, Johnson JT, Ferris RL, Carrau RL, Snyderman CH, Gooding WE, Jr SA, Lai SY, Myers EN. Management of squamous cell carcinoma of the base of the tongue with chemoradiation and brachytherapy. American Radium Society, 2008. e-Pub 2008.
203. Deleyiannis FWB, Rogers C, Ferris RL, Lai SY, Kim, SW, Johnson JT. Reconstruction of the through-and-through anterior mandible defect with a double-skin paddle fibular free flap. 7th International Conference on Head and Neck Cancer, 2008. e-Pub 2008.
204. Lai SY, Feinstein TM, Seethala RR, Heron DE, Ferris RL, Grandis JR, Myers EN, Johnson JT, Argiris A. Prognostic factors in patients with locally advanced salivary gland cancers treated with surgery and postoperative radiotherapy (RT). ASCO Annual Meeting, 2008. e-Pub 2008.
205. Gibson MK, Smith R, Heron DE, Ferris RL, Lai SY, Kim S, Boyer T, Johnson JT, Grandis JR, Argiris A. Phase-I trial of pemetrexed, cetuximab and concurrent radiotherapy (RT) in head and neck cancer (HNC). ASCO Annual Meeting, 2008. e-Pub 2008.
206. Grandis JR, Lai SY, Esteve F, Kim S, Ferris RL, Gibson M, Johnson R, Heron DE, Johnson JT, Argiris A. Erlotinib (E) as adjuvant treatment for patients (pts) with resected head and neck squamous cell carcinoma (HNSCC) with evaluation of neoadjuvant biomarker modulation with E with or without sulindac (S): a feasibility report. ASCO Annual Meeting, 2008. e-Pub 2008.
207. Argiris A, Gibson M, Heron DE, Smith R, Ferris RL, Lai SY, Kim S, Branstetter BF, Johnson JT, Grandis JR. Phase-II trial of neoadjuvant docetaxel (T), cisplatin (P), and cetuximab (E) followed by concurrent radiation (X), P, and E in locally advanced head and neck cancer (HNC). ASCO Annual Meeting, 2008. e-Pub 2008.
208. Nance MA, Egloff AM, Ferris RL, Myers EN, Johnson JT, Lai SY. Treatment and survival outcomes analysis in intermediate grade mucoepidermoid carcinoma. Second International Congress on Salivary Gland Disease, Pittsburgh, PA, 2007. e-Pub 2007.
209. Nance MA, Egloff AM, Ferris RL, Myers EN, Johnson JT, Lai SY. Treatment and survival outcomes analysis in intermediate grade mucoepidermoid carcinoma. Second International Congress on Salivary Gland Disease, Pittsburgh, PA, 2007. e-Pub 2007.
210. Argiris A, Karamouzis MV, Heron DE, Smith R, Ferris R, Lai SY, Kim S, Branstetter B, Johnson J, Grandis J. Phase-II trial of docetaxel (T), cisplatin (P) and cetuximab (E) followed by concurrent radiation (RT), P and E in locally advanced head and neck squamous cell carcinoma (HNSCC). ASCO Annual Meeting, 2007. e-Pub 2007.
211. Argiris A, Karamouzis MV, Heron DE, Smith R, Ferris R, Lai SY, Kim S, Branstetter B, Johnson J, Grandis J. Phase-II trial of docetaxel (T), cisplatin (P) and cetuximab (E) followed by concurrent radiation (RT), P and E in locally advanced head and neck squamous cell carcinoma (HNSCC). ASCO Annual Meeting, 2007. e-Pub 2007.
212. Muthukrishnan A, Mountz JM, Grandis JR, Lai SY. FDG-PET-CT accurately assesses response to intratumoral epidermal growth factor receptor (EGFR) antisense (AS) DNA therapy in recurrent squamous cell carcinoma of the head and neck (SCCHN). Society of Nuclear Medicine Annual Meeting, 2007. e-Pub 2007.
213. Heron DE, Ferris RL, Burton S, Lai SY, Karamouzis MV, Gooding W, Johnson JT, Smith RP, Argiris A, Grandis JR. Phase-I dose escalation study of fractionated stereotactic radiosurgery (fSRS) for recurrent squamous cell carcinoma of the head and neck (SCCHN). ASCO Annual Meeting 25:306s, 2007. e-Pub 2007.
214. Lai SY. Erythropoietin-mediated signaling in head and neck squamous cell carcinoma. NCI Workshop. Rockville, MD, 2007. e-Pub 2007.
215. Lai SY, Koppikar PJ, Thomas S, Childs E, Egloff AM, Seethala R, Gooding W, Argiris A, Johnson J, Grandis J. EGFR and STAT3 expression levels are associated with clinical response to EGFR antisense gene therapy in HNSCC. Molecular Markers in Cancer. EORTC-NCI-ASCO Annual Meeting, Brussels, Belgium, 2007. e-Pub 2007.
216. Lai SY, Lui, VW, Koppikar PJ, Thomas SM, Gooding WE, Seethala RR, Branstetter BF, Argiris A, Grandis JR. Intratumoral epidermal growth factor receptor (EGFR) antisense (AS) DNA in recurrent squamous cell carcinoma of the head and neck (SCCHN): a phase-I trial. ASCO Annual Meeting, 2007. e-Pub 2007.
217. Ferris RL, Lai SY, Kim S, Walvekar R. Expanded indications and technique of minimally invasive thyroidectomy. EUFOS Annual Meeting, 2007. e-Pub 2007.
218. Lai SY, Walvekar, R, Kim S, Ferris, RL. Minimally-invasive video-assisted thyroidectomy (MIVAT): technique and expanded indications. Oral presentation. PAO-HNS Annual Meeting, 2007. e-Pub 2007.
219. Smith R, Karamouzis MV, Heron DE, Ferris RL, Lai SY, Kim S, Boyer T, Grandis JR, Johnson JT, Argiris A. Phase-I trial of pemetrexed (P) in combination with cetuximab (C) and concurrent radiotherapy (RT) in patients (pts) with head and neck cancer (HNC). ASCO Annual Meeting, 2007. e-Pub 2007.
220. Heron DE, Ferris RL, Burton S, Lai SY, Karamouzis MV, Gooding W, Johnson JT, Smith RP, Argiris A, Grandis JR. Phase-I dose escalation study of fractionated stereotactic radiosurgery (fSRS) for recurrent squamous cell carcinoma of the head and neck (SCCHN). ASCO Annual Meeting 25:306s, 2007. e-Pub 2007.
221. Lai SY. Erythropoietin-mediated signaling in head and neck squamous cell carcinoma. NCI Workshop. Rockville, MD, 2007. e-Pub 2007.
222. Lai SY, Koppikar PJ, Thomas S, Childs E, Egloff AM, Seethala R, Gooding W, Argiris A, Johnson J, Grandis J. EGFR and STAT3 expression levels are associated with clinical response to EGFR antisense gene therapy in HNSCC. Molecular Markers in Cancer. EORTC-NCI-ASCO Annual Meeting, Brussels, Belgium, 2007. e-Pub 2007.
223. Muthukrishnan A, Mountz JM, Grandis JR, Lai SY. FDG-PET-CT accurately assesses response to intratumoral epidermal growth factor receptor (EGFR) antisense (AS) DNA therapy in recurrent squamous cell carcinoma of the head and neck (SCCHN). Society of Nuclear Medicine Annual Meeting, 2007. e-Pub 2007.
224. Lai SY, Lui, VW, Koppikar PJ, Thomas SM, Gooding WE, Seethala RR, Branstetter BF, Argiris A, Grandis JR. Intratumoral epidermal growth factor receptor (EGFR) antisense (AS) DNA in recurrent squamous cell carcinoma of the head and neck (SCCHN): a phase-I trial. ASCO Annual Meeting, 2007. e-Pub 2007.
225. Smith R, Karamouzis MV, Heron DE, Ferris RL, Lai SY, Kim S, Boyer T, Grandis JR, Johnson JT, Argiris A. Phase-I trial of pemetrexed (P) in combination with cetuximab (C) and concurrent radiotherapy (RT) in patients (pts) with head and neck cancer (HNC). ASCO Annual Meeting, 2007. e-Pub 2007.
226. Lai SY, Walvekar, R, Kim S, Ferris, RL. Minimally-invasive video-assisted thyroidectomy (MIVAT): technique and expanded indications. Oral presentation. PAO-HNS Annual Meeting, 2007. e-Pub 2007.
227. Ferris RL, Lai SY, Kim S, Walvekar R. Expanded indications and technique of minimally invasive thyroidectomy. EUFOS Annual Meeting, 2007. e-Pub 2007.
228. Nance MA, Ferris RL, Johnson JT, Myers EN, Eibiling, DE, Lai SY. Influence of tumor grade on patient treatment and outcome in mucoepidermoid carcinoma. AHNS Annual Meeting and Research Workshop on the Biology, Prevention and Treatment of Head and Neck Cancer, 2006. e-Pub 2006.
229. Childs EE, Freilino ML, Grandis JR, Lai SY. HIF-1 promotes invasion and metastasis of head and neck squamous cell carcinoma. AACR Annual Meeting, 2006. e-Pub 2006.
230. Nayak JV, Walvekar R, Daamen N, Lai SY, Ferris RL, Branstetter IV BF, Johnson JT. Deferring planned neck dissection after chemoradiation therapy in stage IV head and neck cancer: The utility of PET/CT7. AHNS Annual Meeting and Research Workshop on the Biology, Prevention and Treatment of Head and Neck Cancer, 2006. e-Pub 2006.
231. Childs EE, Wilkinson EC, Freilino ML, Seethala RR, Grandis JR, Lai SY. HIF-1 promotes HNSCC invasion and metastasis through epithelial-mesenchymal transition. AACR Advances and Challenges in Aerodigestive Epithelial Cancer: Genetics, Diagnosis and Therapy Conference, 2006. e-Pub 2006.
232. Childs EE, Wilkinson EC, Freilino ML, Seethala RR, Grandis JR, Lai SY. HIF-1 promotes HNSCC invasion and metastasis through epithelial-mesenchymal transition. AACR Advances and Challenges in Aerodigestive Epithelial Cancer: Genetics, Diagnosis and Therapy Conference, 2006. e-Pub 2006.
233. Nance MA, Ferris RL, Johnson JT, Myers EN, Eibiling, DE, Lai SY. Influence of tumor grade on patient treatment and outcome in mucoepidermoid carcinoma. AHNS Annual Meeting and Research Workshop on the Biology, Prevention and Treatment of Head and Neck Cancer, 2006. e-Pub 2006.
234. Nayak JV, Walvekar R, Daamen N, Lai SY, Ferris RL, Branstetter IV BF, Johnson JT. Deferring planned neck dissection after chemoradiation therapy in stage IV head and neck cancer: The utility of PET/CT7. AHNS Annual Meeting and Research Workshop on the Biology, Prevention and Treatment of Head and Neck Cancer, 2006. e-Pub 2006.
235. Childs EE, Freilino ML, Grandis JR, Lai SY. HIF-1 promotes invasion and metastasis of head and neck squamous cell carcinoma. AACR Annual Meeting, 2006. e-Pub 2006.
236. Lai SY, Ziober AF, Lee MN, Falls EM, Ziober BL. Vav2 modulates cellular invasion through the Rac1 signaling pathway. ASCB Annual Meeting, 2005. e-Pub 2005.
237. Lai SY, Childs EE, Xi S, Coppelli FM, Gooding WE, Wells A, Ferris RL, Grandis JR. Erythropoietin contributes to cellular invasion and metastasis in head and neck squamous cell carcinoma. 13th SPORE Investigators Workshop, 2005. e-Pub 2005.
238. Mountz JM, Grandis JR, Lai SY, Lopresti BJ, Laymon CM, Meltzer CC, Mason NS, Mathis CA. Positron emission tomography assessment of molecular imaging endpoints in clinical therapeutic trials. 17th Annual University of Pittsburgh Cancer Institute Scientific Retreat, 2005. e-Pub 2005.
239. Lin CJ, Fraioli RE, Childs EE, Grandis JR, Lai SY. Phosphatidylinositol 3-kinase (PI3K) is critical for HIF-1 alpha upregulation in head and neck squamous cell carcinoma. American Association for Cancer Research, 2005. e-Pub 2005.
240. Lai SY, Carrau RL, Kassam A, Snyderman CH, Horowitz M. Endoscopic transpterygopalatine fossa approach to the infratemporal skull base. Oral presentation. North American Skull Base Society Annual Meeting, 2005. e-Pub 2005.
241. Lai SY, Ziober AF, Lee MN, Falls EM, Ziober BL. Vav2 modulates cellular invasion through the Rac1 signaling pathway. ASCB Annual Meeting, 2005. e-Pub 2005.
242. Lai SY, Childs EE, Xi S, Coppelli FM, Gooding WE, Wells A, Ferris RL, Grandis JR. Erythropoietin contributes to cellular invasion and metastasis in head and neck squamous cell carcinoma. 13th SPORE Investigators Workshop, 2005. e-Pub 2005.
243. Mountz JM, Grandis JR, Lai SY, Lopresti BJ, Laymon CM, Meltzer CC, Mason NS, Mathis CA. Positron emission tomography assessment of molecular imaging endpoints in clinical therapeutic trials. 17th Annual University of Pittsburgh Cancer Institute Scientific Retreat, 2005. e-Pub 2005.
244. Lin CJ, Fraioli RE, Childs EE, Grandis JR, Lai SY. Phosphatidylinositol 3-kinase (PI3K) is critical for HIF-1 alpha upregulation in head and neck squamous cell carcinoma. American Association for Cancer Research, 2005. e-Pub 2005.
245. Lai SY, Carrau RL, Kassam A, Snyderman CH, Horowitz M. Endoscopic transpterygopalatine fossa approach to the infratemporal skull base. Oral presentation. North American Skull Base Society Annual Meeting, 2005. e-Pub 2005.
246. Lai SY. NRG Oncology NRG-HN006: Randomized Phase II/III Trial of Sentinel Lymph Node Biopsy Versus Elective Neck Dissection for Early-Stage Oral Cavity Cancer. ASCO Annual Meeting.
247. Mohamed ASR, Henderson Y, Chen Y, Stephan C, Cote G, Cabanillas M, Zafereo M, Sandulache V, Lai S. Utilizing a high-throughput approach to identify effective agents for aggressive thyroid cancer. ESTRO 2020.

Book Chapters

1. Weber RS, Lai SY, Hessel A, Lewis CM. Head and Neck Cancer Care: Quality and Guidelines. In: Cancer of the Head and Neck. 5th. Wolters Kluwer, 168-177, 2016.
2. Le X, Huang AT, Chen Y, Lai SY. Regulation of Receptor Tyrosine Kinases by miRNA: Overexpression of miRNA Using Lentiviral Inducible Expression Vectors. In: Receptor Tyrosine Kinases: Methods and Protocols, Methods in Molecular Biology. Serena Germano. Springer Science + Business Media, 135-47, 2015.
3. Lai SY, Grandis JR. Targeted Therapeutic Approaches to Head and Neck Cancer. In: Ballenger's Otorhinolaryngology: Head and Neck Surgery. 18th. People's Medical Publishing House, 2015.
4. Lai SY. Management of benign salivary tumors. In: Maintenance Manual for Lifelong Learning, American Academy of Otolaryngolygy-Head and Neck Surgery Foundation. 3rd. American Academy of Otolaryngology-Head and Neck Surgery Foundation, 2015.
5. Cabanillas ME, Dadu R, Hu MI, Lu C, Gunn GB, Grubbs EG, Lai SY, Williams MD. Thyroid Gland Malignancies. In: Hematol Oncol Clin N Am - Head and Neck Cancer. 6. Elsevier, 1123-43, 2015.
6. Lai SY, Mandel SJ, Weber RS. Management of thyroid neoplasms. In: Head and Neck Surgery and Oncology. 6th Edition Cummings CW, Frederickson JM, Harker LA, Krause CJ, . Mosby Elsevier, 123-28, 2015.
7. Lai SY, Weber RS. Surgical management of locoregional disease. In: Cutaneous malignancy of the head and neck: A multidisciplinary approach. Plural Publishing, Inc, 143-54, 2011.
8. Lai SY, Mandel SJ, Weber RS. Management of thyroid neoplasms. In: Otolaryngology-Head and Neck Surgery. In: Otolaryngology - Head and Neck Surgery. 5th Edition Cummings CW, Frederickson JM, Harker LA, Krause CJ, . Mosby Elsevier Publishers, 1750-72, 2010.
9. Oliver CL, Lai SY. Hematemesis/Regurgitation. In: Differential Diagnosis in Otolaryngology-Head and Neck Surgery. Thieme, 283-8, 2010.
10. Lai SY, Grandis, JR. Targeted therapeutic approaches to head and neck cancer. In: Ballenger’s Otorhinolaryngology: Head and Neck Surgery. 17th, 1035-1043, 2009.
11. Lai SY, Johnson JT. Management of the neck in thyroid cancer. In: Thyroid and Parathyroid Diseases, 2009.
12. Johnson JT, Lai SY. Pharyngectomy. In: Operative Otolaryngology. 2nd, 2008.
13. Duvvuri U, Carrau RL, Lai SY. External approaches to the paranasal sinuses. In: Head and Neck Surgery - Otolaryngology. 4th, 2006.
14. Lai SY, Mandel SJ, Weber RS. Thyroid Neoplasms. In: Otolaryngology - Head and Neck Surgery. 4th, 2687-2723, 2005.
15. Lai SY. Contributor in facial plastics and reconstruction, facial trauma, head and neck disorders, larynx, oral cavity and oropharynx. In: Comprehensive Otolaryngology, 2004.
16. Sewell DA, Lai SY, Weber RS. Non-melanoma cancer of the skin. In: Cancer of the Head and Neck. 4th, 2003.
17. Lai SY, Weber RS. Thyroid Cancer. In: Head and Neck Cancer, 2003.
18. Becker DG, Lai SY. Reconstruction of the outstanding ear. In: Otorhinolaryngology: Head and Neck Surgery. 16th, 2003.
19. Lai SY, Weinstein GS. Conservation laryngeal surgery, supracricoid laryngectomy. In: eMedicine-Otolaryngology and Facial Plastic Surgery, 2001.
20. Lai SY, Becker DG. Sutures and Needles. In: eMedicine-Otolaryngology and Facial Plastic Surgery, 2001.
21. Lai SY, Carrau RL. Parapharyngeal space tumors. In: Multidisciplinary Care of Head and Neck Cancer.
22. Sherman SI, Bast R, Cabanillas ME, Lai SY. Neoplasms of the thyroid. In: Cancer Medicine.
23. Rassekh C, Chang J, Marzouk M, Schaitkin B, Carrau R, Tweel B, Kolenda J, Bhayani M, Lai SY, Joshi A, Walvekar RR, Gillespie MB, Ogden, A, Witt RL, Coffey CS. Xerostomia. In: Gland-Preserving Salivary Surgery - A Problem-Based Approach. Springer Book.
24. Lai SY. The N0 Neck: Diagnostic evaluation in management of upper aerodigestive tract malignancies. In: Maintenance Manual for Lifelong Learning, American Academy of Otolaryngology-Head and Neck Surgery Foundation. American Academy of Otolaryngology-Head and Neck Surgery Foundation.

Letters to the Editor

1. Fuller, C, Brock, K, Hutcheson, KA, Lai, SY. In Regard to Hanna et al. International Journal of Radiation Oncology Biology Physics 124: 229-230, 2026.
2. Schilling C, Lai SY, Chegini S, McGurk M. ASCO Neck Dissection Guidelines Response Letter. J Oncol Pract 15: 560-561, 2019.
3. Cabanillas ME, Dadu R, Lai SY. In reply. Sorafenib in metastatic thyroid cancer: - a systematic review. Oncologist 19: e4, 2014.
4. Bennett CL, Henke M, Lai SY. Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoitin administration for the treatment of cancer-associated anemia. JAMA 300: 2855-2857, 2008.